Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
" •• .;;: "~""'" p •• - ......... - ~., -
SUPREt·1E COURT - STATE OF CALIFORNIA
THE PEOPLE OF THE STATE OF CALIFORNIA,
) ) ) ) } ) ) ) ) ) ) ) )
SUPREME COURT NO.~M J. c/-S-.f')..,
Plaintiff-Respondent,
vs.
KEVIN COOPER,
Defendant-Appellant.
FROM SAN DIEGO COUNTY
HON. RICHARD C. GARNER, JUDGE
San Diego County Superior Court Case No. CR 72787
REPORTERS' TRA~CRIPT
VOLU~E ~ /." '-lJq'l December December
5, 1984, Pages ~ through 4528 6, 1984, Pages 4529 through 4625
APPEARANCES:
For the Plaintiff and Respondent:
For the Defendant and Appellant:
JOHN K. VAN DE KAMP Attorney General State of California 110 West -A- Street San Diego, Ca. 92101
IN PROPRIA PERSONA
ROBERT L. ROACH, CSR 11727 DONNA D. BEARD, CSR 11874 Official Reporters San Diego County Superior Court 220 West Broadway San Diego, California 92101
:n U ,
I , , ,:. J ,-o
-.( o
IN THE SUPERIOR COURT OF THE STATE OF CALIFORNIA
IN AND FOR THE COUNTY OF SAN DIEGO
DEPARTMENT NO. 30
THE PEOPLE OF THE STATE OF CALIFORNIA,
Plaintiff,
va.
KEVIN COOPER,
Defendant.
HON. RICHARD C. GARNER, JUDGE
) ) ) ) ) ) ) ) ) ) )
NO. OCR-9319
----------------------------------)
APPEARANCES:
REPORTERS' TRANSCRIPT December 5, 1984
For the People: DENNIS KOTTMEIER District Attorney
For the Defendant:
WITH: JOHN P. KOCHIS Deputy District Attorney 1540 Mountain Avenue Ontario, California 91762
DAVID L. McKENNA Public Defender BY: DAVID E. NEGUS Deputy Public Defender 1060 West Sixth Street Ontario, California 91762
ROBERT L. ROACH, CSR .1727 DONNA D. BEARD, CSR .1874 Official Reporters
COMPUTERIZED TRANSCRIPT
,-, U , , , , .,~
J ,-a , ,
3
/:----, <
t
~-)
roR ~_ PEOPLE;
GREGONIS, DANIEL J. (Mr. Kochis) (Mr. Negus)
INDEX OF WITNESSES
Direct Cross
4398 4479
COMPUTERIZED TRANSCRIPT
i
Redirect Recross
n U
~ , -j
I . ti :; .-,-W
-t-O
INDEX OF EXHIBITS
Ideo.
5-G Plastic overlay 4473 for Exhibit 5
6-F Plastic Overlay 4400 for Exhibit 6
592 Chart - Phisiological 4425 Fluids from Ryen Home
593 Chart - Phisiological 4464 Fluids from Lease Home
594 Chart - Phisiological 4469 Fluids from Ryen Car
596 Chart - Blood types 4445 of Other Parties
597 3 x 5 Black & White 4443 Amount of Sample A-41
598 Chart - Butcher Paper 4503 Time Lines
COMPUTERIZED TRANSCRIPT
ii
10 Evd.
. ,-, U , , -, ,
.. --, :; .o ·0 .. ::I
... - "'-._ ..
1
2
3
4
5
4394
SAN DIEGO. CALIFORNIA. WEDNESDAY. DECEMBER S. 1984 9:30 A.M ••
--00000-
(Chambers conference reported.)
THE COURT: All right.
6 For the record, we're in chambers out of the
7 presence of the jury, all counsel and the defendant.
8
9
MR. KOCHIS: Your Honor, when we broke yesterday at the
evening recess, it was my desire to ask Mr. Gregonis what the --
10 based on the survey conducted by the FBI, what the approximate
11 population was of the United states of America, and what
12 percentage of the population was black.
13 There was an objection, and the Court was going to
14
15
16
17
18
19
20
21
22
23
24
25
26
27
read the Collins case, and perhaps hear additional argument in
the morning and have a ruling as to whether I could ask Mr.
Gregonis those two questions.
THE COURT: The two questions again are what? What the
population of the blacks are in the United States?
MR. KOCHIS: Population of the people in the country, in
the United States, and what percentage, according to the survey,
are blacks.
THE COURT: Okay. I have read the Collins case.
You want to be heard?
MR. NEGUS: Yes. The only rational, the only grounds
that it could be relevant is if they are going to quantify and
attempt to quantify the number of people in the country that
might have the same blood type as Mr. Cooper. That cannot be
28 done.
COMPUTERIZED TRANSCRIPT
"n u , , , , . I:' J ,
. , . " U
f--·
4395
1 What the information that has been collected is is
2 frequencies of various genes in a limited population. Nobody
3 has ever done a census to try and determine how many people
4 there are with a given gene frequency.
5 The information in its relevant precise form is
6 what the frequency is. Attempting to quantify is (A) misleading
7 because there is no way you could tell from frequencies whether
8 in fact the expected amount turns up or not. It could be a
9 hundred times less, a hundred times greater, and as these
10 particular frequencies are done by multiplying individual
11 frequencies together, the grounds for error even gets greater.
12 In attempting to quantify I would say that what
13 they're trying to do is the same sort of principle as involved
14 in People versus Collins. How many people are there that could
15 fit this particular profile.
16 We don't -- basically, population geneticists at
17
18
19
-20
21
22
this time don't know the answer to that question, and that
encourages speculation on inaccurate and misleading grounds, and
it is not -- there is
THE COURT: Do you claim that any of the quantitative
figures used by Mr. Gregonis thus far were given without
inadequate foundation? That is, so many people of the black
23 population have this ABO breakdown, so many have a secretor, so
24 many have these enzymes and proteins. So, we have got a
25 foundation, adequate foundation for each of those things thus
26 far.
27
28
MR. NEGUS: What you have --
THE COURT: which is unlike Collins.
COMPUTERIZED TRANSCRIPT
J , -j , -
f' .
4396
1 MR. NEGUS: But the difference is, the differp.nce is that
2 going from a frequency to a number is not statistically
3 accurate.
4 I mean, statisticians cannot tell you, based upon
5 the kind of studies they did, how many people in the united
6 States have a particular gene type. That is, that's the
7 conclusion that the prosecution wants to draw, and that is not
8 supported by the figures that we have. We don't have that kind
9 of, that kind of, that kind of figures. All we have is
10 frequencies.
11 They've got everything that they need in order to
12 argue the case. But the frequencies don't change whether you
13 have a population of two hundred million, four billion or
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
whatever. I mean, the frequencies are frequencies, and there is
nothing to say that there is, you know, no matter what the
frequencies are you cannot predict how many people in this
particular type have a particular gene type, how many people in
the country.
As they are stated now, without objection, they are
accurate. You try and quantify it it becomes inaccurate,
misleading.
THE COURT: Mr. Kochis.
MR. KOCHIS: Well, your Honor, it seems to me
THE COURT: Are you sure you want to go ahead on it? I
can distinguish it on -- I am sure you can from the Collins
case, based upon the foundation that you have presented, and yet
I can't deny the logic of his statement as well, some of them.
So, I never know. Do you want to take a chance
COMPUTERIZED TRANSCRIPT
.,' . 1-' U , , -, , .--, J -,
, , .:1 .f:
/~-"
1 f-~·
2
3
4
5
6
7
8
9
10
11
12
13
14 ~-
e 15
16
17
18
19
20
21 2
22
23
24
25
26
, 27 \>--.......
28
4397
getting that kind of evidence in? I don't think it amounts to a
hill of beans for you.
MR. KOCHIS: Well, it seems that the two answers I'm
striving to get are matters that the Court could really even
take judicial notice of. There -- I mean, they are matters of
survey is not even asking anybody to speculate on a figure.
There are relative a finite number of people in the country.
THE COURT: So, you are saying then, Mr. Negus is saying,
basically you have gotten everything that you need to permit you
to argue.
MR. KOCHIS: I didn't draw that analysis, but --
THE COURT: You know, if it only occurs in such -- eleven
out of ten million black people, that is pretty persuasive.
Now, what more do you need?
MR. KOCHIS: Everything I can get.
THE COURT: Well, you know, as a risk to getting it in, I
am not trying to talk you out of it: push your point if you
wish.
MR. KOTTMEIER: I guess one thought maybe, your Honor.
There may be one of the jurors that has a general idea of what
the population is for any of these things and you might find
them bringing that in, and it might be better to have the
accurate figure as opposed to somebody pulling the number out of
the air, saying, yeah, I know how many there are in the United
States and here it is.
MR. KOCHIS: I will think about that area further before
I ask the question. I doubt Mr. Gregonis is going to be done
testifying today.
COMPUTERIZED TRANSCRIPT
. 1-' U
I , -, , I-' J ,
. , .:1 J
1
1
2
3
4
5
6
7
8
9
10
11
THE COURT: All right, we will take it up later.
Okay, let's go.
How do you feel, Mr. Cooper?
MR. COOPER: I'm all right.
THE COURT: Good.
(Chambers conference concluded.)
(The following proceedings were held in
open court in the presence of the jury:)
THE COURT: I bid you good morning.
4398
12 Everybody is present.
13 Mr. Kochis, you still have Mr. Gregonis on the
14 witness stand.
15
16
17
18
19
20
21
22
23
24
25
26
27
MR. KOCHIS: Thank you, your Honor.
DANIEL J. GREGONIS,
called as a witness on behalf of the People, having been
previously duly sworn, resumed the stand and testified further
as follows:
DIRECT EXAMINATION (Resumed)
BY MR. KOCHIS:
Q. Mr. Gregonis, returning for a moment to where we
left off yesteraay afternoon, specifically back with Exhibit
589.
So there is no confusion, for the record, of the
28 six people on the chart, is it accurate to say they are all ADA
COMPUTERIZED TRANSCRIPT
L
'n u I , , ,
. ,:. J ,
. , ·LI ,
1
2
3
4399
type 1, AK type 1?
A. Yes, sir.
Q. NOw, when we finished yesterday afternoon you were
4 talking about frequency with which the defendant's genetic
5 profile would appear in the black population, and I believe when
6
7
8
9
we left off yesterday you mentioned that frequency was eleven
out of every ten million persons. Right?
A. Yes, sir.
Q. And as I recall you qualified that somewhat and
10 indicated that that was a frequency with which the defendant's
11 profile would appear in a population of black persons.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, sir, that is correct.
Q. Could you perhaps then add on the chart, under the
ten million, could you put a line, and could you put a B period,
H period to indicate that is the frequency within the population
of people that have black heritage.
A. (Witness complied).
Q. You may resume your seat for a moment.
Now, did you use the results that you got on this
Exhibit, on 589, to compare against the profile of some stains
that you analyzed in the course of your job in this case?
A. Yes, I did.
Q. And did you, for example, analyze serologically a
number of stains which, through laboratory identification
number, you were able to identify as being collected by Mr.
Stockwell from the Ryen home in this case?
A. That is correct, yes.
Q. Were they essentially the -A- series of stains?
COMPUTERIZED TRANSCRIPT
·le
." U , , -, , ., J ,
. , .. 1: .J
1
2
A.
Q.
4400
Yes, sir.
Were those stains removed by yourself from some
3 location in the lab to be analyzed?
" A. They were removed by myself from the freezer in our
5 laboratory.
6
7
8
9
10
Q.
A.
Q.
A.
Q.
Serological freezer?
Yes, sir.
Do do you have those results with you?
Yes, I do.
NOw, directing your attention to an exhibit which
11 has previously been identified as Exhibit 6; it's been
12 previously identified as a diagram of the Ryen home.
13 For the record, over that we've placed two pieces
14
15
16
17
18
19
20
21
22
23
24
25
26
27
of clear plastic. One has been marked for identification as
6-F, and it was the clear plastic that was filled out by Mr.
Stockwell indicating the various location of the -A- series
items in the Ryen home.
And over that we have placed Exhibit 6-H, an
exhibit that you will be working with here in the courtroom.
And the record should reflect that in black ink I'm
going to put -D. Gregonis- for your name.
Did I spell that last name correctly?
A. Yes, you did.
Q. And today's date, which is -12-5-84- and -Ryen
Home-, so the jury will later know to what this piece of clear
plastic applies.
NOw, starting with, for example, A-2, does A-2
28 correspond to the laboratory identification number that was
COMPUTERIZED TRANSCRIPT
-,-, U , , -, ,
-ID :J -,
- , 6
4401
1 assigned to some blood that was removed from a telephone which
2 was located in the Ryen home?
3
4
A.
Q.
Yes, it does.
And did you undertake some efforts to serologically
5 type that bloodstain to determine the profile of the person that
6 left the blood on the telephone?
7
8
9
10
11
A.
Q.
A.
Q.
A.
Yes, I did.
what results did you get?
Specifically what results?
Yes.
Okay. As far as the results from the telephone, I
12 analyzed it, I found it was blood, it was human blood, it was
13 ABO type A, EsD type 1, PGM type 2-1, EAP type BA, ADA, type 1,
14 AK type 1, Gc result was negative, my Transferrin result is a
15
16
17
18
19
20
21
22
23
24
25
26
27
28
type C, my CA II result is a type 1, my PEPA result is type 1,
my PGM subtyping result is a type 2+1+, and my Haptoglobin
result is a type 2-1.
Q. NOW, did that profile genetically, the profile of
any of the six persons as being the victims and the defendant's
whose profile are defined on Exhibit 589?
A. Yes, it does.
Q. Which one?
A. It matches the profile of Doug Ryen.
Q. Could you then indicate, perhaps with a red felt
pen, that should be in front of you on the witness stand, could
you use the word name -Doug- over the A-2 on the diagram that
Mr. Stockwell has placed.
A. Yes, I can.
COMPUTERIZED TRANSCRIPT
-,-, U
• , , , ., J ,
. , ., ,
2
4402
1 MR. NEGUS: I would object to that procedure, your Honor.
2 There is no -- Mr. Gregonis can only say consistent with the
3 blood of a certain person and we donlt have all the different
4 people that could be.
5
6
THE COURT: Do you want to voir dire?
MR. KOCHIS: Well, perhaps I could let him indicate at
7 the top of the plastic that his results are going to be
8 consistent with. I thought we made that clear yesterday as to
9 what frequency of Mr. Ryenls profile was in the proposed
10 population.
11 THE COURT: I donlt think you need to so indicate, I will
12 overrule the objection.
13 MR. NEGUS: How about they have gone to match as opposed
14 to the consistent With.
15
16
17
ahead.
THE COURT: Rephrase your question in such a manner. Go
MR. KOCHIS: Well, the question I asked, was it
18 consistent with anybody on the chart.
19
20
21
22
THE COURT: All right.
THE ~HTNESS: Well, yes, it is.
BY MR. KOCHIS.
Q. For example, is it fair to say that biologically it
23 is impossible for that stain to have COme from Peggy Ryen?
24
25
26
27
28
A. That is true, yes.
Q. And it is impossible for that stain to have come
from Jessica Ryen?
A. Thatls true, yes.
Q. And it is impossible for that stain to have come
COMPUTERIZED TRANSCRIPT
-,--.J -
··C L
1
2
3
from Chris Hughes?
A. Yes.
........ ~ •
4403
Q. And it is impossible for that stain to have come
4 from Joshua?
5
6
7
8
9
A.
Q.
A.
Q.
Yes.
And that it could not have come from Kevin Cooper?
That is correct. yes.
" But that stain could have come from perhaps six and
a half out of another thousand people who have a profile which
10 is identical to Doug Ryen's.
11
12
13
A. That is correct, yes.
Q. So you are --
MR. NEGUS: Objection, I think that assumes a fact not in
14 evidence, too, because the percentage of the stain of the people
15
16
17
18
19
20
21
22
23
24
25
26
27
28
who could donate the stain are not the same as the percentage
that he has up there for Doug Ryen.
BY MR. KOCHIS:
Q. The bloodstain A-2, Doug Ryen is not the only
person genetically perhaps in the country that could have
deposited that stain.
A. That is correct, yes.
Q. But that stain certainly is consistent with coming
from his body: isn't that true?
A. That is correct, yes.
Q. Could you then indicate on t3e diagram on A-2 his
first name.
A. Yes, I can. (Witness complied).
Q. NOw, while I have you at the board, did you
COMPUTERIZED TRANSCRIPT
-n u , , , , 1:1 :I , ,
-0 ,J
'- ----_.
. ~.
440.4
1 likewise perform a series of serological tests on an item that
2 was identified by a number in the lab, A-3, which appeared to be
3 a long piece of rope that had what appeared to be bloodstains on
4 it?
5
6
A.
Q.
Yes, I did.
And did you perform certain serological tests on
7 the rope itself?
8 A. Yes, I did.
9 Q. What conclusions did you reach at the end of the
10 testing on the rope?
11 A. I had a number of results from a number of
12 different enzymes and my conclusion on A-3 is that it is
13 probably a mixed stain due to some of the results that I did
14
15
get •
Q. Is there any result in particular that leads you to
16 the conclusion that the blood on that rope was mixed?
17
18
19
20
21
22
23
24
25
26
27
A. Both the EAP and the Haptoglobin types indicate to
me that it is a mixed type.
Q. Now, when you're talking about mixed, for the jury,
are you talking about, for example, simply the blood of more
than one human being on that rope?
A. Yes, I am.
Q. Could you perhaps just indicate with the word
-mixed- over A-3.
A. Yes, I can. (Witness complied).
Q. NOw, let me ask you this, though.
Your conclusion that the blood was mixed, the
28 results themselves, were the results consistent with the
COMPUTERIZED TRANSCRIPT
J , -I ,
" ,:i ,,U
". , .. LJ
1
2
3
4405
profiles of any of the victims just taken on their face?
A. No, theylre not.
Q. Was it consistent with the blood of more than one
4 victim being mixed on that rope?
5
6
7
8
9
A. Yep, it is.
Q. Which victims, if any?
A. possibly either Jessica Ryen and Doug Ryen, or
Peggy Ryen and Doug Ryen.
Q. You can resume your seat for a moment.
10 Did you likewise conduct serological tests on
11 various samples of the comforter that were seized in this
12 particular case?
13
14
15
16
17
A. Yes, I did.
Q. And were those the samples that were labeled, for
example, the A-s series?
A. Yes, sir.
Q. Did you test certain samples of the comforter that
18 came from the top of the comforter, which I believe were
19 numbered A-Sa through A-sn?
20
21
22
23
24
25
26
27
28
A. Yes, I did.
Q. Now, on the comforter samples, were you able to get
genetic profiles which were as complete as the profiles that you
have talked to the jury about on s89?
A. No, I was not.
Q. Is it fair to say that information you got from the
sheets was more limited?
A. That is true, yes.
Q. Were there some stains on the -- 11m sorry -- on
COMPUTERIZED TRANSCRIPT
r '-•
of ... ..
-:"
3
4406
1 the comforter, in which you were only able to get the ABO and
2 perhaps the CA II?
3
.. A.
Q.
Yes, sir.
Was A-Sc, I believe, a stain that gave you
5 information which was more complete than that?
6
1
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
2l
24
25
26
27
28
A. Yes, it is.
Q. And can you tell the jury which enzymes you were
able to reach a conclusion on and what the results were?
A. Yes, I can.
Okay. First of all, I analyzed the stain to see if
it was blood. It is blood, of human origin,
THE COURT: A-Sc now.
THE WITNESS: Yes, your Honor.
It is an EsD type 1, PGM type 2-1, EAP type BA, ADA
type 1, AK type 1, the Haptoglobin or Hp is negative, along with
the Gc also being negative. The Transferrin is a type C, the CA
II is a type 1, the PEPA is negative again, and the PGM
subtyping is a 2+1+.
BY MR. KOCHIS:
Q. Was that -- were those results consistent with the
genetic profile of any of the six persons whose names appear on
the chart?
A. Yes, it is.
Q. Who?
A. Doug Ryen.
Q. Were you able to get a result or some results on
the stain which was labeled A-Sf?
A. Yes, I was.
COMPUTERIZED TRANSCRIPT
n u , , , ,
. '-, :; '-, o .J t.
.......... '.-.-"-~.
1
2
o. A.
4401
What results did you get?
Okay. Again, I analyzed it to see if it was blood,
3 to see if whether it was human blood, which it was. The ABO is
4 consistent with an ABO type B. The EsD type was negative, the
5 PGM type is a type 1, the EAP type is inconclusive, the ADA and
6 the AK are both types lis, the Gc type is inconclusive, the
7 Transferrin is inconclusive. The Haptoglobin or Hp is a type 1,
8 the CA II is type 1, the PEPA is negative, and the PGM subtyping
9 is negative. -.. ~.;,;.:
10 Excuse me. I also did get Transferrin's on that at
11 another run which was type C.
12 o. Were those results consistent with the genetic
13 profile of any of the five victims in this case?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, sir.
Q. Which victims?
A. Peggy Ryen.
Q. NOw, did A~5d, did that appear to be a stain which
may have contained the blood from two people?
A. Yes, it did.
Q. what led you to that conclusion.
A. Basically, my typings along with the physical
appearance of that stain looks like a mix stain.
Q. When you talk about the physical appearance of that
stain, A-Sb, what lead you to the opinion that it may have been
from more than one person?
A. Just looking at the stain it appears that there are
two overlapping bloodstains to it, that are kind of smeared
28 together.
COMPUTERIZED TRANSCRIPT
n u , , , ,
- ,--, :; ,--, o J J
4408
1 Q. What about the results gave you an indication that
2 stain was the blood of more than one person?
3 A. Okay. Again, the mixed results from that on the
4 ABO and several of the enzymes look like it may be a mixed
5 stain.
6 Q. The actual results themselves, did that profile --
7 was that profile consistent with the profile of any of the two
8 of the victims?
9 A. If you look at the results on any of the two
10 victims, yes.
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Q. Was that essentially Mr. and Mrs. Ryen?
A. That is correct, yes.
Q. Now, other than the three stains from the top that
we have talked about, did you analyze the other stains of the 5a
and Sn series?
A. Yes, I did.
Q. Did those stains give you varying amounts of
information depending on how many tests you were able to get a
result on?
A. Yes, it did.
Q. Were the remainder of those stains, were they all
then consistent -- with the limited information you received
from them, were they all consistent with coming from Doug Ryen?
A. With the exception of A-5q and A-Sr, yes, they are.
Q. So, the limited profile on the stains, other than
26 the five, the- three we have talked about, two we're going to
27 talk about, those were consistent with, in the limited sense,
28 that you got profiles with Doug Ryen's profile?
COMPUTERIZED TRANSCRIPT
'£j~';";
" U ~ , , ,
'0 :J
" CI tJ I
,
I
"
L".,..
1
2
3
4
A.
o. A.
o.
4409
Yes, sir.
And be consistent with him bleeding on the sheets?
Yes, sir.
Now the two that you mentioned, A-Sq and A-Sr, were
S those -- do your notes reflect those were actually taken off the
6 bottom of the comforter?
7
8
9
10
A. Yes, they do.
o. Now, did either of those stains -- let's start with
o. Did Q appear to be a mixed stain?
A. Q is possibly a mixed stain. I got low, if not
11 inconclusive, results for what are called a A Antigen on the ABO
12 type.
13
14
IS
16
17
18
19
20
21
22
23
24
25
26
27
Q. Did you find the presence of any other Antigens at
that location.
A. Yes, I did. The B Antigen.
O. SO, was the low level of the presence of the A
Antigen, did that lead you to what is called an inconclusive
result?
A. Yes, it did.
Q. If there is only the B Antigen present that's an
indication of a person whose an ABO type B; is that correct?
A. That is correct, yes.
Q. Excuse me. In this case Josh Ryen is an ABO type
B; is that correct?
A. That is correct, yes.
O. If you have both the A Antigens present and the AB
Antigen present in a stain, that's an indication of a person
28 whose ABO type AB.
COMPUTERIZED TRANSCRIPT
." U , , , , -" :;
" CI ,-J
' ... -"~'.- -"-
f~'
4
l . .......
1
2
3
4
A.
Q.
A.
Q.
That is correct, yes.
Now, you have to answer the question.
That is correct, yes.
4410
And, in this case we have two such people, those
5 being mother and daughter, Jessica and Peggy.
6
7
A.
Q.
Yes, sir.
Was there anything about the stain itself which
8 caused you to believe that it might have been mixed?
9 A. Except for the very low level of A, no. That is
10 basically it.
11 Q. Were you able to get any of the enzymes or serum
12 proteins on that stain?
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, I was.
Q. Were those results consistent with coming from
either the mother or the daughter?
A. They could be consistent with coming from Peggy
Ryen.
Q. The other stain you mentioned was the R stain.
Were you able to get an ABO on the R stain?
A. Yes, I was.
Q. Was that ABO type AB?
A. Yes, it is.
Q. Consistent with either the mother or the daughter.
A. Yes, sir.
Q. \'lere you able to run some and successfully complete
some enzyme and serum protein tests on the R stain?
A. Yes, I was.
Q. which ones?
COMPUTERIZED TRANSCRIPT
", U
~ , , , . " :i o la, ,a
1
4411
1 A. The successful ones are the EAP, which is type B
2 and the Haptoglobin, or Hp, which is a type 1.
3 Q. Did those results allow you to discriminate between
4 the mother and the daughter as being the possible donor of that
5 stain?
6
7
8
9
A.
Q.
A.
Q.
Yes, sir.
And who is the possible donor?
It is consistent with coming from Peggy Ryen.
The limited results you got then as to the R stain
10 are consistent with Mrs. Ryen's profile?
11
12
A.
Q.
Yes, sir.
But is it fair to say that unless you were actually
13 there watching her bleed onto the sheets, you can't say with
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
absolute certainty that this blood stain came from Peggy Ryen.
A. That is correct.
~s,-ma~<: Q. Could it have come from another person that had her
profile?
A. Yes, sir.
Q. The remainder of the samples on the bottom of the
comforter that you analyzed, other than the Rand Q stain, are
they consistent with coming from a person who had the genetic
profile of Doug Ryen?
A. Yes, sir.
Q. Turning to the sheets, the bed sheets, and perhaps
starting with the top sheet, did you analyze the number of those
stains as well?
A. Yes, I did.
COMPUTERIZED TRANSCRIPT
", U , , , , o :J ,--, CI , ,
, '_.
4412
1 Q. And did you analyze a number the stains on A-10,
2 the bottom sheets?
3
4
A.
Q.
Yes, I did.
Starting with A-8c, did you analyze that particular
5 stain?
6
1
8
9
10
11
A.
Q.
A.
Q.
A.
Q.
A-8c?
Yes.
Yes, I did.
And was there any indication that stain was mixed?
No, there was not.
Were you able to get a complete profile, a profile
12 as complete as you were on Exhibit 589 or did you get somewhat
13 limited results?
14
15
16
11
18
19
20
21
22
23
24
25
A. I got somewhat limited results on that stain.
Q. What results did you get, which ones?
A. Do you want the types also?
Q. Yes.
A. Okay. It is ABO type AB. PGM type 1. AX type 1,
and that's all I was able to get.
Q. Is that consistent with coming from either the
mother or the daughter in this case?
A. Yes, it is.
Q. Did you also find evidence of a stain, evidence of
two stains which were consistent with being deposited either by
Peggy Ryen, the mother, or by someone who had her genetic
26 profile, those being A-8e, and A-Sk?
21
28
A.
Q.
Yes, I did.
Were you able to get a complete profile on those or
COMPUTERIZED TRANSCRIPT
i
L
'n u , , -, , 9 o [J
·0 o
; 0...,. •.
4413
1 not?
2
3
A.
Q.
NO, I was not.
What results, for example, did you get first on the
4 A-8e stain?
5 A. On the A-8e I got ABO type AB, PGM type 1, EAP type
6 B, AK type 1, haptoglobin or Hp type 1, and a CA II type 1.
7 Q. And that's consistent then with either Peggy Ryen
8 bleeding on though to the sheets or another person who happened
9
10
11
12
to have her profile in those catagories bleeding on the sheets?
A. Yes, sir.
Q. Do you recall what the results on K were?
A. Yes, I do. These were ABO type AB, EAP type B, AX
13 type 1, and Hp type 1.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Q. And likewise was that consistent with a person. of
either Mrs. Ryen's profile or Mrs. Ryen herself?
A. Yes, sir, it is.
Q. Now, the other stains on the top sheet that you
analyzed, were they all consistent with either coming from Mr.
Ryen or a person of his profile, just on A-a? • A. Yes, they are.
Q. SO, at this point, based on the comforter and the
top sheet, you had blood which is consistent by being shed by
the victims while they were attacked in their home?
A. Yes, sir.
Q. Did you likewise perform tests on A-I0?
A. Yes, I did.
Q. NOW, did you find blood on that sheet that is
28 consistent with either coming from Chris Hughes or a person who
COMPUTERIZED TRANSCRIPT
,-, U
I , -, , I-' :I o (J
·CI ::J
1
2
3
4
4414
had his profile, and specifically A-lOe?
A. Yes, I did.
Q. what results did you get on that stain?
A. As far as the results, I did find that it was hUman
5 blood. The ABO was inconclusive, PGM is a type 1, AK is a type
6 1, transferrin or Tf is a type C, CA II is.a type 1, and PGM
7 subtyping is a type 1+.
8
9
10
11
Q. Now. the H stain, the A-lOh, was that a stain that
all you could get was that it was blood and that it was human?
A. That is correct, yes.
Q. The other stains on that bottom sheet, the A-lO
12 series other than Hand E -- excuse me.
13 Did you analyze F, A-lOf?
14
15
16
17
18
19
20
21
22
23
24
25
26
27'
A. Yes, I did.
Q. And what results did you get?
A. Okay. As far as the results, again it's human
blood. It is -- as far as the results that I did get, it's an
EAP type B, AK type 1, a Tf or transfe~rin type C, a Hp type 1.
Q. What was the ABO type?
A. AB.
Q. And was that consistent with coming from either
Mrs. Ryen or a person that had her profile?
A. That is correct, yes.
Q. New, other than those stains, other than F, E and H .
on the A-lO series, the stains which came from the bottom sheet,
were they all consistent with coming from Doug Ryen while he was
bleeding or from a person that happened to match his genetic
28 profile?
COMPUTERIZED TRANSCRIPT
, " U ~ , , ,
, " J
" :; , ,~
LI
2
1
2
A.
Q.
4415
Yes, they are.
Moving back to the chart, specifically to A-26, the
3 blood that was taken from the carpet beneath Chris Hughes, were
4 you able to analyze that serologically?
5
6
A.
Q.
Yes, I was.
What results, could you tell the jury what results
7 you were able to obtain?
8
9
A. Okay. As far as the results, it is blood of human
origin. It's an ABO type 0, EsD type 2-1, PGM 1, PGM 1, EAP BA,
10 ADA type 1, AK 1, CA II 1, PEPA a 1, Gc is negative, Tf is C,
11 and the PGM subtyping is a type 1+.
12 Q. Was that in fact consistent with the genetic
13 profile of Chris Hughes?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, it is.
Q. And again, that's consistent with being shed by
Chris Hughes after he was attacked or being shed by a person
that had his same genetic profile that was able to get his blood
underneath Chris Hughes' body; is that correct?
A. Yes, sir, it is.
Q. Could you step to the diagram and could you locate
A-26 on the diagram, and could you put ·Chris· above that
number?
A. Above it?
Q. Right on top of the A-26 actually.
Did you likewise analyze A-27 , the blood which was
taken from the carpet underneath where Mrs. Ryen's body lay?
A. Yes, I did.
Q. Were you able to get a genetic profile?
COMPUTERIZED TRANSCRIPT
." U , , , ,
. ,:I :I o ::J , ,
("" 1
2
3
A.
Q.
A.
4416
Yes, I did.
what profile did you get?
Okay. Again it is blood of human origin. It is
4 ABO type AB, Esd type 1, PGM type 1, EAP type B, ADA type 1, AX
5 type 1, Hp type 1, Gc is negative, Tf is a type C, with CA II
6 type 1, PEPA type 1, and PGM subtyping type 1+ 1-.
1 Q. Was that consistent with the profile of the
8 daughter Jessica Ryen?
9
10
11
12
A.
Q.
A.
Q.
A-27?
I'm sorry, with Mrs. Ryen Peggy Ryen?
Yes, it is.
So that was consistent with either being shed by
13 Peggy Ryen or by having someone that had her profile getting
14 their blood underneath Mrs. Ryen?
15
16
17
18
19
20
21
22
23
24
2S
26
21
28
A. Yes, it is.
Q. Could you indicate perhaps over A-27 the word -Peg-
for Mrs. Ryen?
A. Yes, sir.
Q. Did you analyze A-2B, the blood which was removed
from underneath Jessica Ryen, the pool of blood?
A. Yes, I did.
Q. Were you able to get results?
A. Yes, I did.
Q. Were those results consistent with the genetic
profile of Jessica Ryen?
A. Yes, they are.
Q.
A.
Could you tell the jury what the results were?
Okay. The results, again it's blood of human
COMPUTERIZED TRANSCRIPT
n u , , -, ,
'l~' J l~' J
.:1
.(
(---
1
, ..........
( ~'.
4417
1 origin. It's ABO type AB, EsD type 1, PGM type 1, EAP type BA,
2 ADA type 1, AK type 1, haptoglobin or Hp is a type 2-1, Gc was
3 negative, Tf is a type C, CA II type 1, PEPA type 1, and a PGM
4 subtype which is a 1+ 1-.
5 Q. Could you indicate on the diagram next to that
6 number, which I believe is A-27, ·Jess· for Jessica?
7
8
9
A. Yes, sir.
Q. And with the last pooled sample, A-30, the blood
which came from underneath Mr~ Ryen, were you able to perform
10 certain serological tests on that sample?
A. 11 Yes, sir, I was.
Q. 12 Were the results consistent with coming from Doug
13
14
15
16
Ryen?
A.
Q.
A.
Yes, sir, they were.
What were those results?
Okay. Again it's blood of human origin. It's an
17 ABO type A, EsD type 1, PGM type 2-1, EAP type BA, ADA type 1,
18 AK type 1, CA II type 1, PEPA type 1, Gc type 2-1, Tf type C,
19
20
21
22
23
24
25
26
27
28
and PGM subtype type 2+ 1+.
Q. Could you indicate -Doug- over that particular
letter and number to indicate whose blood it's consistent with?
A. Yes, sir.
Q. NOW, starting to move around the room away somewhat
from the victims, did you analyze A-31, the blood which came I
believe from the southeast wall dresser?
A. Yes, I did.
Q.
A.
Were you able to get some results?
Yes, I did.
COMPUTERIZED TRANSCRIPT
, , - " :1 ,-~ -, -j
,. •..
4418
1 Q. Were those results consistent with the genetic
2 profile of any of the victims?
3
4
5
6
7
A.
Q.
A.
Q.
A.
Yes, they are.
Which victim?
Of Doug Ryen.
Could you indicate what those results are?
Okay. That blood -- that stain is blood of human
8 origin. It's type ABO A, EsD 1, PGM 2-1, EAP BA, ADA 1, AK 1,
9 Hp type 2-1, Tf type C, Gc was negative, CA II is a 1, PEPA is
10 again negative, and PGM subtype was a negative.
11 Q. Could you then indicate over the A-3l the name
12 "Doug" for Doug Ryen?
13
14
A.
Q.
Yes.
Now, serologically what that would mean is that at
15 one point Mr. Ryen's blood or a person who had the same profile
16 as Mr. Ryen had their blood deposited at that location?
17
18
19
20
21
22
23
24
25
26
27
28
A. That is correct, yes.
Q. For example, being injured in an attack?
A. Yes, sir.
Q. Bleeding at that location?
A. Yes.
Q. Or having Mr. Ryen's blood come off a weapon and
land at that location?
A. That is another possibility, yes.
Q. Did you likewise perform the same type of test with
A-32?
A. Yes, I did.
Q. And A-33?
COMPUTERIZED TRANSCRIPT
I , -J ,
- .-: :; .--.J
·l I
":~ ...
.,.-'4- ... ____ • __ ._ ~ ~_
1
2
3
4
A.
Q.
A.
Q.
4419
A-33?
Yes.
Yes, I did.
Do your notes reflect at least by identification
S where approximately A-32 came from?
6 A. A-32 from my notes says that it's a white slide box
7 containing blood from east head of bed.
8
9
10
Q.
A.
Q.
Was that blood analyzed serologically?
Yes, it was.
was the profile of the blood consistent with coming
11 from Mr. Ryen?
12
13
14
15
16
17
18
19
20
21
22
23
24
2S
A. Yes, it is.
Q. What results did you get?
A. Okay. On A-32, again it's blood of human origin.
It's an ABO type A, EsD type 1, PGM 2-1, EAP BA, ADA 1, AK 1, Hp
2-1, Tf is a C, Gc is a type 2-1, CA II is a 1, PEPA is a 1, PGM
subtype is a 2+ 1+.
Q. Could you indicate on the diagram over the A-32 the
A. Yes, I can.
Q. Did you likewise perform a set of tests on A-33
through 35?
A. Yes, I did.
Q. And were the results of the prof~les on those three
stains consistent as well as coming from either Doug Ryen or a
26 person that matched his profile?
27
28
A.
Q.
Yes, they are.
Could you tell the jury according to the notes
COMPUTERIZED TRANSCRIPT
n u , , -, ,
, 1:1 :I
" ,J " ,-J
f 1
2
4420
where those samples came from and what the results were?
A. Okay. According to my notes A-33 is a metal pill
3 box identified as containing blood spatter from above east bed.
4 A-34 is a metal pill box identified as containing
5 blood from bed stand. Okay.
6 And A-35 is one metal pill box identified as
7 containing blood from closet doors on west side.
8
9
10
11
12
Q.
A-33 through
A.
type A, EsD
Can you tell the jury the results serologically
A-35?
Yes, I can. Okay.
ABO -- A-33 is the blood of human origin. It's
1, PGM 2-1, EAP BA, ADA 1, AK 1, Hp type 2-l,Tf
of
ABO
C,
13 Gc is negative, CA II is a 1, PEPA is a 1, and PGM subtype is a
14
15
16
17
18
19
20
21
22
23
24
25
26
2+ 1+.
Q. All those three samples are consistent with being
shed by Doug Ryen; is that correct?
A. Yes, they are.
Q. Could you indicate on the overlay with the word
"Doug" his name at those locations, A-33, A-34, and A-35?
A. Yes, I can.
Q. Did you analyze a stain which had the laboratory
identification number of A-36?
A. Yes, I did.
Q. Did your serological results lead you to any
conclusion as to whether or not the stain was mixed?
A. Yes, it did. It -- I believe that the stain is a
27 mixed bloodstain.
28 Q. Why?
COMPUTERIZED TRANSCRIPT
'r, u , , -, ,
0.:1 J o oJ .f: o
2
4421
1 A. Two reasons. One is the ABO result gave -- the
2 forward and reverse test gave results that are inconsistent with
3 any blood type that I know of, and the haptoglobin or Hp simply
4 will collect a mixed bloodstain.
5
6
7
Q.
A.
Q.
Can you indicate then over A-36 the word -mixed-?
Yes, I can.
Turning your attention next to A-37, the stain
-8 removed from the northwest wall near the bathroom exit, did you
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
analyze that stain?
A.
Q.
A.
Q.
victims?
A.
Q.
A.
Q.
were?
A.
Yes, I did.
And did you get a genetic profile?
Yes, I did.
Was that consistent with the profile of any of the
Yes, it is.
Was that Jessica?
Yes, sir.
Could you tell the jury what the results actually
Yes, I can.
Okay. Again it's blood of human origin. The ABO
is consistent with an ABO type AB, EsD is type 1, PGM type 1,
EAP type BA, ADA type 1, AK type 1, Gc is inconclusive, Tf is a
C, Hp is a type 2-1, CA II is a type 1, PEPA is a type 1, and
25 PGM subtype is an 1+ 1-.
26 Q.- And again, was that consistent with being shed by
27 Jessica during or after an attack or by a person with her
28 identical profile?
COMPUTERIZED TRANSCRIPT
, , -Ii J ,-; --1 -
1
2
A.
Q.
4422
Yes, it is.
Could you perhaps place the word ·Jess· at that
3 location on the clear plastic?
.. 5
A.
Q.
Yes, I can.
Did you also analyze A-3a, a stain that came from
6 the location of the bathroom doorjamb, or bathroom door?
7
a 9
10
A.
Q.
A.
Q.
Yes, I did.
And did you get a profile?
Yes, I did.
Is that profile consistent with coming from blood
11 that was shed by Doug Ryen, the father?
12
13
14
15
16
17
were?
A.
Q.
A.
Q.
A.
A-38? No.
I'm sorry, by Joshua.
Yes, sir, it is.
And could you tell us the jury what the results
Okay. Again it's blood of human origin. It's ABO
18 type B, EsD was negative, PGM was negative, EAP is a type B, ADA
l~ is a 1, AK is negative, Hp is a type 1, Gc is a type 2-1, Tf is
20 a type C, CA II, PEPA and PGM subtyping were all negative.
21
22
23
24
25
26
27
28
Q. That's consistent with coming from Josh?
A. Yes, it is.
Q. Could you indicate his name over that location?
A. Yes, I can.
Q. While I have you at the diagram, Mr. Gregonis, you
analyzed A-39, which is a sample taken from somewhere in that
location, I believe the bath doorjamb, is that correct?
A. Yes, sir.
COMPUTERIZED TRANSCRIPT
., "" • , •
....
. , I ~
r~'
4423
1 Q. And is that consistent with the profile, the
2 genetic profile of Josh's father, Doug?
3
4
A.
Q.
Yes, it is.
While you are at the board could you put -Doug-
5 over 39?
6
7
A.
Q.
Yes, I can.
And could you return to your seat and tell the jury
8 what the results of A-39 were?
9 A. Okay. A-39 again is blood of human origin. It's
10 an ABO type AB, EsD type 1, PGM 2-1, EAP BA, ADA 1, AK 1, Gc
11 2-1, Tf C, Hp is a type 2-1, CA II 1, PEPA 1, and PGM subtype is
12 2+ 1+.
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Q. And that's consistent again with coming from Mr.
Ryen?
A. Yes, it is.
Q. Were the serological results obtained from A-40,
the blood from the north wall closet doors, likewise consistent
with coming from the father, Doug Ryen?
A. Yes, they are.
Q. Could you tell the jury what the results are?
A. Okay. Again it's blood of human origin. ABO type
A, ESD 1, PGM 2-1, EAP BA, ADA 1, AK 1, Hp 2-1, Gc 2--1, Tf C,
CA II 1, PEPA 1, and PGM subtype is a type 2+ 1-.
Q. Could you indicate on the chart on the clear
plastic over the location of A-40 the word -Doug-?
A. Yes, I can.
Q. Now did you likewise analyze a drop of one -- a
28 drop of blood which has been given the laboratory identification
COMPUTERIZED TRANSCRIPT
.-'r, u , , -, ,
1-:' :I II .:1 ., :I
4424
1 number of A-41, the blood from the hallway?
2
3
A.
Q.
Yes, I did.
NOw, did you get a genetic profile of the person
4 that may have deposited -- or that deposited that blood?
5
6
A.
Q.
Yes, I did.
Is it fair to say of that genetically it is
7 impossible for that blood to have come from any of the victims
8 in this case?
9 A. That is correct, yes. .
10 Q. And were you able to get results, for example, in
11 the PEPA, the haptoglobin, and the transferrin groups?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, I did.
Q. Did the results of the tests in those groups
indicate whether or not that drop of blood, A-41, was shed by a
person of black heritage?
A. Yes, it does.
Q. And does it indicate it was shed such a person or
not?
A. It indicates that a person of black heritage
deposited that blood, yes.
Q. Let's skip over that drop for a minute and let's go
down to A-42.
Did you likewise conduct a serological test on
A-42, some blood that was found on the north wall on the hallway
across from the bathroom?
A. Yes, I did.
Q. Was the profile of that drop of blood consistent
28 with Jess, one of the victims?
COMPUTERIZED TRANSCRIPT
" U I ,
,o I· II I" LJ I·
.t..
3
1
2
3
A.
Q.
A.
4425
Yes, it is.
Could you tell us the jury what your results were?
Okay. Again it's blood of human origin. It's ABO
4 type AB, EsO 1, PGM 1, EAP type BA, AK 1, ADA 1.
5 And there was an insufficient quantity for further
6 analysis.
7 Q. Did you also analysis A-43, A-44, and A-45, all of
8 which were of blood samples from the carpet in that bathroom,
9 the master bathroom?
10
11
A.
Q.
Yes, sir, I did.
And were the profiles on all three of those samples
12 consistent with being shed by Josh Ryen?
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes, they are.
Q. Could you tell the jury what the results were on
the A-43 through 45 series?
A. Yes, I can. Okay.
Starting with A-43, it is blood of human origin.
The ABO is a type B, EsD type 1, PGM type 2-1, EAP type BA,
excuse me, B, ADA 1, AK 1, Gc is negative, Tf was a type C, Hp
is a type 1, CA II is a type 1, PEPA is a type 1, and PGM
subtype is a type 2+ 1-.
Q. Could you then indicate on the diagram with A-42
with Jess and then A-43 through 45, Josh, indicating the
consistency of the profiles?
A. Yes, I can.
Q. Directing your attention for a movement, Mr.
27 Gregonis, to a chart we've marked for identification as Exhibit
28 592, do you recognize what this is a chart of?
COMPUTERIZED TRANSCRIPT
~
'n u
I , .-, o I-' U ,-, U
• ,
;--""
1
2
A.
o.
4426
Yes, I do.
And is it a chart of the serological results of
3 three of the stains that you analyzed in this particular case?
.. 5
A.
o. Yes, it is.
The first, going from top to bottom, the first
6 stain on the chart, is that the stain we briefly skipped over,
7 the A-41 stain which came from the hallway located in the Ryen
8 home?
9
10
A.
o. Yes, it is.
And is that the serological results of the
11 bloodstain that could not have come from any of the victims in
12 this case?
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. That is correct, yes.
o. Did you start testing that stain back in June of
1983, on approximately June the 9th of 1983?
A. Yes, I did.
o. And did you continue to test that stain at various
times through and into the month of October of 1983?
A. Yes, I did.
O. And have you indicated on the chart the results of
that particular stain?
A. Yes, I have.
O. You tested that stain according to the chart, did
you not, to determine whether or not it was blood?
A. Yes, sir.
O. And was it blood?
A. It is blood, yes.
O. And did you likewise test it to determine whether
COMPUTERIZED TRANSCRIPT
'rl U , , .--, o
." u " u .J L
r"
;,""---,
4421
1 it was blood from a human being or from a reptile or something
2 else?
3
4
A.
Q.
It is is human blood, yes.
NOw, did you -- you performed a test on A-4l to
5 determine what the ABO type of that stain was, is that correct?
6
1
A.
Q.
Yes, I did.
And the ABO type of the person who shed that blood
8 was what?
9
10
A.
Q.
Is an ABO type A, or that person is an ABO type A
Did you perform the forward and the reverse test on
11 that stain or was there enough there?
12
13
14
A. I did both the forward and reverse, yes.
Q. NOW, does any of the six persons on the chart,
which is the 589, any of those people were the same blood type
15 as the person who deposited A-4l?
16
11
18
19
20
21
22
23
24
>'25
26
27
28
A. As far as ABO?
Q. ABO only.
A. Yes. Both Doug Ryen and Kevin Cooper are ABO type
A, so they are consistent with that.
Q. SO, with the first three columns from left to
right, going only that far, that stain is consistent by being
shed by Kevin Cooper.
A. Yes, sir.
Q. Doug Ryen?
A. Yes, sir.
Q. And all the other people that happen to have ABO
type Als?
A. That is correct, yes, sir.
COMPUTERIZED TRANSCRIPT
o o , ,-, U
" ,U
3
" -==t
4428
1 Q. Then you also did the group one test on that stain
2 using the multisystem; is that correct?
3
4
A.
Q.
Yes, I did.
And were you able to get results for both the EsD
5 and the PGM?
6
7
A.
Q.
Yes, I was.
And the person that deposited that stain, the A-41
8 stain, what is that person's EsD and PGM type?
9
10
A.
Q.
That person is an ESD type 1 and a PGH type 1.
NOW, does Mr. Cooper have different EsD and PGH
11 types or the same EsD and PGM types as A-41?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
A. He has the sa~e EsD and PGM type as A-41.
Q. Turning to the other person on the chart who is an
ABO type A, Doug Ryen, is his PGM type consistent with the PGM
type of A-41?
A. No, it is not.
Q. So, when you get up through the first multisystem
test running the EsD and the PGM, is it fair to say tha"t you can
exclude Doug Ryen as being the human being that deposited that
drop of blood in the hallway in the Ryen home?
A. Yes, it is.
Q. However, is that blood consistent with coming from
the defendant in this case, Kevin Cooper?
A. Yes, it is.
Q. The Group II system, is that the EAP, the ADA and
26 the AX?
27
28
A.
Q.
Yes, it is.
And did you get results from that system when you
COMPUTERIZED TRANSCRIPT
, ... ,.; ... -
. " U I ,
1-' o ,-, u ,-, U
L' ,
- " '-'-.--. -. -.~~.- --~ -
4
4429
1 ran it in the laboratory when you were conducting your
2 investigation in this case?
3
4
A.
Q.
Yes, I did.
And do you recall the date at which you first got
5 the results that you could read for all three enzymes?
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, I do.
Q. When was that?
A. This would be -- I ran the test overnight starting
on the 2nd, so I would have read it on the 3rd of August, 1983.
Q.
A.
Q.
A.
Q.
defendant's?
A.
Q.
A.
Q.
A.
Q.
A.
Q.
type?
A.
Q.
A.
Q.
And did you get an AK result?
Yes, I did.
What did you call it?
It was a type 1.
And is that the same AK type, for example, of the
Yes, it is.
Did you get an ADA type?
Yes, I did.
What type?
Type 1.
And is that the same ADA type as the defendant?
Yes, it is.
NOW, back in Augu~t of 1983, did you get an EAP
Yes, I did.
And what did you call it?
I called it a B at that time.
Did you also run Mr. Cooper's blood at that time?
COMPUTERIZED TRANSCRIPT
''-, U , , " o
. " U
" U
·C -'
1
2
3
4
5
6
7
8
9
'-- ... ::-.=:-'
A.
Q.
A.
Q.
A.
Q.
A.
Q.
Yes, I did.
And did you get a result, an EAP result?
Not that same day, no.
Did you get one on about August the 5th?
Yes, I did.
And what did you call his EAP type?
A type B.
4430
Back in August when you ran the test did the EAP
type of A-4l according, to your analysis was it the same EAP
10 type as the EAP type of Mr. Cooper's blood?
11
12
A.
Q.
Yes, it was.
NOW, you now -- had you ever seen an RB that you
13 knew of when you ran A-41 back in August?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. No, sir.
Q. Did you take a photograph of the electrophoretic
run that you ran back in August of A-4l?
A. Yes, I did.
Q. Have you since gone back to that photograph to
attempt to read the photograph?
A. Yes, I have.
Q. Now, you have since done some additional testing on
Mr. Cooper's blood; is that right?
A. Yes, I have.
Q. And at this point you know that he is what is
called an RB; is that correct?
A. That is correct, yes, sir.
Q. Have you gone back to the photograph of A-4l to
28 read it?
COMPUTERIZED TRANSCRIPT
'n u , , 1-' CI ." u
" u
6
1
4431
A. Yes, sir, I have. 1
2 o. And would that be to determine whether or not there
3 is an -- Let me stop for a minute.
4 Again with the B and the RB, as you showed us
5 yesterday the first two bands are in essentially the same
6 position; is that correct?
7
8
9
A. That is correct, yes.
o. And the difference between the B and the RB is
whether there is a storage band which appears in the B EAP type,
10 is that correct?
11
12
A.
o. That is correct, yes.
Or whether there is the R band which appears in the
13 RB?
14 A. That is correct.
15 o. In the photograph you have of A-41 for the EAP run,
16 is the area of the plate which the R band would show up in an RB
17 or the storage band in the B band, is that area in the picture?
18
19
20
21
22
23
24
25
26
27
28
A. It's in the picture, however the development is cut
off at that point.
O. SO that plate was not developed high up into that
area; is that correct?
A. That is correct, yes.
o. So, at this point can you determine from the
picture whether A-4l is a B or an RB?
A. No, I cannot.
o. What's in the picture, is that consistent with
being a B or an RB?
A. Yes, it is.
COMPUTERIZED TRANSCRI~
" o ." u
" u -I ,
4432
1 Q. It would have to be stained up higher to make that
2 further separation?
3
4
A.
Q.
Yes, it would.
But back in August the EAP type of Mr. Cooper's
5 blood and A-4l appeared to you to be the same; is that correct?
6
7
A.
Q.
Yes, they did.
Now, did you also run the serum protein in Group
8 III?
9
10
11
12
A.
Q.
A.
Q.
Yes, I did.
And were you able to get results on A-4l?
Yes, I did.
And which -- well, could you tell us what the
13 results are?
14
15
16
17
18
19
20
21
A. Okay. As far as the serum proteins, the Gc, Tf and
Hp, I was unable to get a conclusive result on a Gc. The Tf,
Transferrin, is type CD, and the Hatpoglobin is a type 2-lM.
Q. Now, the Transferrin type that you got on A-4l, is
that the same Transferrin type that the defendant has?
A. Yes, it is.
Q. And does that finding on A-41, for example, that
finding alone, would that exclude A-4l being deposited by any of
22 the five victims in this case?
23
24
25
26
27
28
A. Yes, it would.
Q. The other serum protein you talked about was the
Haptoglogin; is that correct?
A. That is correct, yes.
Q.
A.
Did you get a finding on that?
Yes, I did.
COMPUTERIZED TRANSCRIPT
'n u ~ ,
., o
. " U ,~
U .f: .LI
1
2
3
Q.
A.
Q.
4433
What was the finding?
It was Haptoglobin, Hp, type 2-1M.
Was. that the same Haptoglobin type that the
4 defendant had?
5
6
A.
Q.
Yes, it is.
That result alone, the Haptoglobin result, for
7 example, would that exclude the possibility of that blood coming
8
9
10
from any of the other five victims in this case?
A. Yes, it would.
Q. And that is consistent, however, with coming from
11 the defendant?
12
13
A.
Q.
Yes, it is.
Did you likewise get Peptidase A, and did you
14 actually get a Peptidase A result?
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, I did.
Q. What was it?
A. The Peptidase A on this stain is a type 2-1.
Q. And is that in fact the same Peptidase A type that
the defendant in this case has?
A. Yes, it is.
Q. Does that result also, in and of itself, simply the
Peptidase A result, exclude the possibility that A-41 came from
the five victims in this case?
A. Yes, it does does.
Q. However, it is consistent with coming from Kevin
Cooper; is that correct?
A. That is correct, yes.
Q. Now, excuse me. You mentioned the variance of
COMPUTERIZED TRANSCRIPT
f
r'~
,e ,. L ,.. l.
'o(
-"-:
f -',
~"
4434
1 enzyme types that are indicative of a blood type of a person who
2 has black heritage; is that correct?
3
4
A.
Q.
Yes, sir.
And I believe you testified that among the enzymes
5 that have this variance or varient would include the
6 Transferrins, the Haptoglobin, and the Peptidase A; is that
7 correct?
8
9
A.
Q.
That is correct, yes.
Is the Transferrin type CD an example of an enzyme
10 type which is indicative of a person who had black heritage?
11
12
A.
Q.
Yes, it is.
Is the Haptoglobin 2-lM type the type of serum
13 protein that is indicative of a person of black heritage?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes, it is.
Q. Likewise the Peptidase A type 2-1, is that type
also indicative of a person who has black heritage?
A. Yes, it is.
Q. On 592 and 589, could you perhaps circle for the
jury, for their use later, the three types that we have talked
about that are indicative of a person with black heritage.
A. Yes, I can.
Again, it would be the Peptidase A 2-1, the
Haptoglobin, or Hp type 2-IM, and the Transferrin CD. (Witness
complied).
Q. Now, based on your serological results, do you have
an opinion as to whether or not A-4l, that drop of blood, is
27 consistent with coming from the defendant in this case?
28 A. Yes, I do.
COMPUTERIZED TRANSCRIPT
." U , , ,-, CI
, ,-, U , ,
'. " L'
1
2
o. A.
4435
what is your opinion?
It is consistent with coming from the defendant,
3 yes.
4 o. Again, to say A-4l came from the defendant and no
5 other person that had his profile, would you have to actually
6 see him drop, shed the blood and then analyze it?
7
8
9
10
11
A. Yes, you would.
o. But you can say that it was impossible for that
blood to have corne from any of the victims in this case.
A. That is correct, yes.
o. Could you indicate then on 592, perhaps in blue,
12 just the sir name wCooper-.
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. (Witness complied).
Q. And likewise, in the horne on the clear plastic, on
A-41, in the hallway, can you indicate in blue ·Cooper-.
A. (Witness complied).
Q. You may resume your seat for a moment.
THE COURT: I think this would be a good point, Mr.
Kochis.
MR. KOCHIS: I guess this would be one.
THE COURT: We will take the morning recess. Be mindful
of the admonition, please.
(Recess)
THE COURT: Please resume.
DIRECT EXAMINATION (Resumed)
28 BY MR. KOCHIS:
COMPUTERIZED TRANSCRIPT
... ,--,. l
l "--~
2
--
4436
1 o. Mr. Gregonis, I would like to direct your attention
2 back to A-41.
3 Was June the 9th of 1983 the first day at which you
4 started testing that drop of blood in the laboratory?
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. ·Yes, it is.
Q. And which test did you perform on the 9th?
A. I did what is called the presumptive or color test,
the ortho-to1idine, to see if it was blood.
O. You found that A-41 was blood?
A. Yes, sir.
Q. Did you next test the stain on the 12th of June?
A. Yes, sir. I did.
Q. And what test did you perform on the 12th?
A. I did the Species Analysis and the Forward and
Reverse ABO Analysis.
Q. Did you get results?
A. Yes, I did.
Q. And was that consistent with the ABO type A.
person?
A. Yes, it is.
Q. The following day, the 13th, is that the next day
that you performed serological tests on A-41?
A. Yes, it is.
Q. And thus far the tests would have been performed by
you in the laboratory; is that correct?
A. Yes.
Q. In San Bernardino?
A. That is correct, yes.
COMPUTERIZED TRANSCRIPT
r ,--,. l
• . ,. l
t~·-·
Ul7
1 Q. . Did you do the Group I test, specifically the EsD
2 and the PGM on the 13th of June?
7
8
9
chart?
A.
Q.
A.
Q.
A.
Q.
Yes, they are.
On the 28th and 29th of June, did you likewise run
10 tests on A-41?
11
12
13
14
15
A.
Q.
A.
Q.
A.
Yes, I did.
Did you do the Group II system on the 28th.
Yes, I did.
Did you get results?
I got a result for ADA which is type 1. The EAP
16 and AK were both inconclusive.
17 Q. Was that the only test you did on the 28th? On
18 that stain. Excuse me.
19
20
21
22
23
24
25
26
27
28
A. Yes, sir, it is.
Q. \'lhich test did you perform on the stain the
following day on the 29th?
A.
PEPA.
Q.
A.
Q.
chart?
A.
The Group IV Test, which are the CA II and the
Did you get results?
Yes, I did.
Are those the results that you indicated on the
Yes, they are.
COMPUTERIZED TRANSCRIPT
" o . " U
~ , ',J .::1
;' -. .
4438
1 Q. Now, up until this time did you have a sample, a
2 whole sample of the defendant's blood?
3
4
5
6
1
8
9
10
11
A.
Q.
A.
Q.
A.
Q.
No, I did not.
Did you get that sometime after August the 1st?
Yes, I did.
And after you got it did you start to analyze it?
Yes, I did.
And that's the sample that bears the laboratory
identification number of VV-2; is that correct?
A. That is correct, yes.
Q. When did you -- did you start to test that sample
12 on August the 2nd?
13 A. Actually started to test that on August 1st.
14 That's when I did the ABO.
15
16
17
18
19
20
21
22
23
24
25
26
21
28
Q. Now, when was the next time you tested, you
performed any tests on A-41?
A. That would be August the 2nd, 1983.
A. And was that the Group II series of tests?
A. Yes, sir.
Q. And were those the results that you posted
indicating what you got the first time?
A. Yes, sir.
Q. When was the next time that you performed any tests
on A-41 after August the 2nd?
A. The next time was for the Gc and the Transferrin or
the Tf on October the 3rd, 1983.
Q. Now, where was that test performed?
A. That was performed in the laboratory in San
COMPUTERIZED TRANSCRIPT
'n u I ,
I-' o ,-, U
I , ·LI ,
" ..• .,. '. ~ ... ~.-. -... ..:.
.- ......
4439
1 Bernardino.
2 Q. NOw, prior to that date, prior to October the 3rd,
3 had you conducted a series of tests on Mr. Cooper's blood, VV-2?
4
5
A.
Q.
Yes, I did.
Had you, for example, completed the Group I
6 results?
7
8
9
10
11
12
13
14
15
16
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
Yes, I did.
And the Group II results?
Yes, I did.
And the serum proteins in Group III?
Yes, I did.
And the Group IV results?
Yes, I did.
And do you have those results?
Yes, sir, I did.
Were those results made available in the discovery
17 process?
18
19
20
21
22
23
24
25
26
27
28
A. Yes, they were.
Q. NOW, on the 3rd when you tested A-41 for the
Transferrin and the Gc, were you the only person present at the
time of that test?
A. No, sir, I was not.
Q.
A.
Q.
A.
Q.
A.
Was there another person present?
Yes, sir, there was.
Do you happen to remember that person's name?
Yes, I do.
Who is it?
It is Dr. Edward Blake.
CCMPUTERIZED TRANSCRIPT
<f l
,. r •
" l
;'-----...,
1 {-
2
3
.. 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
,~,
4440
o. Does he have, to your knowledge, any training or
experience in this field of Serology?
A. Yes, sir, he does.
O. NOW, is it fair to say that the group -- that the
tests, excuse me, for the Transferrin and Gc, were started on
the 3rd of October and read on the following day, on the 4th?
A. That is correct, yes.
O. Was Dr. Blake there when the results were read?
A. Yes, he was.
O. On the 4th then was the Haptoglobin started?
A. Yes, it was.
O. Were the results of that test on A-41, just A-4l,
not read until the following day, October the 5th?
A. That's correct, yes.
O. Now, you work for San Bernardino County; is that
correct?
A. Yes, I do.
O. In the crime lab?
A. Yes, I do.
O. Does Dr. Blake work for the crime lab?
A. Excuse me. Could you repeat the question.
O. Does Dr. Blake work in your crime lab?
A. Yes, he does. Oh, excuse me. No, he does not. He
was working that day in the crime lab.
O. Is he employed by the County of San Bernardino as a
criminalist, for example?
A. No, he's not.
O. Do you know where his office is located?
COMPUTERIZED TRANSCRIPT
-n u
~ , fJ (J
- " U j ,
,o
3
I
2
3
.. 5
6
7
8
9
4441
A. His office is in Emeryville, California.
Q. And to your knowledge is he retained as an advisor
by anybody in this courtroom?
A. Yes, he is.
Q. who is that?
A. By the defense.
Q. NOw, was A-U, the drop of blood from the hallway
in the Ryen home, was that serological sample, was that as large
as, for example, the EDTA samples of whole blood that you worked
10 with in this case?
11
12
A.
Q.
No, sir.
And in terms of size, was it consistent with having
13 at one time been a long blood drop?
14
15
16
A. Yes, sir, it is.
Q. NOw, after the 5th of August, the 5th of October of
1983 -- well, Dr. Blake was there when you actually read the
17 results; is that true?
18
19
20
21
22
23
24
A. On the 4th and the 5th, yes.
Q. And was the procedure essentially that you
conducted the test?
A. Actually it was kind of a jOint effort.
Q. Between you and Dr. Blake?
A. Yes, sir.
Q. And he was present when the plates actually came up
25 and were read by yourself; is that true?
26 A. Yes, sir.
27 Q. Now, in terms of quantity, the amount, if you can
28 remember, how much of A-41 was left, if anything, after you and
COMPUTERIZED TRANSCRIPT
I?';'~
"
L
r r -.,. l
•
. .
1
'-.~-- --.--
4442
1 Dr. Blake performed the Haptoglobin test on October the 4th and
2 October the 5th?
3
" A.
Q.
It was a very small amount.
Let me move to another area.
5 Was it -- what was done with the remainder of the
6 Haptoglobin test?
7 A. After the Haptoglobin test, until approximately the
8 October the 17th, 1984, the remainder of the sample was placed
9
10
11
12
in the serology freezer.
Q.
A.
Q.
Was it tested again on the 17th?
October the 17th, 1984. Yes, sir.
Now, did that take -- did that test -- excuse me --
13 take place in San Bernardino County?
14
15
16
17
18 own?
A.
Q.
A.
Q.
NO, it did not.
Did that take place in northern California?
Yes, it did.
Was that in a serology laboratory other than your
A. Yes, sir, it was.
Q. Were you the only other person present when A-41
19
20
21
22
23
was tested in October of 19841
A. No, sir.
24
25
26
27
Q.
A.
Q.
A.
Q.
28 Wraxa11?
Was Dr. Blake present?
Yes, sir, he was.
Was there anyone else present?
Yes, sir.
Did that include a man that you know as Brian
COMPUTERIZED TRANSCRIPT
I· II
,. l~ -·r l
.f ,--
4443
A. Yes, sir, it did. 1
2 Q. The man who actually developed the system that you
3 used?
4
5
A.
Q.
Yes, sir.
Now, directing your attention to a photograph we
6 have marked for identification as 597, a very small picture,
7 three by five black and white.
S Do you know what that is a picture of?
9
10
11
A.
Q.
A.
Yes, I do.
What is it a picture of?
It is a picture of the amount of sample in A-41 on
12 July the 11th, 1984.
13
14
15
16
Q. NOW, it appears that there is some type of
container separated into two parts; .is that correct?
A. That is correct, yes.
Q. And does one of the parts contain what at one time
17 was a portion of A-4l?
18
19
20
21
22
A. Yes, sir, it does.
Q. And as you face the photograph, is that the right
or the left container?
A. That would be the right container.
Q. Now, there appears to be some.speckles in the
23 picture on the right container, in the right container.
24 Do you know what that substance is?
25 A. well, there's some white sUbstance which is plaster
26 or paint identified as being from the hallway in the Ryen home.
27 Q. NOW, do they appear somewhat light color or whitish
28 in the photograph?
COMPUTERIZED TRANSCRIPT
r ,--·r l
-
1
2
A.
Q.
4444
Yes, they do.
When you first saw A-4l, was essentially the blood
3 that appeared to have been scraped off -- a bloodstain that
4 appeared to have been scraped off a plaster wall?
5
6
7
8
9
A. Yes, sir, it did.
Q. The chips, the specks of plaster in that picture,
were they all soaked with blood?
A. Not all of them, no.
Q. Does that depict the specks of blood that may have
10 existed in that canister after you and Dr. Blake did the testing
lIon October the 5th? Can you see some of them?
12 A. Yes. Unfortunately it is a black and white picture
13 so you can't see all of them.
14
15
16
17
18
19
20
21
22
23
24
25
26
Q. Was there a large or small quantity left of A-41
after you and Dr. Blake finished with it on October the 5th?
A. It was a very small quantity.
Q. Now, what type of test was performed on the 17th of
October, 1984, in northern California on A-41?
A. The test that we did up there was a test called
isoelectric focusing, and it is a test for EAP that we tried to
distinguish whether A-4l was either a B or an RB.
Q. And is that a technique that is often used when the
sample itself is extremely small?
A. It can be used when the sample is extremely small l _
yes.
Q. Were you and Dr. Blake and Mr. Wraxall able to get
27 a result on the 17th of October when what was left of that
28 sample was attempted to be tested?
COMPUTERIZED TRANSCRIPT
,-, U , , 1-' o ,-, u :I L
. ,-, U
1
2
A.
o.
4445
No, we were not. It was inconclusive.
Now, back to the chart. Something perhaps that was
3 skipped over on 589.
4 You have, for example, underneath the Gc column
5 next to Mrs. Ryen and her daughter, what look like minuses or
6 lines.
7 What does that symbol stand for?
8
9
A.
o. That means I was unable to get a conclusive result.
So, for example, on Peggy Ryen, Jessica Ryen, you
10 can't tell what their Gc type was.
11
12
A.
o. That is correct, yes.
Directing your attention next to a chart which has
13 been marked for identification as Exhibit 596.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Do yo~ recognize what this is a chart of?
A. Yes, I do.
Q. And is this a chart which shows the serological
profiles of a number of different people?
A. Yes, it does.
Q. Is the chart similar in its outline to that of 589?
A. Yes, it is.
Q. For example, as you look at the chart, to the far
left, does the chart describe the laboratory identification
number that was assigned, for example, to that number of blood
samples?
A. Yes, it does.
o. Are these blood samples that appear on this chart
on 596, were they bloodstains or were they the whole blood
28 sample for EDTA type samples?
COMPUTERIZED TRANSCRIPT
, ,-, U , , J~' o
. ,-, u .:.1 .-, ,
2
1
2
A.
Q.
4446
Those were blood samples.
Does that column likewise reflect the name of the
3 person from whom this sample was taken?
.-5
A.
Q.
Yes, it does •
Then across, moving from left to right, have you
6 indicated, for example, the ABO types of all the persons whose
7 names appear on the chart.
8
9
A.
Q.
Yes, I have.
And did you perform all the serological analysis of
10 which the results appear on this particular exhibit?
11
12
A.
Q.
Yes, I did.
For example, you did all the enzyme and serum
13 protein typing on the whole bloods of these people, the persons
14
15
16
17
18
19
20
21
22
23
24
25
whose names appear on 596; is that true?
A. Yes.
Q. Was that all through the use of thi&
electrophoretic technique?
A. Except for the ABO, secretor status, yes, it was.
Q. And the forward and reverse test that you performed
on the ABO, excuse me, to determine the ABO from the whole
blood, was that the same procedure that you used on the victims
and defendant in this case?
A. Yes, it is.
Q. NOw, is it accurate to say that genetically it is
impossible for anyone of the persons whose names appear on 596
26 to have been the person that left A-4l at the Ryen home?
27
28
A.
Q.
That is accurate to say, yes.
For example, Rodney Parish, whose name appears on
COMPUTERIZED TRANSCRIPT
II U , , l~' o " u , ,--, ,--
1
2
3
4
5
6
7
8
9
10
11
12
13
r-' 14
15
16
17
18
19
20
21
22
23
24
25
26
27 "---
28 //~,
U47
the bottom of the chart 596, is it biologically impossible for
Rodney Parish to have left A-4l?
A.
Q.
Mr. Balau?
A.
Q.
A.
Q.
the chart?
A.
Q.
Yes, it is.
And would that likewise be true, for example, with
Yes, it is.
Mr. Knorri?
Yes.
Likewise, every other person whose names appear on
Yues.
Back again for a moment to 592.
Did you likewise conduct that serological tests on
stains other than the KAK series that were actually removed from
the inside of the Ryen house?
A. Yes, I did.
Q. Would that have included a stain which was given a
laboratory identification number of L-3~ which was a stain taken
from an empty Oly Gold can found in the field between the Lease
and the Ryen home?
A. Yes, sir.
Q. Was there a limited quantity to that stain?
A. Yes, there was.
Q. Were you only able to perform a limited number of
tests?
A. Yes, sir, I was.
Q. What was the only test you could perform?
A. The only test I could perform that was to identify
COMPUTERIZED TRANSCRIPT
'" U I I ,-,
o ,-, LI , ,-.-, :I
'--"
, '-...
4448
1 it as blood, was the presumptive test. It was positive for
2 blood.
3
4
5
6
7
Q.
A.
Q.
A.
Q.
You indicated that on the chart; is that correct?
Yes, I did.
Now, with the other can. Did you also analyze L-4?
Yes, I did.
The stain taken from the full can of Oly Gold beer,
8 which at one time was in the refrigerator in the Ryen home
9
10
A.
Q.
Yes, sir, I did.
were you able to test the stain to determine if
11 it was blood?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A.
Q.
A.
Yes, I did.
Was it blood?
It is blood and of human origin.
Q. So you were able to perform the ouchterlony test on
it; is that correct?
A. Yes.
Q. Now did you try to determine what the ABO blood
group type WqS of the person whose blood ended up on the beer
can?
A. Yes.
Q: Were you able to do that?
A. . NO, I was not.
Q. Did you attempt to run the Group I multisystem?
A. Yes, I did.
Q.
A.
Q.
And did you get a EsD result, for example?
No, I did not.
Were you able, however, to get a PGM result?
COMPUTERIZED TRANSCRIPT
'" U , , ., CI
" u , ,-.-·LI
I
(-" 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
,.-.,
4449
A. Yes, I was.
Q. with what result did you at the time?
A. I got a PGM type 2-1.
Q. Now, of the persons on the chart 589, is that PGM
result consistent with the genetic profile of anybody on the
chart?
A. Consistent just with PGM alone with Doug Ryen or
Joshua Ryen.
Q. And so there is no misunderstanding on the part of
the jury, that would also be consistent then with the genetic
profile of other persons who happened to have a 2-1 PGM type.
A. That is correct, yes.
Q. In this case, in terms of the victims that were
attacked inside the house, it is only consistent with two of
those; is that correct?
A. That is correct, yes.
Q. Could you step to 592, and can you put ·cw· perhaps
for consistent with, and then could you put ·Josh· or -Josh and
Doug- •
A. (Witness complied).
Q. Now, for example, would the presence of that stain
L-4 on the beer can, would that be consistent with either one of
those victims going into the refrigerator while they were
bleeding?
A. Yes, it would.
Q. would it also be consistent with an assailant
having on his hand the blood of either Josh Ryen or his father,
and leaving that blood on some beer when he reached in the
COMPUTERIZED TRANSCRIPT
I , .. ,-: -,.. L .. ,. -..
. --
3
1
2
3
refrigerator?
A.
o.
4450
Yes, it would.
Before I take this down, was there another -- was
4 there another -La series item? Specifically, I believe either
5 L-l or L-2, which you analyzed in this particular case?
6
7
8
9
10
11
12
some
A.
o. A.
o. type of
A.
o.
Yes, there is.
Which number did it have.
It is an L-l.
And was that what appeared to be visually a stain,
stain?
Yes, it is.
Were you able to test the stain -- was that a stain
13 that, according to the lab notes, was taken off the head of the
14 hatchet in this case?
15
16
A.
Q.
Yes, it is. Do you want me to read them?
Were you able to determine whether the stain that
17 was on that hatchet was blood or not?
18
19
20
21
22
23
24
25
A. Yes, I did.
o. Were you able to determine if the bloodstain on the
hatchet was human blood or not.
A. Yes, it is.
o. l'lere you able to determine the ABO type of the
human being who had his blood end up on that hatchet?
A. Yes, I did. It is ABO type B.
o. NOW, that blood then could not have come from the
26 defendant in this case.
27
28
A.
o. That is correct. Yes.
Is it consistent with coming from either of the
COMPUTERIZED TRANSCRIPT
r l
r r ,. ,. l •
r ,.
1
2
3
4
5
6
7
8
9
10
11
12
13
c-' 14
15
16
17
18
19
20
21
22
23
24
25
26
27 --28
---
.uS1
five victims in the case?
A. It is consistent with coming from Joshua Ryen.
Q. Perhaps could you indicate on the chart, I notice
that has not been filled in, can you perhaps put a L-I in what
appears to be a blank column underneath L-4, and can you write
·suspected blood from hatchet-.
A. (Witness complied).
Q. Then can you also indicate in the appropriate
column what your result was when you tested that stain for
blood.
A. Yes, I can. (Witness complied). The test for
blood was positive.
Q. Likewise could you proceed to the next column which
is human.
A. Yes, I can. It is, according to my tests, human
blood, and it is ABO blood type consistent with a type B.
Q. Then -- and you mentioned that was consistent at
least with that, thus far, the profile of Joshua?
A. Yes.
Q. It would be consistent with Josh getting his blood
deposited on that hatchet. For example, being struck and having
Josh's bleed on to the hatchet.
A. Yes, it is.
Q. Can you indicate then over in the comment section,
·CW· for consistent with and then Josh's name.
Q. And, again, so the jury is not misled, the human
blood on that hatchet genetically could have come from persons
other than Joshua Ryen.
COMPUTERIZED TRANSCRIPT
'-'" U , , o o
" u .J
.f.. , ,
'. -...., , ..... --~::..... -,-"-
(~' 1
2
3
4
5
6
7
8
9
10
11
12
13
~, 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 ~-
4452
A. That is correct, yes.
Q. But it is human blood.
A. Yes, it is.
Q. Did you likewise analyze some stains that had the
laboratory identification number, the -J- series stains, on
items which were taken out of the 2991 residence, that residence
that was owned by Mr. Lease and Mr. Lang?
A. Yes, I have.
Q. Directing your attention to what has been marked
for identification as Exhibit 593, appears to be another chart.
DO you recognize this particular chart?
A. Yes, I do.
Q. And does this chart reflect some of the serological
results of examinations you performed in the laboratory in San
Bernardino on stains which were removed from items seized in
that 2991 residence?
A. Yes, it does.
Q. Did you remove from the serological freezer an item
which was marked for identification as J-6?
A. Yes, I did.
Q. And did that appear to be a green button?
A. Yes, it is.
Q. Did it have a stain on it that was consistent,
visually consistent with a blood stain?
A. Yes, it did.
Q. And did you perform some tests on that?
A. Yes, I did.
Q. Was there a large stain on that button or a small
CCMPUTERIZED TRANSCRIPT
,-, o 1-' U , ,---·0 .0
1
2
3
4
5
6
7
8
9
10
4453
stain?
A. It was a rather small sustain.
Q. Now, were you able to test the stain to determine
whether or not it was blood?
A. Yes, I did, and it is blood.
Q. Were you also able to test the stain to determine
whether or not the stain was from a human being, or from a
reptile, or something?
A. It is human blood.
Q. Did you then perform tests to determine whether or
11 not you could determine the ABO blood group type of that
12 particular stain?
13
14
IS
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, I did.
Q. Were you able to do that?
A. Yes, I did. It is a ABO type A.
Q. Were you able to perform any electrophoretic tests
on which gave you a result?
A. Yes, I did.
Q. What result did you get?
A. I did the Group I test and I got the EsD result
which is a type 1, the PGM result was inconclusive.
Q. Now, based on those results, based on the ABO
result and the EsD result, for example, is it true that you can
exclude various persons from the chart 589 as being the
potential donor of that stain?
A. Yes, I can.
Q. For example, that stain could not have come from
28 young Chris Hughes, could it have?
COMPUTERIZED TRANSCRIPT
''-, U ,
I CI o " IJ J L
9
1
'-
1
2
A.
Q.
4454
Yes, that is correct.
It likewise could have not have come from Jessica
3 or her mother?
4
5
A.
Q.
That is also correct, yes.
The ABO type and the ESD type, however, is that
6 consistent with coming from one of the victims in this case?
7
8
9
10
A.
Q.
A.
Q.
Yes, it is.
Would that be Doug Ryen?
Yes.
Now, based on the limited -- is the information on
11 this chart somewhat limited?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, it is.
Q. Certainly not as complete as the profiles which
appear on 5891
A. Yes.
Q. And the stain which came off the green button, the
human bloodstain, Mr. Ryen is not the only person in the country
that has a profile consistent with what you've got?
A. That is correct, yes.
Q. And, in fact, an example of another person who has
an ABO type A and an EsD type I is Mr. Cooper; isn't that
correct?
A. Yes, sir, it is.
Q. So genetically J-6 could have come from Doug Ryen
or Kevin CooperJ is that correct?
A. Yes, it could.
Q. Or anyone else who is an ABO type A and an EsD type
28 I?
COMPUTERIZED TRANSCRIPT
n u , , ., o " u J ~
. " U
-.....
4455
A. That is correct, yes. 1
2 Q. Could you indicate in the comment section, ·CW· for
3 ·consistent with,· and just put Doug slash Cooper?
A. (Witness complied.)
5 Q. I apologize for not having that attached a little
6 better.
1 Mr. Gregonis, directing your attention to Exhibit
8 91, which contains a pill box which apparently bears the
9 identification number of J-6, could you open it and tell the
10 jury if there's anything inside it?
11
12
A.
Q.
Yes, there is. There's a green button inside.
Was that the button that you removed the stains
13 from and tested and got the ABO A and the EsD I?
14
15
16
A. Yes, it is.
Q. Was there any stain left after you performed the
tests that you've testified to with the chart for you to perform
11 further analysis?
18
19
20
21
22
23
24
A. No, there was not.
Q. Likewise did you find on a rope, a nylon rope,
stains that appeared visually to be bloodstains?
A. Yes, I did.
Q. Was that a white nylon rope?
A. Yes.
Q. And did you see that first in the serological
25 freezer in your crime lab in San Bernadino?
26
21
A.
Q.
Yes, I did.
And do the notes indicate that it was a rope picked
28 up from the Lease house in the closet?
COMPUTERIZED TRANSCRIPT
,e ,. L .. ---
,.-...
"'--'
1
2
3 blood?
A.
Q.
A.
Q.
4456
Yes, it does.
Now, did you test that stain to determine if it was
A. 6 Yes, it is.
Q. 7 In addition to that, did you test the stain to
8 determine if it was human blood?
9
10
A.
Q.
Yes, and it is human blood.
Were you able to determine the ABO type of that
11 bloodstain?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes. The ABO type was a type A.
Q. NOw, did you run the Group I systems to test for
the EsD and the PGM?
A.
Q.
A.
Q.
Yes, I did.
Did you get results that you could call?
No, I did not.
And is that what the initial -I-N-C- will indicate,
A. Yes, it is.
Q. However, were you able to get some of the results
when you ran the Group II system?
A. Yes, I did.
Q. That did not include, however, the EAP results?
A. That is correct, yes, sir.
Q. The AK and ADA results you got, were they both type
27 I?
28 A. That is correct, yes.
COMPUTERIZED TRANSCRIPT
I~I o I-' U ~,
,:I ',j ,L
4457
1 Q. Then it appears that you also were able to conduct
2 another test.
3
4
A.
Q.
Yes.
And you were successful at least as far as the CA
5 II?
6
7
8
9
A.
Q.
A.
Q.
That is correct, yes.
And that was a type 1 personJ is that correct?
Yes, sir, it is.
The other tests that you ran, were you unable to
10 get a result that was conclusive?
11
12
A.
Q.
That is correct, yes.
Now, based on the results you got on that stain,
13 you can exclude a number of the persons on 589 as being donors
14 of that stain, is that true?
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, I can.
Q. That would include, for example, Josh, Chris
Hughes, Peggy Ryen, and Jessica Ryen?
A. That is correct, yes.
Q. with the CA II results, can you also exclude the
defendant?
A. with the CA II? No, I cannot.
Q. Can you exclude him with the AK and the ADA.
A. No, I cannot.
Q. So, are we in the same position with J-9 as we were
essentially with J-6 in terms of serological results of what you
have done?
A. As far as being consistent with either Doug Ryen or
28 Mr. Cooper, yes.
COMPUTERIZED TRANSCRIPT
,-, U , , ., o ,-, u ~, :;
.:1 :J
4458
1 o. So, those results, they could have come from
2 it's consistent with coming from Doug Ryen if he at one point
3 had had his blood placed on that rope?
" 5
A.
o. Yes, it is.
It's also consistent with the defendant -- with the
6 test you have done, being placed on that rope?
7
8
9
10
11
12
13
14
15
16
A. That is correct, yes.
o. NOw, when you finished the test that you performed
on J-9, was that stain exhausted?
A. No, it was not.
O. Was there some left?
A. Yes, sir.
Q. Have you since you completed your work on J-9 sent
that rope to another location?
A. Yes, I have.
Q. Would that be to Brian Wraxall's laboratory in
17 Emeryville, California, or Oakland, California?
18
19
20
21
22
23
24
2S
A. Yes, sir.
Q. For the purpose of doing additional tests?
A. Yes, sir.
Q. You did not do those tests?
A. That is correct.
Q. And is it possible with additional tests,
potentially, to discriminate the possible donor of this
bloodstain further, for example, between Mr. Ryen and Mr.
26 Cooper?
27
28
A. Yes, it is.
MR. KOCHIS: Could record reflect that in the comment
COMPUTERIZED TRANSCRIPT
" . r lJ
,. G I" e-.. -
·L
--.'.~ .. :.. ..
1
2
3
4
5
6 2
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4459
column next to J-9 11m going to draw a line and place ·D.G.· in
the upper part.
o. Could you step to that and indicate with simply the
results you have done up to this point, starting with the ·cw· for ·consistent with·, which persons on the chart the stain is
consistent with coming from?
A. It is consistent with coming from either Doug Ryen
or Mr. Cooper.
o. You may resume your seat again for the moment.
Now you mentioned yesterday when we started that in
this field of serology you could test body fluids other than
blood; is that correct?
A. That is correct, yes.
Q. And did you mention that two of the other body
fluids that you could test would include saliva and semen?
A. Yes, it does.
Q. Did you test certain items in this case to
determine the presence of either one of those body fluids?
A. Yest I did.
Q. For example, did you perform some tests on a green
blanket ~hich was removed from the closet in the 2991 residence
which was assigned the laboratory identification No. J-13?
A. Yes, I did.
Q. Did that stain appear to you to be a bloodstain?
A. No, sir, it did not.
Q. NOW, did you perform any test on the stain itself
to deter~ine scientifically what type of stain it was?
A. Yes, I did. Itls a semen stain.
CCMPUTERIZED TRANSCRIPT
f
'''" U ~ , .,
o
" u , .:1 .J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 '-~
28
4460
o. What did you do to determine that?
A. Okay. A couple of the tests that I did, one was a
test looking for an enzyme called acid phophatase, and that's an
enzyme which is present in very high quantities in seminal
fluid.
And there was high quantities of that enzyme
present.
O. Let me stop you there for a minute.
So you test for something that you find in semen,
and that's this acid phophatase?
A. Yes, sir.
O. And that leads you to a conclusion that the stain
on there was semen?
A. It indicates the presence of semen, yes.
O. It's an inference?
A. Yes, sir.
Q. Did you also look at the stain under a microscope
for any purpose?
A.
Q.
A.
O.
A.
Q.
A.
O.
A.
that stain.
Yes, I did.
For what purpsoe?
For looking for spermatozoa.
And they exist in semen; is that correct?
Yes, they do.
Did you see any?
Yes, I did.
And what conclusion did that lead you to?
That there was seminal fluid and spermatozoa in
COMPUTERIZED TRANSCRIPT
"n u ~ ,
" o
" u -.J .~
··C .U
1 ,'~
I
2
3
4
5
6
7
8
9
10
11
12
13
. ~, 14
15
16
17
18
19
20
21
22
23
24
25
. 26
27
28
/~',\
4461
Q. Now, is there a procedure by which you can test a
semen stain to determine what the ABO blood type is of the
person whose semen is on the blanket?
A. Yes, there is.
Q. And what was the name of that again?
A. There was duly two tests. One is called the
absorption-~other is called the absorption-elution.
Q. Did you perform either or both of those tests from
that semen stain from the blanket?
A. I perform the absorption-inhibition.
Q. And what did you determine?
A. I determined that the stain, especially with the
presence of a large quantity of semen, is consistent with what's
called a nonsecretor •
Q. NOW, was that from the inhibition test?
A. Yes, sir.
Q. Did you then perform another test to allow you to
determine what the ABO blood type was?
A. Brian Wraxall and I did, yes.
Q. Was that an absorption-elution test?
A. Yes, it is.
Q. And does that allow you to determine the ABO blood
group type in a body fluid stain from someone that is not a
secretor?
A. Yes, sir, it does.
Q. For example, to explain to the jury, putting aside
issues such as vasectomies and things of that nature, Doug Ryen
is an ABO A secretorJ is that correct?
COMPUTERIZED TRANSCRIPT
.. ,-, U
I , I-' CI I-' U -, :I ., ,
'-.' '
1
2
A.
Q.
4462
Yes, he is.
And if the stain, the semen stain on the green
3 blanket in the Lease house came from Doug Ryen, would you get
4 evidence of that in the absorption-inhibition test?
5
6
7
8
9
A. Yes, you would.
Q. And you did not get that indication in this case?
A. That is correct, yes.
Q. so, is it fair to say once you do the ABO test and
the secretor test, the absorption-inhibition and the
10 absorption-elution test, that you can exclude the possibility of
11 Doug being the one that had his semen on the green blanket?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Yes, I can.
Q. Did you continue then to test that stain on the
blanket serologically to see how far you could take the profile?
A. Yes, I did.
Q. Were you able to get any other results?
A. Yes, I did.
Q. Did they include a result in the Group I system,
specifically the second enzyme that you read, the PGM?
A. The PGM, yes. It's a type 1.
Q. And is that consistent with, for example, semen
coming from Kevin Cooper?
A. Yes, it is.
Q. And likewise the ABO type, the A, that's consistent
with semen deposited by the defendant?
A. Yes, it is.
Q. The fact that the semen came from a nonsecretor,
28 that also is consistent with being deposited by the defendant?
COMPUTERIZED TRANSCRIPT
o o " u :I J
·0 o
;-, ;
, ''-...,
4463
1 A. Yes, sir.
2 Q. Were you able to get any results in either the PGM
3 sub typing or the peptidase A?
4 A. Yes, I was. The PGK subtyping is a 1+ and the
5 peptidase A, or PEPA, is a type 2-1.
6 Q. Does the subtyping that you got on J-13 match the
7 sub typing of the defendant?
8
9
A.
Q.
Yes, it does.
And likewise does the result you got from the
10 peptidase A result match the defendants peptidase A?
11
12
A.
Q.
Yes, it does.
NOW, within the results that you got on J-13 on the
13 semen stain, did you get any results in any category, any type,
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
that were indicative of the person's racial heritage?
A.
Q.
A.
Q.
A.
Q.
A.
Q.
Yes, I did.
Would that have been in the peptidase A result?
Yes.
And was that the 2-l?
Yes.
Could you perhaps circle that with a blue pen.
(Witness complied.)
Now that result alone, the 2-1 result alone, would
that also enable you to exclude as a donor Doug Ryen?
A. Yes, it would.
Q. And is that the same peptidase A type that you got
off the stain of blood in the hallway of the victims' home?
A. Yes, it is.
Q. Is that also the same peptidase A type that you got
COMPUTERIZED TRANSCRIPT
:'1' U
~ , " CJ Ii LI -.J ,-,
S
r--"
1 , I
2
3
4
5
6
7
8
9
10
11
12
13
~ 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
,-,
4464
in VV-2, the sample of Mr. Cooper's whole blood?
A. Yes, it is.
Q. NOw, based on the information that you have on this
chart, on 593, are you able to determine a frequency with which
the genetic profile that appears in this stain, with the ABO,
the PGM, and the PEPA, the frequency with which this profile
would appear in the population?
A. Yes, I can.
Q. And what would that frequency be?
THE COURT: Which population?
MR. KOCHIS: Well, that's probably a good pOint.
Q. Which population do you have to turn to when you
get a peptidase A 2-l?
A. Because the peptidase A 2-1 is an indication of
black heritage, I'm looking at the black population.
Q. What frequency would you get of this profile then
in the black population?
A. It's approximately .26 percent.
Q. And in terms of a hundred or a thousand, how does
that translate?
A. 2.6 per thousand.
Q. Could you perhaps indicate that --
Well, first on the comment section, could you
indicate "Cooper", because it's consistent with Mr. Cooper, and
the frequency of that type.
A. Yes, I can.
Q. And can you also indicate after the thousand, "S·
period "H" period for black heritage.
CCMPUTERIZED TRANSCRIPT
o o
" u U . , ." U
1
2
A.
Q.
4465
(Witness complied.)
And then just not to overlook something which is
3 obvious, patently obvious, this, when you're talking profile,
4 this is a profile that could only have existed based on the fact
5 that it's semen being deposited by a male?
6
7
A.
Q.
Yes, sir.
C9uld you perhaps put male behind about 8B.B.8 or
8 black heritage.
9 Q. So, the -- the population that we are comparing the
10 profile to would be 2.6, or approximately three people out of
11 everyone thousand black males?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes, sir.
Q. You may return to your seat.
So with the information that you got off that
stain, that's the same -- those are the same results you could
get off a semen stain left on the green blanket by the
defendant?
A. Yes, sir, they are.
Q. NOW, did you also perform a test on J-20, the
Viceroy cigarette butt which was removed from that home as well?
A. Yes, sir.
Q. Did you first test the stain to determine if there
was saliva on the stain?
A. Yes, I did.
Q. HOw do you do that?
A. The test that I look for is called amylase. And
27 it's again an enzyme which is present in a high quantity in
28 saliva.
COMPUTERIZED TRANSCRIPT
,crl U
I , I-' o I-' U LI ,
I ,
"' .. -. '" , ~. - .,.-- --.- .. '. - .. -.. - . - ~. - -._.
1
2
3
4
5
Q.
A.
Q.
A.
Q.
4466
Do you smoke cigarettes?
No, I do not.
Have you seen people smoke cigarettes?
Yes, I have.
Is one of the ways that saliva gets on the end of a
6 cigarette the fact that someone has smoked it at one time?
7
8
9
10
11
12
A.
Q.
A.
Q.
A.
Q.
Yes, sir.
Now, did you find amylase on J-20?
Yes, I did.
And that too to you indicated what?
Indicates that there is saliva present.
Would that indicate, for example, that one at one
13 time had smoked the cigarette, had it in their mouth?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes, it would.
Q. Now, did you attempt to determine the person's ABO
type?
A. Yes, I did.
Q. Were you able to to do that?
A. No, I was not.
Q. Which which of the two tests, the
absorption-inhibition or absorption-elution did you use?
A. I used the absorption-inhibition.
Q. And did you find any antigens when you did that
test?
A. No, sir, I did not.
Q. Would that be then consistent with a person that
27 does not secret their antigens in a body fluid?
28 A. Yes, sir, it is.
COMPUTERIZED TRANSCRIPT
1-' U , , ,-, o ,-, u u , .J L
.... -.' ,. .... ' .. -_. ~ .. -.-. -, .. ~
1
2
3
o. A.
o.
4467
For example, Mr. Cooper?
Yes, sir.
Now, Mr. Cooper is not the only person on the
4 chart, 589, that's a nonsecretor; is that correct?
5
6
7
8
9
10
A.
o. A.
o. A.
o.
That is correct, yes.
For example, Chris Hughes is such a person?
Yes.
And so was Peggy Ryen's daughter, Jessica?
That is correct, yes, sir.
If Kevin Cooper had smoked that cigarette butt and
11 left his saliva behind, would the test results you got on the
12 absorption-inhibition test be the same as in fact the results
13 you got?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Yes, they would.
o. And is that finding consistent with, for example,
Mr. Cooper's saliva being on the cigarette butt?
A. Yes, they are.
Q. But it's also consistent, for example, if Jessica
or Chris were old enough to smoke and they smoked; is that
correct?
A. That is correct, yes.
Q. SO could you indicate then on the chart "CW· for
"consistent with" Cooper.
MR. NEGUS: Object. I believe on this particular one
that it's also consistent with everybody else in the world, and
I would object to that particular procedure.
MR. KOCHIS: Well, I can ask some additional.
o. Mr. Gregonis, for example, if peggy Ryen didn't
COMPUTERIZED TRANSCRIPT
. " U I ,
" CI
" u I..J ,
.J ·::J
,r-"
1
2
3 4
4
5
6
7
8
9
10
11
12
13
14 ~.
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4468
hate cigarettes and became a cigarette smoker herself and had I
left saliva on J-20, with her being a secretor performing the
absorption-inhibition test would you have expected to have found
A and B antigens?
A. Yes, I would.
O. And you found no such antigens in the
absorption-elution tests that you did on the cigarette butt?
A. That is correct, yes, sir.
O. And likewise if Doug Ryen happened to have been a
cigarette smoker and put his saliva on the end of that cigarette
when he had it in his mouth, would you have expected to find
doing the absorption-inhibition test A antigens in the saliva?
A. Yes, sir, I would.
Q. And you found no such antigens?
A. Tha is correct.
MR. NEGUS: Your Honor. I believe there has been
testimony, if you want to hear about this, we have had testimony
that the test that Mr. Gregonis performed and the way he
performed it is not conclusive of anything, and I think that's
what Mr. Wraxall will testify.
THE COURT: It may have little or no weight at all, sir,
but it -- your objection goes to the weight of it.
MR. NEGUS: Well, no. I think it goes to the foundation
for what -- for this particular test.
THE COURT: I will permit it. Overruled.
BY MR. KOCHIS:
O. That means you can step to the chart put "CW" and
"Cooper" on it.
CCMPVTERIZED TRANSCRIPT
l·;~:{~
,.
- ,-, LI
I I ,-,
o ,-, u U , U ,
'.-0., , ___ ~. __________ _
r- 1
2
3
4
5
6
7
8
9
10
11
12
13
;---, 14
15
16
17
18
19
20
21
22
23
24
25
26
--- 27
28 ;--- ,
4469
A. (Witness complied.)
THE COURT: Again, ladies and gentlemen, I don't assign
the weight to any evidence that's admitted, simply that it may
come in for whatever significance, if any, it has to you.
BY MR. KOCHIS:
Q. Now, is it fair to say that you do not know the ABO
type of the person who placed their saliva on that Viceroy
cigarette butt?
A. Yes, sir, it is.
Q. And to do that the absorption-elution test which in
some cases may have been more sensitive would have had to have
been performed; is that correct?
A. That is correct, yes.
Q. Were you present with Mr. Wraxall when any such
test was performed?
A. Yes, sir, I believe I was.
Q. Were you able to determine at the end of the test
whether or not -- what the ABO type was of the person whose
saliva was on that butt?
A. May I look at Py notes a minute?
Q. Yes.
A" Okay. AS far as J-20, I don't have any notes of it
so it's possible that I did not test that or was present when
Mr. Wraxall tested it.
Q. Directing your attention to another chart which has
been marked for identification as Exhibit 594; do you recognize
what this chart displays?
A. Yes, I do.
CO~PUTERIZED TRANSCRIPT
.-, U , , o o " u _LJ
5
-.- - ---.. -
4470
1 o. And does this display some of the serological
2 results that you obtained after you tested, in a controlled
3 setting in a laboratory, stains on items which were taken from
4 the Ryen station wagon which was eventually found in Long Beach?
5
6
A.
o. Yes, sir, it does.
Did you test two cigarette butts that were taken
7 from the Ryen station wagon?
8
9
10
A.
o. A.
Yes, sir.
Did they both appear to be manufactured cigarettes?
Yes, it does -- excuse me. Manufactured
11 cigarettes.
12 The V-12 is a, I believe a hand-rolled type of
13 cigarette, and V-17 is a manufactured type cigarette.
14
15
16
17
18
19
20
21
22
o. NOW, did you test either one of those cigarette
butts, the one that was manufactured or the one that was
hand-rolled to determine whether or not there was saliva on it?
A. Yes, I did.
Q. When you -- when you did V-12, what did you find?
A. AS far as V-12 is concerned, I did find the
presence indication of saliva being present.
MR. KOCHIS: Your Honor, would this be a convenient place
to take the recess? I need to get some exhibits.
23 THE COURT: Sure. All right.
24 We will take the noon recess. Remember the
25 admonition. Return at 1:30, please.
26 . (Noon recess taken.)
27
28
COMPUTERIZED TRANSCRIPT
" U , , o o
" u U , 6
.... ------ -- . ~ .
-.
1
2
3
4
5
6
7
B
9
10
4471
SAN DIEGO, CALLFORNIA, WEDNESDAY, DECEMBER 5. 1984 1:35 P.M ••
--00000-
THE COURT: Okay, Mr. Kochis.
DANIEL J. GREGONIS,
called as a witness on behalf of the People, having been
previously duly sworn, resumed the stand and testified further
as follows:
11 DIRECT EXAMINATION (Resumed)
12 BY MR. KOCHIS:
13 Q. Mr. Gregonis, when we broke for lunch we were
14 talking about some of the cigarette butts that you performed
15
16
17
serological tests on this case. Do you recall that?
A. Yes, I do.
Q. Directing your attention for a moment to an exhibit
18 we have marked for identification as 584, from which I'm going
19
20
21
22
23
24
to remove a metal can which has been marked with your laboratory
identification number as V-12.
Is that one of the Cigarette butts that you in fact
analyzed in this particular case?
A. The remainder of it, yes.
Q. NOW, the way the contents of that can appears
25 today, is that the same ~ondition the cigarette butt was in when
26 you first saw it in the laboratory?
27
28
A.
Q.
No, sir, it is not.
Does it appear that the condition of the cigarette
COMPUTERIZED TRANSCRIPT
1
L
r l
.. ,. -r L l •
~,
1 ( ..
2
3
4
5
6
7
8
9
10
11
12
13
14 ~ 15
16
17
18
19
20
21
22
23
24
25
26
27
28
/
~ . .,... ..
4472
butt has changed between the time you first saw it and as it
exists on the witness stand today?
A. Yep.
Q. Do you know who is responsible for changing the
condition of the cigarette butt?
A. In part I am, and in part Brian Wraxal1 is.
Q. How did the form of the cigarette butt get changed?
A. Basically because the tests that we do for the
Amylase to detect saliva and also to try and detect ABO, I guess
these were taken and that portion of the paper extracted with it
with saline.
Q. Is it fair to say that today in court the V-12, the
cigarette butt, has been separated and that the tobacco has been
taken out of the paper?
A. Yes, sir.
Q. That is not the way it appeared when you saw it in
the lab?
A. No, sir, it did not.
" Q. Would it likewise be the situation with V-17, the
manufactured cigarette butt?
A. Yes, sir.
Q. Do you recall that happened to J-20 as well, the
cigarette butt which came out of the 2991 residence?
A. I identified it. It would be myself alone that
changed J-20 somewhat because I did the work on that.
Q. Before you took the butts apart, for example, did
you take pictures of them?
A. V-12 and V-17, yes.
COMPUTERIZED TRANSCRIPT
'r, u
I , o o I-' U U , ·0 o
4473
1 Q. Now, directing your attention to an exhibit which
2 has been marked for identification as Exhibit 79.
3 Does that color photograph, the eight by ten color
4 photograph, depict the rope, J-9, that you tested for
5 bloodstains?
6
7
A. Yes, it does.
MR. KOCHIS: Your Honor, could the record reflect that
8 also on the board we have placed Exhibit 5, the diagram of the
9 Lease house, which is partially hidden by 589. Over that we
10 have two pieces of clear plastic, well, 5-E, which is a sheet of
11 plastic which accompanied Mr. Ogino's testimony and his location
12 of certain items inside the Lease home, and then 5-G, which is a
13 sheet of plastic which Mr. Ogino is going to use during his
14
15
16
17
testimony.
THE COURT: You mean Mr. Gregonis.
MR. KOCHIS: Mr. Gregonis, I'm sorry.
Likewise on 5-G I am going to place Mr. Gregonis
18 name, today's date, and 2991 residence to orient the jury as to
19
20
21
22
23
24
25
which diagram the clear plastic applies to.
Q. Mr. Gregonis, could you join me for a moment at the
diagram, and can you locate, first of all, the approximate
location of the green button, J-6, on the diagram.
Do you see that?
A. Yes, I do.
Q. And you indicated that the serological results of
26 the stain to that button were consistent with the stain being
27 deposited, for example, by either the defendant or Mr. Ryen or
28 someone that had their profile?
COMPUTERIZED TRANSCRIPT
, t
.r---- .\
~.
• ..... # ....... '._-- •• -
I
2
3
..
A.
Q.
A.
Q.
4474
That is correct, yes.
Could you indicate -Doug/Cooper- on top of J-6.
(Witness complied).
And likewise could you locate on the diagram J-9,
5 which is the rope that's depicted in the photograph above you.
6 And I believe you testified that the serological
7 result on the stains on that rope were likewise consistent with
8 being deposited either by Mr. Ryen, Mr. Cooper or someone of
9
10
11
their profile. Is that correct?
A. That is correct, yes.
Q. Could you likewise indicate -Doug/Cooper- at that
12 location.
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A. (Witness complied).
Q. DO you see J-13 on the diagram?
A. Yes, I do.
Q. And that was the number which corresponds to the
the green blanket which was removed from that closet?
A. Yes, it does.
Q. The serological results of that blanket indicate a
stain to that blanket as to the six people on the chart, 589,
could have only come from the defendant~ is that correct?
A. That is correct, yes.
Q. Could you place -Cooper- then on J-13.
A. (Witness complied).
Q. And then likewise the results of J-20, the
cigarette butt that was taken out of the piece of furniture on
27 the diagram, that was consistent with being in Mr. Cooper's
28 mouth at one time?
COMPUTERIZED TRANSCRIPT
j , .i o ,~
u .--. .J
. , .. tJ
2
4475
I A. Yes.
2 Q. Could you indicate that perhaps on the diagram r
3 -Cooper-.
4 A. (Witness complied).
5 Q. Now r you also testified r however r that if Chris and
6 if Jessica would have been smokers r that would also be
7 consistent with corning out of their mouth as well.
8 A. That is true, yes.
9 Q. Could you perhaps then put a line and put -Chris-
10 and -Jessica-.
11
12
13
14
15
16
A. (Witness complied).
Q. You may resume your seat for a moment.
Returning once again to Exhibit 594, the list of
items that were analyzed from the Ryen car.
You tested both the hand-rolled cigarette, the
remains of which are with us in court today, and the
17 manufactured cigarette butt to determine whether or not there
18 was any saliva on those butts; is that correct?
19
20
21
22
23
24
A. Yes.
Q. The presence of saliva would be consistent with
that cigarette being smoked at one time by a person that left
their saliva on the cigarette butts?
A. That is true, yes.
Q. Did you find Amylase present in both your
25 serological examinations of the hand-roll~d cigarette, V-12, and
26 the manufactured cigarette, V-17?
27
28
A.
Q.
Yes r I did.
NoW, on both of those cigarettes, did you performe
COMPUTERIZED TRANSCRIPT
I· Ll
,. o ,. Ll ,. -. ..1
(.
" .....
4476
1 the Absorption-Inhibition test to detect the presence of
2 Antigens?
3
4
A.
Q.
Yes, I did.
Were you able to find, with that test, with the
5 Absorption-Inhibition test, Antigens on either of those
6 cigarette butts?
7
8
9
10
11
A. No, I was not able to.
Q. Now, is that then consistent with a person who does
not secrete their Antigen into their body fluids?
A. Provided that there is enough saliva present, yes.
Q. Is there a test that can be performed on the saliva
12 to indicate the quantity or the amount of saliva that is present
13 on a cigarette butt?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. There are quantitative means, yes, of testing for
Amylase.
Q. Were those tests performed on either of the
cigarette butts in your presence?
A. At a later date, yes; they were.
Q. Initially did you do those yourself?
A. Yes, I did. However, my tests were not
specifically quantitative of -- they were semiquantitative.
Q. What type of tests are ~e talking about?
A. My test was a phaebus test. The other test that is
quantitative is called an Amylase Diffusion test.
Q. Did you perform the phaebus test on both the
handled-rolled and manufactured cigarette butt?
A. Yes, I did.
Q. Did the results indicate that there was, for
COMPUTERIZED TRANSCRIPT
1-' U
I , o o I-' U ,.:1 .:1 .L
4477
1 example, enough Amylase there for you to draw the inference that
2 saliva was there?
3
4
A.
Q.
Yes.
NOw, at a later time, were additional tests
5 performed on both of those cigarette butts, V-12 and V-17?
A. 6 Yes, they there were.
7 Is that using the Absorption-Elution method? Q.
9
10 yours?
A.
Q. lias that performed in a laboratory other than
11 Yes. A.
Q. 12 Were you present during those tests?
A. 13 I was present during part of the tests, yes.
Q. 14 which tests were you present during?
A. 15 The initial Amylase testing, plus part of the
16 Absorption-Inhibition and the Absorption-Elution test.
17 Q. \"ere you, for example, present when the
18 Absorption-Elution test was completed on the manufactured
19
20
21
22
23
24
25
26
27
cigarette butt, V-17?
A. I don't remember whether I was present when it was
completed, no.
Q. Were you present when a determination was made as
to the ABO blood type of the person who deposited saliva on
V-17?
A. Again, I'm not sure whether I was -- specifically I
was present at the laboratory.
Q. Dropping down then to the ·w· series of items, W-l
28 through W-5, leaving out for a moment W-4.
COMPUTERIZED TRANSCRIPT
I-' o I-' U .:I -J :J
4478
I Did you test certain stains that were collected by
2 your laboratory and assigned those identification numbers to
3 determine if in fact they were blood?
4
5
A.
Q.
Yes, I did.
And did your test results lead you to the
6 conclusion that all four stains W-l, 2, 3 and 5 were blood?
7
8
9
A. Yes, I did.
Q. Were you able to test those stains further to
determine if in fact they were human blood or blood from a
10 reptile or something else?
11
12
A.
Q.
They were are all human blood.
And were you able to obtain any additional
13 information from anyone of those stains?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. The only other information that I was able to get
was from W-3, and that I found both the A and the B Antigen
present.
Q. That was then the stain that apparently was removed
from the driver's door of the station wagon, the Ryen station
wagon?
A. That is correct, yes.
Q. And you were able to determine from your testing
that the person whose blood that was, was what we call a ABO
type AS; is that correct?
A. That is correct, yes.
Q. That result was consistent with the human blood of
two of the victims in this case1 is that true?
A. Yes, it is.
Q. And would that be Mrs. Ryen and her daughter,
COMPUTERIZED TRANSCRIPT
. ,. LJ
• _ •• - _ w .......... __ ••
~', !
1 r--2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20 3
21
22
23
24
25
26
27
'--- 28
~
4479
Jessica?
A. Yes.
Q. So the results on that portion of the car would be
consistent with either Mrs. Ryen or her daughter actually
bleeding at that location onto the car?
A. Yes, it is.
Q. Or an assailant who had the blood of either Mrs.
Ryen or her daughter getting into the car and leaving some of
that blood behind?
A. Yes, it is.
MR. KOCHIS: I have nothing further at this time.
THE COURT: Mr. Negus.
CROSS EXAMINATION
BY MR. NEGUS:
Q. Mr. Gregonis, the education and background for your
particular position that you spoke about, has this case been
part of that educational process?
A. I think any case is an education of -- I mean, the
more cases that you do the more you learn.
Q. HOW about this particular one?
A. Yes, it is.
Q. DO you know a lot now that you didn't know when you
started?
A. I have learned quite a bit from this case, yes.
Q. Involved in this particular case have there been
people with considerably more experiences and education than
yourself, who you have talked about the different procedures and
COMPUTERIZED TRANSCRIPT
rl U
I , ,~,
o I-' U ,-J
5
, -----,
1
2
3
4
5
6
7
8
9
10
11
12
13
14 ,~
15
16
17
18
19
20
21
22
23
24
25
26
27 -. 28
~
U80
results, analysis thereof?
A. Yes.
Q. Mr. wraxall, you have mentioned, he certainly has
more experience than yourself; is that correct?
A. Yes, he does.
Q. And Dr. Blake has both more experience and more
education than yourself?
A. I don't know about Dr. Blake's experience. I would
assume since he's been at it longer than I have he would have,
but he's got more education than I do, yes.
Q. And there was also a Dr. George Sensabaugh that you
received some input from in this case; is that right?
A. Myself? Not specifically, no. I believe he was
called as a prosecution witness.
Q. Was that at your recommendation?
A. I believe it may have been, yes.
Q. You didn't talk to Dr. Sensabaugh about any of
these particular things?
A. No, I did not.
Q. Well, have you taken various of your results to
other people and asked them to comment on them?
A. Yes, I have.
Q. For example, the, the Haptoglogin test that you did
on the drop, on the blood, A-41, did you preserve the actual
test? That is, preserve the results of the tests, not just in
the photographic form, but the actual plate itself?
A. Yes, I did.
Q. And did you take that plate up and did you show
COMPUTERIZED TRANSCRIPT
n u , , o o " u ,:J
6
4481
1 that plate to Brian Wraxall?
2 A. I believe I may have showed it to him possibly down
3 in the laboratory in San Bernardino.
4
5
6
Q.
A.
Q.
Wherever, you did show it to him: is that right?
I believe so, yes.
And he looked at the plate, and he wasn't able to
7 confirm for you that in fact the A-4l was what you said it was?
8
9
10
11
MR. KOCHIS: Objection, that would call for hearsay, this
statement of another person.
THE COURT: What's the hearsay purpose, Mr. Negus?
MR. NEGUS: The normal type of thing that an expert would
12 rely on. He's testified he has~relied upon the opinions of
13 Mr. Wraxall in this case.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
THE COURT: But not that particular one. You to have lay
a better foundation.
MR. NEGUS: Well, I mean --
THE COURT: The general methodology perhaps, but I don't
recall him saying he relied upon Mr. Wraxall's consultation on
that particular slide.
BY MR. NEGUS:
Q. Did you rely on Dr. Wraxall? Well, not Dr.'
wraxall, Mr. Wraxall.
A. That is correct, yes.·
Q. Did you rely on Mr. Wraxall's consultation as far
as your testimony about Haptoglobin is concerned?
A. No, I did not.
Q. Why not?
A. Basically because the plate and the photograph
COMPUTERIZED TRANSCRIPT
rl U , , ,-, o " u ,-.J -, ,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
/-----, 15
16
17
18
19
20
21
22
23
24
25
26
27 ''-
28
4482
were -- first of all, the photograph was not going to pick up
everything off the plate, and the plate itself is degraded to
the point where it is not in its original condition. So, I
believe Dr. Wraxall, or Mr. Wraxall, excuse me, was not able to
make a call off of it for those reasons.
Q. Well, why did you show him the -- why did you show
him the plate then to begin with? Was it to try and get advice
from him?
A. Just to see what his opinion would be of that
stain.
Q. So, the fact that he was not able to confirm your
opinion was of no, no account to you?
A. For reasons stated, because it was not in the
original condition, yes.
Q. You mentioned that you can get more information
from looking at the actual plate itself than you can from a
photograph.
Is there anything particularly difficult about
photographing a Haptoglobin gel?
A. It is not difficult to photograph it. However,
with any photograph you are not going to pick up what's actually
on the plate, I mean, everything that's on there.
Q. But, what color is the -- what color is the gel
that you see when you look at the Haptoglobin run?
A. Well, the banding patterns themselves?
Q. The gel.
A. Well, the gel is pretty much clear. It may have a
blue color from the solution I developed the Haptoglobin with.
COMPUTERIZED TRANSCRIPT
(j U
,~
CJ .--.J
·C tJ
,/--.
1 ,-I
2
3
4
5 1
6
7
8
9
10
11
12
13
14 /"'~
15
16
17
18
19
20
21
22
23
24
25
26
27
28
~~
4483
Q. Okay. And what color are the bands?
A. They're anywhere, depending on the time, they are
anywhere from a dark blue-green color to a brown color.
Q. Is it a dark brown color?
A. It can be.
Q. In terms of photography, as far as getting an image
that shows what you have on the gel, what you want to make sure
of is the contrast in your gel; is that right?
A. That is true.
Q. You can't ask for much more contrast than a light
gel with dark colored bands.
A. It does give it a pretty good contrast, yes.
Q. Then I take it that you have experimented with
various photographic filters in order to enhance whatever
contrast is on the gel; is that right?
A. Yes, I have.
Q. So, as far as your photographs are concerned, it
certainly is not very difficult to get a nice high contrast
photograph of the Haptoglobin.
A. Again, it is not difficult. However, you are still
not going to pick up everything that is on that gel.
Q. Well, what -- in the the Haptoglobin photo, did you
show that to Dr. Wraxall, too?
A. I don't remember whether I did or did not.
Q. Of the photo, the photo that you took about the
Haptoglobin of A-41, does that show what's missing from that
photo that you saw there when it was before you and Ed Blake in
the lab?
COMPUTERIZED TRANSCRIPT
n u
~ , " o
" L' ,-:1
·0 ...J
-. ~ .' ..... -~- .............. - -.. ,~ ~-.. -- - - -_.
4484
1 A. Basically it is, I guess, if you would say the
2 contrast in the darkness of the band that I am actually seeing
3 in the photograph as opposed to actually on the plate.
4 o. So there is more contrast on the plate than there
5 is in the photograph?
6
7
8
9
10
A. I would say so, yes.
o. Is there anything on the plate that doesn't appear
in slightly less contrast on the Haptoglobin photograph? Any
missing bands?
A. I don't believe so. But I did not do a comparison
11 directly from the photograph to the plate at that time, so I
12 can't tell you for sure.
13 o. Isn't that the point of doing it with the Polaroid
14 so you can do that?
15
16
17
18
19
20
21
22
23
24
25
26
27
A. I don't generally compare the photographs
immediately to all the plates that I do.
Q. Well, that particular photograph, that was, that
was the only run that you and Ed were doing on that at that
particular time; is that right.
A. That is correct, yes.
Q. And I suppose that at that point in time nobody
knew what the Haptoglobin results of A-41 were going to be; is
that right?
A. That is true, yes.
O. It is of major interest.
A. Yes.
O. And the photographic process was likewise of some
28 major interest, was it not?
COMPUTERIZED TRANSCRIPT
;'.' or, '-'
I , ,-, o ,-, u ,-o
. " u ,-
1
4
5
6
7
8
9
10
11
date,
A.
Q.
did Ed
A.
Q.
A.
Q.
A.
Q.
A.
4485
It is to preserve the results, yes. However, since
The particular procedure that you used on that
tell you how to do it?
No, he did not.
Had you ever done it before?
Yes, I did.
In case work?
Yes.
How many times?
Probably analyzed around a hundred stains and
12 possibly fifty unknown or standard bloods.
13 Q. How many actual Haptoglobin runs, using that
14 particular technique that you used on October 4th and 5th, 1983,
15 had you done prior to this case work, prior to that date?
16 How many times have you set up your machine?
17
18
19
20
21
22
23
24
25
A. Probably I would say 20 to 25 times.
Q. Isn't it a fact that you didn't go into routine
work with Haptoglobin in your laboratory until after that time?
A. As far as routine on every -- as many cases as
possible, no, that is a fact.
Q. Did Ed help you take the picture?
A. No, he did not.
Q. When you -- when you changed your mind about what
Acid Phosphatase type Mr. Cooper was -- first of all, when did
26 you change your mind?
27 A. Basically after doing some work on seeing what an
28 RB actually does look like on my. system. Seeing what --
COMPUTERIZED TRANSCRIPT
" CI ,-, U 1-o , ,
-,
1 (-
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
,.-,
4486
Q. Just when. What date, month?
A. I don't have a date on that. I can't remember.
Q. August, 1984, sound right?
A. That is a possibility, yes.
Q. And was that after consulting people who had more
experience and education than yourself about Mr. Cooper's blood?
A. In part, along with --
Q. Just answer the questions and then --
THE COURT: I don't think he had finished, counsel. In
part along with something else. You have got to give him a
chance to fully answer.
MR. NEGUS: I think that was a full answer. He said in
part. what other things we can get to later. If I don't get
it, Mr. Kochis can bring them out. But I think that was a full
answer to the question.
THE COURT: The way your questions are phrased, I think
the question just calls for part of the reasons.
MR. KOCHIS: Well, your Honor, I'd object to Mr. Negus
cutting the witness off and not allowing the witness to give a
complete answer. If he asked a question which calls
THE COURT: There is nothing pending right now, Mr.
Kochis.
Go ahead, sir.
BY MR. NEGUS:
Q. When you changed your mind, was that after you
received a phone call from Mr. Kochis about Ed Blake'S analysis
of Mr. Cooper's blood?
A. I am not sure if I learned it from Mr. Kochis or
COMPUTERIZED TRANSCRIPT
or, u , , ,-, o
" u ,-o -:I c:
1 .. -~
2
3
4
5 2
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
~.-
4487
not, but it was after I learned of Mr. Cooper actually being an
RB, yes.
o. So, after you -- if you learned from some source
other than yourself Mr. Cooper actually was an RB, then you went
back and changed your mind; is that correct?
A. No, that is not correct.
O. Certainly -- how many times before -- well, let me
just back-up.
When was it that you that you changed your mind
about A-41? Was that after you learned that Mr. Cooper didn't
match your original call of A-4l?
A. Well, it was after, basically after I learned what
an RB looks like on my system: after I learned where the R or
the diagnosis area for an R is, and after calling several
experts, in particular Jim White.
I also talked to some people. I don't think I
can --
O. You have answerd the question.
Did you change your mind about A-4l after you
learned that if your original call was accurate, A-41 couldn't
have come from Mr. Cooper?
A. Not immediately, no. But it was after.
A. Yes.
O. Prior to your learning that if your original call
about A-41 was correct, then it couldn't have come from Mr.
Cooper, how many times did you testify on the witness stand,
under oath, that A-41 was a B and nothing else but a B1
A. It is probably about three times.
COMPUTERIZED TRANSCRIPT
i
1-' U
I , I-' 13 I-' U 1-o
1
:lj Ji
!
~ I
I
I r--, .
I
2
Q.
A.
4488
What is blind testing?
Blind testing is something where you do not know
3 anything about the sample and then you proceed to test it and
4 give the results and compare those to standards or something
5 else after you have done all the testing.
6 Q. When you tested A-41 in June and August of 1983,
1 were you -- were you trying to test it blind?
8
9
A.
Q.
Up until the end of June, yes.
Prior to doing any enzyme testing on A-41, did you
10 learn from a serologist in Pennsylvania by the name of Walter
11 Lawrence that he had information which made him believe that Mr.
12 Cooper was a PEPA type 2-1 and a PGM type l+?
13 A. I think that that information came to me after I
14 had done the EsD and PGM along with after doing the ABO.
15
16
11
18
19
20
21
22
23
24
25
26
21
28
Q. When was it that you got that information?
A. I don't know specifically. I believe it may have
been after June the 14th, somewhere between June the 14th and
June the 29th.
Q. IS it possible it was prior to June the 14th?
A. I don't remember it that way, but it's possible
that it was.
Q. How come you don't know what the Gc types of the
victims are?
A. Simply because I tested their bloods at too late a
date to pick them up. Gc is very labile, it goes away quick, if
you will.
Q. Why did you wait so long?
A. Basically I was not doing the Gc routinely at the
COMPUTERIZED TRANSCRIPT
'n u , , D o " u ,a ·LI . ,
""
1"--- ....... \
1 ... ~-"-.
2
3
4
5
6
7
8
9
10
11
12
13
14
~ 15
16
17
18
19
20
21
22
23
24
:25
26
27
28
~
4489
time that would have been good to pick those up.
Q. How come you don't know Chris haptoglobin type?
A. Again, the same thing. There is just -- did not
get a good result to call them.
Q. Is that because you weren't doing haptoglobin
routinely at that point in time when you first got the sample?
A. That is correct, yes.
Q. with respect to your analysis of Kevin's blood, the
sample VV-2, I take it that at this point in time there's as
long as Kevin gives a sample of blood there's no problem, any
serologist in the world can come back and check your results; is
that right?
A. That is true, yes.
Q. Same with Josh?
A. That is true, yes.
Q. But for -- and I suppose that same for some of the
various and sundry people that you all have included in your
rest of the world chart, Exhibit 596; is that correct?
A. Hopefully for all of them.
Q. But for -- for all of the other -- all of the other
evidence in this particular case, is that any longer true?
A. Not for all of it, no.
Q. For some of the -- for some of the evidence you've
tried to do everything that science, or at least serologists
currently know how to do in order to keep the samples from
degrading; is that right?
A. That is correct, yes.
Q. Other that you have testified about today, that
COMPUTERIZED TRANSCRIPT
n u , , o o " U fa 5
I
2
4490
hasn't been done, correct?
A. That is correct. It's being done at the current
3 time.
4
5
6
Q.
A.
Q.
But it wasn't done from the beginning?
That is correct, yes, not with all the samples.
And you basically can't go back and recoup what
7 you've lost by ignoring it at the beginning; is that right?
8
9
A.
Q.
That is correct, yes.
Now, with respect to the -- to each of these tests
10 that you performed, the tests are not like looking at something
11 under a microscope in the sense that every time you do one of
12 these tests you consume, use up a portion of your sample; is
13 that right?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. That is correct, yes.
Q. And -- I mean, that's a common problem with samples
of blood or other body fluids that are involved in the evidence
of crime; is that right?
A. Yes, it is.
Q. There's rather extensive literature dealing with
about how to try and maximize the information that you can get
from any particular sample; is that right?
A. That is correct, yes, sir.
Q. As far as the actual work that you did when you
were consuming the samples in your analysis, did you at all
stages of your work attempt to do those tests which would use
the least amount of sample for the maximum amount of
27 information?
28 A. Not in all cases, no.
COMPUTERIZED TRANSCRIPT
.-, U , , ,-, o I-' U ,-o 6
.... ~." '~-",- .... --: .. -.
•• -<-'
I
2
4491
1 Q • A-41, was that one of the cases where you didn't
2 maximize the information for the least amount of sample?
3 A. As I know it now, that is true. However, since I
4 thought that I was going to be able to run all my systems on it
5 from the beginning I wasn't too worried about what order I was
6 going to do it in.
7 Q. And you weren't too worried about saving enough
8 left over so that somebody else could go back and check your
9
10
11
work when you started out, right?
A. Yes, I was.
Q. Did you waste any of A-41 and get no information in
12 return?
13 A. I believe there's two points of A-41 which could
14 have been different -- done differently to get more information,
15
16
17
18
19
20
21
22
23
24
25
26
27
28
and that is I ran the Group II test with a smaller amount trying
to conserve a sample on June the 28th, 1983, which I was enable
to get the EAP or the AK type.
Q. So, that was sort of a waste?
A. It turned out to be, yes.
Q. Any other sample that was wasted?
A. Also I redid the ABO. I first did it on June the
12th, 1983, and I did it again on June the 29th, 1983.
Q.
right?
A.
Q.
A.
Q.
Your original results were clear and unambiguous
They seemed to be, yes.
So that was a waste to be doing it?
As you look at it now, yes.
Did it appear to be a waste as you looked at it
COMPUTERIZED TRANSCRIPT
." U I ,
,-, o I-' U ,a
.. -, ,
1
.......
· 4492
1 then?
2 A. well, after reviewing it, yes.
3 Q. Did you -- did you unnecessarily fail to preserve
4 us adequate photographs of those parts of your analysis of A-41
5 which could be photographed?
6 A. I tried to photograph to the best of the
7 laboratory's and the best of my abilities those photographs from
8 A-4l, so I disagree with that question.
9 Q. Let's just start out, when you -- when you
10 photographed the first thing that -- the first thing that you
11 did that could be photographed was your Group I test that you
12 did on June the 13, 1983; is that right?
13
14
A.
Q.
That is true, yes.
You got a photograph -- you took two different
15 photographs, one of the erterase D and one of the PGM?
16
17
A.
Q.
That is correct, yes.
Did you bother to look at either of those
18 photographs to see if they came out when you -- when you did it?
19
20
21
22
23
24
25
26
A. As with all the photographs that I use, I make sure
that a what is on the plate or essentially the exposure is
correct.
Q. But did you look to see whether it was -- the image
that you got was such that another serologist could come back an
check your work?
A. No, sir, I did not.
Q. Both of the photographs that you took on June the
27 13th of the Group I are not of sufficient quality due to one
28 technical problem or the other for you to -- for another
COMPUTERIZED TRANSCRIPT
" o
" L' ,-" .-·0 .0
............ --~ ...... -.---~-.-,.--- -' - .
/~
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
, 27 "---
28
, ~\
4493
serologist to check your work, is that right?
A. That is correct, yes.
Q. Is it your position that the haptoglobin photograph
is not of sufficient quality for another serologist to check
your w'ork?
A. Not entirely, no. I have shown it to other people
and they seemed to agree with me as far as the result.
Q. Do they tell you that you it would be a 1, 2-1M, or
a 2-1, you can't really tell from the photographs?
A. One person that I know that I showed it to told me
that it was a 2-lM.
Q. Who was that?
A. That was a Barbara Johnson from the L.A. Sheriff's
Office.
Q. How about anybody that you showed it to, did they
tell you can't tell between a 2-1 and a 2-lM?
A. Not that I recall, no.
Q. Mr. Wraxall?
A. Again I do not recall his statements about the
photograph or the plate.
Q. Jim White?
A. Did not show it to Jim White.
Q. And let's see, I think you've testified today that
at least in your opinion now the Group II photos, at least as
far as the acid phophatase, won't tell us anything between
whether you were right the first time or not?
A. They basically tell me that its either a B or an
RB. It doesn't differentiate between the, two.
COMPUTERIZED TRANSCRIPT
1-' U , , .-., o " U 1-o ·0 ,J
1 {--
2
3
4
5
6
7
8
9
10
11
12
13
14 r-'
15
16
17
18
19
20
21
22
23
24
25
26
27 -
28
/--,
4494
Q. And your explanation was that it was a technical
fault on your part, you made a mistake?
A. Essentially, yes.
Q. The -- How about the CA -- the CA II result on
A-4l, can you tell us from the photograph whether that's any
good or not?
A. NO, you cannot.
Q. Well, leaving aside the ADA and the AK which --
Well, basically ADA and AK don't discriminate
between hardly anybody, is that right? There is' over 90 percent
of the -- any population, has the same type as all the victims
and Mr. Cooper and all the other people involved in the case as
far as ADA and AK is concerned; is that right?
A. That is true, yes.
Q. SO leaving aside those two that don't tell us much,
is it fair to say that you only preserve an adequate record for
another serologist to come back and check of two, the
transferrin and the peptidase A?
A. As far as photographs, yes.
Q. And the only thing besides photographs that you
preserved was the piate in the transferrin and the plate in the
haptoglobin, right?
A. Along with my notes on the actual run itself.
Q. But you can't tell, your notes are just numbers, we
can't tell whether you're right or wrong about that, right?
A. That is correct, yes.
Q. I mean, if your notes are right, then A-41 we know
for sure didn't come from Kevin Cooper?
COMPUTERIZED TRANSCRIPT
1-' U
I I ,-,
o I-' U -, . I " I-' U
1 r· ... --..,
I
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
,23
"24
25
26
27 '---
28
4495
A. My notes indicate that it's either a B or an RB.
Q. That's not what you originally wrote down, is it?
A. That is correct.
Q. That's something you changed in the course of time,
your original notes that you read.
When you were reading off the plate when it was at
the optimum advantage, if did your notes are correct thenA-41
is not correct?
A. Well, using the same argument as my original notes,
my original call on VV-2 the blood sample from Cooper was also.
Q. I'm just talking about A-4l, pleas~. The question
I'm asking, if your original notes, if A-4l is correct, did not
come from Kevin, r~ght?
A. If A-4l is actually a B, then it could not have
come from Mr. Cooper.
Q. And you wrote down on August 3rdi 1983, when you
read it off the plate when you had the maximum advantage -B-,
straight B, right?
A. That is correct.
Q. So, when we're relying on your notes, that's what
we got, right, what you saw at that point in time?
A. If you're only looking at A-41, yes.
Q. As far as the proficiency that it takes to be a
forensic serologist,' the actual techniques of plugging up the , ..
machine, preparing the samples, running the test, putting on the
dyes or the stains, whatever you want to call them, that sort of
thing, that particular those particular techniques are such
that you don't have to be a Ph.D in biochemistry in order to do
COMPUTERIZED TRANSCRIPT
., o
" u , , j ,
2
1
2
3
4496
it correctly~ is that right?
A. That is correct, yes.
Q. You don't even have to have the training that you
4 have~ is that right?
5 A. Not all my training, no, but you definitely have to
6 have some of it.
7 Q. Okay. But it doesn't take any real knowledge of
8 biochemistry or anything of that nature to actually run the
9
10
11
test?
A.
Q.
No, it does not.
Interpreting the test, however, is another matter,
12 is that correct? It takes considerable amount of training and
13 experience.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Takes definitely more training and experience to
interpret the test, yes.
Q. And as far as A-4l is concerned, at least today,
with the exception of the transferrin and the peptidase A and
perhaps Ed Blake's perceptions about the haptoglobin, the
accuracy of our knowledge about A-4l depends upon the accuracy
of your perceptions: is that correct?
A. That is true, yes.
Q. Before today you have testified at least ten days
in this particular case, is that reasonable?
A. Yes, it is.
Q. Have you gone over that testimony in transcript
form after you gave it from the witness stand?
A. Somewhat, yes.
Q. Did you note whether or not any of your testimony
COMPUTERIZED TRANSCRIPT
n u , , o o
" u , , .:.1 .L
~ ,
1
2
3
4
5
6
1
8
9
10
11
12
13
,~, 14
15
16
11
18
19
20
21
22
23
24
25
26
21 " .........
28 /r--,
4497
demonstrated any incorrect perceptions about the biochemistry
which is involved in interpreting these particular tests?
A. Not as a whole, no.
Q. I mean, did you make a lot of mistakes?
A. No.
Q. Did you make some?
A. I made some different answers which may be
interpreted differently depending on the phrase of your
question.
Q. Mr. -- Dr. Sensabaugh has written many articles,
has he not, about mistakes of interpretation that analysts can
make in looking at plates; is that correct?
A. That is correct, yes.
Q. And at least as to some of those, you read and
studied those?
A. Yes, I have.
Q. To your knowledge, did your testimony about the
various things you have to watch for in order to make a correct
interpretation contradict those things that you've read from Dr.
Sensabaugh?
A. Not to my knowledge, no.
There are -- there were -- there is some confusion
as to one thing in particular, the deamidation reactions which
happen to PGM in particular, but I believe that was made clear
at a later time.
Q. That's the only thing that you can recall?
A. That I can recall,
Q. Did you -- did you ever see Mr. Wraxel1's advise
COMPUTERIZED TRANSCRIPT
.. ---"';.,-......
'rl U
I , I-' CI
" u , , ,
, ~,
.:3
1
2
3
4
5
6
7
8
9
10
11
12
13
( ~, 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 /'-
about the methods that you used in analyzing the various
cigarette butts that you looked at in this case?
A. Yes, we did.
4498
Q. Did he tell you that your conclusions were not --
were not sustained by your data?
MR. KOCHIS: Your Honor, I would object. That's going to'
call for hearsay.
THE COURT: It's a good objection.
BY MR. NEGUS: :~~~~
Q. Did you take into account in your opinions here
today in court Mr. Wraxell's opinions that he expressed to you?
A. Somewhat, yes.
Q. Is that opinion that your original conclusions as
to the cigarette butts were not supported by your data?
A. I would say as far as his conclusions what he draw
drew and the reasons for drawing them.
My conclusions are definitely weakened because he
is looking at a quantative type of analysis where I was looking
at what I would term a semiquantitative.
Q. Let's -- Let's get down to specifics for just a
second.
On the cigarette butt, J-20, you can -- your --
your particular testing procedure was such that you were able to
determine that there was saliva on that cigarette butt, right?
A. That is correct, yes.
Q. And that when you did the absorption-inhibition
test you didn't get any information~ is that right?
A. I got no antigens present, that is correct.
COMPUTERIZED TRANSCRIPT
. ':".;' .. ,
." U , , 1-.' 13
" u , , ·L' ,
4499
1 Q. NOw, the -- you used the word, I think you said
2 that that result was consistent with Mr. Cooper having smoked
3 the cigarette: is that right?
4
5
A.
Q.
Yes, it is.
You don't know what my blood type secretor status
6 are whatsoever: is that correct?
7
8
9
10
A. That is correct.
Q. It's just as consistent with my having smoked a
cigarette as Mr. Cooper, is it not, based on your information?
A. Not knowing what your blood types and stuff are,
11 that is correct, yes.
12 Q. It's consistent with being a secretor or
13 nonsecretor?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. It's more consistent with being a nonsecretor.
Q. What do you mean "more consistent-?
A. Basically I found amylase, which by my
semiquantitative test, if you will, is at least a medium amount
of amylase present, and I did not find any antigens.
Q. Is this simply -- quantative, is that a new word
that's come into your description of your testing procedures for
today's testimony?
A. It may be in court today, but it's something that
I've used before.
Q. Did you ever say that you didn't try and reach any
quantitative result about the amount of saliva present
whatsoever?
A. Not -- Well, not by Mr. Wraxell's method, no, that
28 is correct.
COMPUTERIZED TRANSCRIPT
rl U
I , .--, o I-' L' -, . , 5
3
4500
1 o. Well, basically isn't it a fact that merely
2 demonstrating that there's saliva present doesn't tell you
3 whether or not you should get a you will necessarily get a
4 positive result from a secretor on a cigarette butt test, is
5 that right?
6
7
A.
o. That is correct, yes.
So basically you have no way of knowing from your
8 particular testing techniques as to J-20 whether or not it was
9 smoked by a secretor, and there was not enough left there to --
10 to get a test result it was smoked by a nonsecretor, there is
11 not enough left there to get a test it was smoked by a
12 nonsecretor, and the reason that there is not enough there is
13 because he is a nonsecretor, can't tell any of those different
14
15
16
17
18
19
20
21
22
23
24
25
26
possibilities, right?
A. Not absolutely, no.
Q. SO, basically as far as what you did to this date
on J-20. you can't exclude a single person on the face of this
earth as being the person that smoked that cigaret~e.
A. Given your basis that if there was not enough there
to give me a result, yes.
O. And you have no way of knowing whether there was or
there wasn't, right?
A. Only from my past experience with cigarette butts
and the amount of amylase and the phaedebas amylase test.
Usually when I get -- or I cannot recall getting a positive
amylase which I did not term a weak amylase test where I had a
27 secretor that did not give me results.
28 O. But you've never done a systematic study of that.
COMPUTERIZED TRANSCRIPT
II U
I , 1-' o I-' U -, . , 6
'--:.- -"-~ ~ < -"'---_.,- - ---
, !
! ........
4501
1 And Mr. Wraxa11, who has studied more systematically than
2 yourself. disagrees, right?
3 A. He would definitely put a quantative test in there,
4 yes.
5 Q. And he states flat out that based on what you did,
6 could have been anybody in the world?
7 A. Okay. As far as J-20. I don't know what his
8 opinion would be on that.
9 Q. Well. you did the exact same thing with respect to
10 V-12 and V-17, did you not?
11 A. That is correct.
12 Q. And when you finished your analysis, before he
13 helped you out the situation was that anybody in the world at
14
15
16
17
18
19
20
21
22
23
24
25
26
27
that point in time when you finished could have smoked the
cigarette butts, right?
A. I believe that's essentially what Mr. Wraxell would
say, yes.
Q. Well. did you take the cigarette butts up to have
him do further testing on it because he had more experience and
knowledge and -- about that than yourself?
A. Partly, and also because he had different
techniques than myself.
Q. After you had used up -- when you -- when you
tested the cigarette butts you used up the -- the portion of the
cigarette butts that were most likely to be informative: is that
right?
A. I used up the portion of the cigarette butts that
28 were -- most likely would have the largest quantity of saliva on
COMPUTERIZED TRANSCRIPT
"r, u
I , ,--, o ,-, L' -, . ,
," -, ,
·'--;
' .....
4502
1 them, yes.
2 Q. Okay. That would be the most likely to be
3 informative?
4 A. If you are looking for a large quantity of saliva,
5 yes.
6
7
8
Q.
A.
Q.
That's what you were looking for, was it not?
Yes.
After you used up the best portion of the cigarette
9 butts, you and Mr. Wraxell were unable to come to any conclusive
10 determinations as to the that -- as to the secretor status of
11 the person that smoked the cigarette; is that right?
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. That is correct, yes.
Q. Had you not -- had you not used up the sample doing
your your particular test, most likely we would have been
able to know that; is that correct?
A. I can't say whether that's true or not. I don't
know how much --
Q. How much you used up?
A. Well, how much? I don't know whether there would
have been a sufficient quantity for Mr. Wraxell to make his
conclusions.
Q. Would you say that the odds of our knowing the
answer to that would have been significantly increased?
MR. KOCHIS: Objection. That would call for speculation
if we're talking about odds.
THE COURT: He has given probabilities on other methods
before. It's a matter of his expertise. Overruled.
THE WITNESS: I think there would have been a better
COMPUTERIZED TRANSCRIPT
" U , , o o
" u -, . , ·0 o
1 (-
2
3
4
5
6
7
8
9
10
11 1
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4503
chance of getting more information out of it, yes.
BY MR. NEGUS:
Q. Was that one of the things that you learned during
the course of this particular case?
A. Yes, it is.
MR. NEGUS: I need to get some paper up, your Honor,
maybe we could -- it's just about the right time.
THE COURT: Sure. All right. We will take the afternoon
recess.
Remember the admonition.
(Recess taken.)
THE COURT: Please continue, counsel.
CROSS EXAMINATION (Resumed)
BY MR. NEGUS:
Q. Directing your attention to a piece of paper on the
board behind you, which I'm putting a sticker, on which says
Exhibit 598.
If you could get one of the colorful Sharpies, I'd
like to, as far as, as far as your analysis of A-41 is
concerned, just to put, make a sort of a time line.
The actual putting of that little tin box that we
had the picture of up here into the freezer, was that done by
yourself or somebody else?
A. That was done orginally by Mr. Stockwell.
Q. Okay. So, on June the 9th then, did you go to the
freezer and get it out?
COMPUTERIZED TRANSCRIPT
-,-... ~ ! ~~~~ ...... ,
" o
" u , , ',0 .:1
c- 1
2
3
4
5
6
7
8
9
10
11
12
13
"r-- 14
15
16
17
18
19
20
21
22
23
24
25
26
27 ---
28
A. Yes, I did.
Q. Okay. And on that date you said you did the
ortho-tolidine test on the, on that particular, on that
particular sample.
A. Yes, I did;
Q. Could you put then up here "6-9-, O-Tol-.
A. (Witness complied).
Q. NOW, that happens to be your abbreviation for
ortho-tolidine that you use in your notes: is that right?
A. Yes, it is.
Q. On that particular date, when you did the
4504
ortho-tolidine test, do you, do you have to do anything to the
sample in order to do that particular test?
A. Well, you have to take an extremely small quantity,
put it on a filter paper and then add the reagent to the filter
paper.
Q. Okay. When you did that, do you have like all the
different, all the different containers that you had to analyze
out on the table together, and go one by one, or how do you work
that out?
A. I basically analyze one sample at a time, and just
open the container, do the test and then close the container and
go to the next sample.
Q. So, you get them, you get them all out, open one at
a time and close it?
A'. If Ilm analyzing more than one at a time, yes.
Q. On June the 9th you were doing a whole slew of them
for ortho-tolidine; is that right?
COMPUTERIZED TRANSCRIPT
',-, U
I , .-, o ,-, u .-, o
, " U
/ 'I,
(--. 1
2
A.
Q.
4505
Yes, I did, yes.
Then the next time, June 9th, was a Thursday, is
3 that correct?
4
5
A.
Q.
I have no idea.
At that point in time were you working weekends on
6 this particular case?
7 A. I don't know if that's when I started working
8 weekends. I'm not sure.
9 Q. You certainly have since, but at least the
10 beginning you don't remember doing it: is that right?
11
12
A.
Q.
Not the beginning, no.
Then next, on June the 12th, if we have a calendar
13 for '83, I think that the record would reflect that is in fact a
14 Sunday.
15
16
17
18
19
20
21
22
23
24
2S
26
A. Well, if the 5th was a Sunday, correct.
Q. Here we go. We just happen to have, Mr. Bailiff, a
1983 calendar.
So, the 12th being a Sunday, on the 12th you did
come in and do some more work on this particular case; is that
right?
A. Yes, I did.
Q. And that was the day that you did the test for
human species and it is two tests that you do in order to
determine the ABO type of a particular substance.
A. That is correct, yes.
Q. SO, could you put -6-12-83- and then, let's see.
27 Well, the abreviation that -- what abreviation do you use for
28 the species test?
COMPUTERIZED TRANSCRIPT
. ,-, U , , ,-, CI I-' U ,-, o
I ,
{-1
2
3
4
5 than
6
7
8
9
A.
o. A.
o.
A.
Q.
A.
Q.
4506
I use a small -ppt-.
Okay. That's stands for precipitin.
Yes.
That's another name for that particular test other
That is a more general name, yes.
So could we put -6-12-83- and then -ppt-.
(Witness complied).
And then -- the two tests that you did on the dry
10 blood samples or ABO 1 you used the Ab-EI abreviation. The
11 other one you use Lattes?
12
13
14
15
16
17
A.
Q.
A.
o. A.
Q.
Lattes, yes.
L-a-t-t-e-s?
Yes, sir.
So could you put those along there as well.
On that Sunday again you did a whole slew of divide
18 of those different tests for different samples; is that right?
19
20
21
22
23
24
25
26
you do
first?
time.
A.
Q.
the
A.
Q.
Yes, I did.
Then on your procedure on that particular date, did
ones to determine what species you are dealing with
I really don't know. It may have been at the same
Okay. HOW did you, how did you handle that?
Do you just -- let's just focus in on A-4l. Did
27 you just take a little chip of blood out and use that, or did
28 you prepare it in some way?
COMPUTERIZED TRANSCRIPT
.,..
L
.. r -,. l .. r -•
61942583500 PAGE 02
·~.',-""""",.,,,,,,.,,,,,,_ ' ..... 0 " ••••
2
'-
.~.
1
2
3
•
about?
A ..
o • A.
• ............... " .. - 1_ ••
4507
AI far a& the species, that 18 wbat you are talking
Did you do it separately?
The species and the Absorption-Elution and the
5 Latta ••
o. I think 1 am getting -- 8lowing down 1ft the
7 afternoon..
8 On June the 12th, let's just be mote concrete. the
9 first thing you 90 back to the freezer and get the little
10 container out again.
11
12
A.
Q.
That 1s true, ye ••
You put it back there on June the 9th vben you got
13 through with it.
l' IS
16
17
18
19
20
21
22
23
25
A. That is correct.
O. And then when you were. when you weee getting a
little bit on your filter paper you just basically have to dab
the filter paper against some little speck of blood and it picks
it uPCi9ht, and that's all you need do to the ortho-tolldine
teat?
A. Basically. yes.
O. Now, the test that -- your diagnosis on the 12tb
they require more samples than by just I guess the dab and cub
method ..
HoW did you get that sample out of that container?
A. Wp.ll, t would have at that time, basIcally the type
26 of ~~mplp ~hat this was in a scraping like a powder or flakes of
27 blood. so [ si~plY would have done two. Either with a sDall
28 spatula. pOssiblY an e!qhth of an inch ac~osa. and with a pair
OOHPUTBRIZED TRANSCRIPT
'n u , , B D B -j
61942583500 02-13-96 10:21AM P002 ~42
02/13/1996 10:19 61942583500 PAGE 03
No " ~)
R=94%
c 1
2
3
4
5 ,
_ ... \._ ...... - -, 1.1""" ..... '1 ...... • ~
4508
of tweelers. 1 ~ould have extracted it with tho8e.
O. Okay. Would you have taken just a8 mucb as you
needed for those two, for the species test, or enougb for the
species and the ABO teGt or. you know, ~bat ~uantlty of sa_pte
you were extractIng at that point in time?
A. Okay. As tar as what I would have taken for each
7 of those individual tests, flest of all, 11m taking tbree
8 different samples for each of those testa.
9
10
o. A.
Okay.
As far as the quantities ar~ concerned~ the latter
11 is perhaps a third of what is required for tbe
12 Absorption-Elution, and the Ab-El up there, and the precipitin
13 is approximately I guess two-thirds to a third of what'S
14
15
16
17
18
19
20
21
22
23
2. 25
26
27
required of the Absorption-Elution.
O. Well, r'm just trying to get a concrete idea of
what you do ..
When you do these tests, are you using chips, or
are you usIng a solution1 What is the physical form that the
blood is 1n when you are doing it1
A. For the Lattes -- well, the beginning is obviously
chips or scrapings or powder, depending on what condition the
blood is in. oc depending on what tests I'm doing.
The Lattes, using the chips themselves, and the
precipitin and Absorption-Elution use an e~tract. In other
words. 1 put Moisture on it, get the blood into solution aqaln
since it is dried, and use that.
Q. Okay. NOW, when you prepared the solution, do you
28 prepare just enough for one individual test, or do you prepare a
COMPUTERIZED TRANSCRIPr
n u , , B n u .B " LJ
61942583500 02-13-96' 10: 21AM P003 #42
~LtlJ/l~~6 10:19 61942583500 PAGE 04
(1
=94%
4S0g
1 Golution that you can U8~ in a whole bunch of different tbtn981
2 A. Basically wha~ I'll do with th~ sample, 1 will take
3 411 ~he 8~pl.s out, prepare the samples dry in individual
f tubes, and ~heD go from there. And it 18 indlviduel samples.
5 I think what you are getting et is do I take one
, extract and uap. it for three different tests? NO, I do not.
7 o. SO each different test then is & separate extract?
8 A.
9 o. 10 A.
That is correct, yea.
What do you do wi tb the leftover,' if there is any?
Basically, I'll use it for another test if there is
11 A lef~over ~amp1e ready. But normally I usually know tbe amount
12 that Lc requlrQd, and I will put only a minimum aMount in there.
13
14
15
16
17
18
19
20
Zl
22
23
24
~5
o. Ac you were workinq"on the the 12th, are you also
do1n9 -- wore you al~o doin~ like known whole bloods from the
victimc in tha same ~@n~ral time frame?
A. I did ~om@ analysis on the victims blood on June
the 12th, 1993, yes.
O. FOr th~ victims who died, when did you knov the
reaul~a of all of th~ir ABO typeS?
A. This would be on the I knew soroe of them on the
8th, another one on th~ 12th, and another one on the 15th.
Q. Who wa~ it that y.ou knew on the 15th?
A. Okay. AS far a~ Douq RYen's blood, t knew some of
his information on the 8th. t ran the reverse test from his
blood on the 15th. so, that would be ooug Ryen's.
2ti O. Okay. so, at least you had -- by the 12th then you
27 bad at least an indication AS to all four of the victims who
COMfUTERIZED TRANscnIPr
n u I ,
8 n u
B ·5
61942583500 02-13-96 10:21AM P004 #42
61942583500 PAGE 05
--'-- ... --- .... _- .. " '.
--f
""
0-, i
=94% , ,
1
2
1
.. ••• ..:.......:-._ ....... .., ..... ·~ .... -- .. _I .. , - •
4510
A. That is ttue, yea.
Q. While you were dOing A-41', vere you alao at the
same time dOing other samples that Mr. Stockwell had collected
4 feom you, for you fro. the house, and j~st aa a specific
5 example, A-f3l
A. Yes, I vas.
7 O. Okay. So on JUne the 12th, then, vere you able to
8 tell from the knowledge that you had, as of June the 12th, that
9 all four ABO types were represented in the blood samples you had
10 from the Ryen house?
11 A. Yes, sic, ! could.
12 Q. Could you then put all four ABO'S -- let's see.
13 How about a different color in blue over ther&o
14
15
16
17
18
19
20
21
22
21
24
25
26
27
28
A. (witness complied).
Q. June 13, back to black. You ran Group, Group I on
A-el; is that ri9ht?
A. That is correct. Yes.
O. Okay. And do you know what tl~e of day you dld
that? Do you cemember?
A. Okay. AS far as ~y -- I started the run at
approximately 2:10 in the afternoon. on June the 11th, 1983. I
stopped the run and began development of the run at 5:05.
Q. SO, you would have wocked overtime and found out .
tbe answers to the particular results like by about 6:00 o'clock
in the evening. Is that about a cough estimate?
A. 6:00 to 7:00. Somewhere in there.
o. A.
Could you then put -6-13-83, Group I-, in black.
(Witness complladJ.
COMPUTERIZED ~RANSCRI~
.... . .... . .. .......
·n u , , B n u .8 :6
61942583500 02-13-96 10:21AM P005 ~42
02/13/1996 10:19 61942583500 PAGE 136
~. )
1
2
4511
Q. A~ the 8~O time that you ar~ doing Croup 1'8 for
A-fl, you'ce aleo leacning about aoae of the Graup t results
3 foc, for ~e other aa.ples that havo be~n eol1ee~ed, ia that
4 right!
5 That Is co~~.c~, yes.
Q. You knew, did you. sOmO of them on sunday before.
7 and then you did more on ~une the 11th as vell. 80 you did Group
8 I for both of tho3C times, ia tha~ right?
, A. , 'Yeo, I did.
10 o. Dy the time tha~ you finishpd at 7:00 p.m. looking
11 at th~ A-41 re~ul~a, juat baaed on your ABO'S and Group I, you
12 knew tbat you had more, a lQ~ger numbor of qene~ic profiles ift
13 that house lhan you had victime, is that right?
l!)
1ti
17
18
19
20
21
22
2]
2t
25
26
A.
Q. Okay. So then let's -- let'~ SQ2. I guess put
-Non-U Blood- in blUe, if you could. I've got the blue right
here tot' )'ou.
A. (Witness co~plied). -Non-victims Blood-.
Q. Yeah. O~ non --
A. (Witne3~ complied).
Q. NOW, sOIIIewbcrc in this Cjenp.ral time ,frallle, but you
are not exactly sure whe~e, ~hatlG ~h~n you found out that Kevin
was a 1~ and a PEPA 2-1; 10 that r19h~?
A. I believe it ~48 after tho 13th, hu~ [em not
exactly sure of the d4te.
Q. Let's j~t tiort of out in limbo out here. in
27 another C010t. How 4bout ced, if you could, th~n -Ie·, -PGH-
llJ
COMPUTERIZED TRANSCRIPT
rl U , , 8 r, u B i ,
R=95% 61942583500 02-13-96 10:21AM P006 ~42
r I
2
A.
o.
4512
(Witness complied).
Just -- attempting not to get too technical but
3 when you wrote PGM, by force of habit you put a little subscript
4 -1-; is that correct?
5
6
A.
o. That's correct.
That is basically there are three different types
7 of PGM's that one finds in blood, but as far as routine forensic
8 typing, only one of them is significant, and the PGM subscript 1
9 is the one that is of serological significance for forensic
10 purposes; is that correct?
11
12
A.
o. Essentially, yes.
On the same date, June the 13th, did you determine
13 that the green blanket had semen on it?
14
15
A.
o. Yes, I did.
Unlike -- if I can refer to them as wall samples to
16 indicate collectively the samples of blood that Mr. Stockwell
17 and Ms. Schechter collected from walls and carpets of the Ryen
18 house, unlike that particular sample, the J-13 analysis,
19
20
21
22
23
24
25
required you to focus in on one individual semen sample that you
had in the case; is that right?
That is, you weren't doing a whole bunch of
different semen samples all together.
A. Well, I analyzed several things for semen samples,
or semen.
o. You mean~ all at the same time or was that done
26 separately?
27 A. I think after my initial screening of other samples
28 I believe it was done pretty much separately.
COMPUTERIZED TRANSCRIPT
.... , o I-' L' .--, CI ·0 .D
-" ,
1 /"' . ....::.. .... , I
2
3
4
5
6
7
8
9
10
11
12
13
f' 14
15
16
17
18
19
20
21
22
23
24
25
26
, 27 ........
28
;~,
4513
o. Well, in fact basically the J-13 was the only thing
that you, that you screened on June the 13th; is that right?
A. I believe it is, yes. For semen, yes.
O. And you knew then, did you not, that that semen had
a large amount of Peptidase A contained in it?
~ Is that right.
A. Yes, I did.
O. SO, of all the different body fluids semen is the
one that you are most likely to get a Peptidase A result, is
that right?
A. That is true, yes.
O. NOw, let's -- "6-13", could we also put "J-13·,
"Semen". I will give you the Sharpie in green.
A. (witness complied).
O. Do you know if you turned your attention to the
green blanket before or after you had the Group I that involved
A-41?
A. I don't'know at this point.
O. On June the 14th did you do a test for Peptidase A
on the green blanket?
A. Yes, I did.
O. Could you then put "6-14-83" in green and then
"J-13·, "PEPA·.
A. (Witness complied).
O. Okay. At the same time that you ran the PEPA you
also ran the, ran that sample for CA II; is that right?
A. Yes. That is basically the test that is run.
O. Okay. That's what you call a Group IV test?
COMPUTERIZED TRANSCRIPT
J , " o " u
" o ·0 :.J
1
2
A.
Q.
4514
Yes.
Now, basically semen doesn't contain CA II; is that
3 right?
4 A. Not if it contains -- it doesn't contain any
5 significant amount.
6 Q. So, the only reason that you develop it, you
7 develop the CA II at all, is because you are developing blood at
8 the same time you are running semen and you want to see what the
9
10
11
blood result is; is that right?
A. That is true, yes.
Q. NOW, normally 4s you were working through this
12 particular case, were you sort of working on your charting from
13 Group I to Group II, to Group III, Group IV, and that is doing
14 it basically in an orderly process. In other words, you do the
15
16
17
18
19
20
21
22
23
24
25
26
Group I before the Group IV.
A. Essentially, yes.
Q. with respect to the green blanket, you varied, is
that right? You did the Group -- you did the Peptidase A before
you did the Group I.
A. That's true, yes.
Q. Was that because you got the information from Mr.
Lorenz that Mr. Cooper had a black variant as far as Peptidase
A; you wanted to see what you had in the blanket.
A. That is a possibility, yes.
Q. So at least as far your present memory is
concerned, it is at least possible that you heard from Mr.
27 Lorenz before you did the PEPA on the 14th?
28 A. Yes, sir.
COMPUTERIZED TRANSCRIPT
:-,-, U , , ,-, o " u
" :J
-" u
(~.
1
, '-
4515
1 Q. Now, on June the 16, you did the -- on J-13 you did
2 the Group 11 is that right?
3
4
5
6
A.
Q.
A.
Q.
June the 16th? Yes.
So could you put down -6-16-83-, -J-l3-, Group Ie.
Yes.
Is there esterase D in semen in sufficient
7 quantities to pick up?
8
9
10
11
12
13
A. Not normerly, no. -Q. You do Group I then again just because essentially
it doesn't cost you anything to do it and you are doing it along
with the bloods and so you have to develop the bloods anyway?
A. Essentially, yes
Q. At that point in time you were not doing the PGM
14 subtyping; is that right?
15
16
17
A. Not routinely. no. Our system was faulty, if you
will, and I didn't want to put it on the case load.
Q. So at least as far as this particular case is
18 concerned, you didn't do any of that back at that -- in 1983; is
19
20
21
22
23
24
25
that right?
A. Not at this time, no.
Q. In 1983, you were not -- you did not do any work on
the Kevin Cooper case or the Ryen homicide investigation with
respect to PGM subtyping, is that more or less accurate?
A. For all of. '83?
Q. Well. I'm trying to remember when you started. At
26 least before November of 1983?
27 A. That does sound reasonable, yes.
28 Q. Okay. NOW when -- on the -- on the chart tha~ you
COMPUTERIZED TRANSCRIPT
I l
•
"-
4516
1 had I don't remember whether you went into this with Mr.
2 Kochis or not but just in case you didn't -- what's called the
3 PGM result and the PGM subtyping result, they are not
4 independent of one another~ is that correct.
S
6
A.
Q.
No, they are not.
Basically what you've got is -- basically all of
7 these genetically determined proteins types have essentially two
8 components to them. one of which is inherited from the mother
9 and the other from the father of the individual; is that right?
10 A. That's correct, yes.
11 Q. Technical name for the component, the half, is an
12 allele, spelled, a-l-1-a-l-e right?
13
14
15
16
17
18
19
20
21
22
23
24
2S
26
A. Yes, it is.
Q. Now in fact with the PGM, what you have is four
different allales that you can have in various combinations; is
that right?
A. That is true, yes.
Q. And in the case of Jessica we can tell, can we not,
that Jessica got a 1+ allale from her father and a 1- allale
from her mother?
A. That is true, yes.
Q. And Joshua got a 2+ allale from Douglas and a 1-
from Peggy?
A. That is true, yes.
Q. We don't write it that way, but technically a PGM
result which is not subtyped is in fact normally 2-1 allales, so
27 it would be a 1 is the same as a l-l~ is that right?
28 A. Leaving aside nonallales?
COMPUTERIZED TRANSCRIPT
'" U , , ,-, o ,-, u .~, :I
.:f L
(~
'-
1
2
3
4
5
4517
A. . Leaving aside nonallales.
o. Nonallales are not particularly involved in this
particular case and they are a very complex subject, right?
A. In essence, yes.
o. But they don't matter as far as what we're talking
6 about any of the cast of characters we have in this particular
7 case as far as you know, right?
8
9
10
A. Well, there is one possibility, but it's Rodney
Parish may be half an ala1le.
o. But leaving aside, Rodney Parish is neither victim
11 nor suspect, is merely a person in the house; is that right?
12
13
14
15
16
17
18
19
20
21
22
23
24
2S
26
A. Correct.
Q. Okay. Now back to -- back to the PGM's and the PGM
subtitles, what this No. 1 here means then is that the PGM
subtype could be either a 1- 1-, 1+ 1-, or 1+ 1+; correct?
A. That is correct, yes.
Q. And the reason that they are all lumped together
was that for a period of time nobody could tell the difference,
but now we can?
A. That is true, yes.
Q. SO, long roundabout way back to the point.
~'lhen you found out that Kevin was a 1+ 1+, that
also told you that he was a PGM straight type 1, right?
A. Not necessarily. It's important to run the PGM
straight type, if you will, before you run the PGK subtype.
Q. Wait a minute. If he is a 1+ 1+ you know he is
27 also an 1, right?
28 A. Well. due to some, I guess they call them
COMPUTERIZED T~~SCRIPT
f
n u , , o (J
" ·U CI J :I J
4518
1 idiosyncrasies of the subtyping system, I feel it's necessary to
2 run the PGM straight type, as you call it, before I run the PGM
3 subtype.
4 Q. That -- 11m not arguing with you about your
5 procedure.
6 But generally, if you know, I mean, leaving aside
7 how you know for the moment, but if you know he is a 1+ 1+, then
8 that's the same thing a saying he's an 1, right? It's an
9 identity? 'ie;,;"F<
10 A. If you know for sure that he is a 1+ 1+, yes.
11 Q. Okay. Back to the ranch. Okay.
12 Now when did you find out that -- for sure that
13 Josh was an ABO type B?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A.
Q.
A.
Q.
A.
This would be on June the 22nd of 1983.
Okay. In blue -- Have you got blue there?
live got the blue.
Could you put -6-22- over here.
(Witness complied.)
Q. And then at that point in time you could say for
certain without any doubt that A-41 didn't come from a victim,
right?
A. Yes, I could.
Q. Okay. So could you put 6-22, A-4l, not victim just
indent it there underneath the blue. There, yeah.
A. (Witness complied.)
Q. You also knew at that point in time -- Well, your
hypothesis that you were testing for at that pOint in time that
28 A-41 carne from Kevin Cooper, the only person who had been
COMPUTERIZED TRANSCRIPT
.,--,.. L r --l
".~'" -. -.... '---.---... -
(-,
2
.-
1
2
4519
charged with the crime?
A. My hypothesis is that it came from an assailant not
3 necessarily Mr. Cooper.
" 5 trying
Q. Okay. Were you -- were you concerned, I mean,
at that point in time you knew that the only person
6 charged with this particular crime was Kevin, Kevin Cooper,
7 right?
8
9
.10
A. I knew that Kevin Cooper was a person charged with
the crime. I didn't know whether he was the only one or not.
Q. And you had at least some knowledge that his
11 types -- at least at that point in time his PGM types were not
12 inconsistent with him having been the person that -- from whom
13 A-41 came?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. That is true, yes.
Q. At that point in time did you how many -- how
many tests did you think that could you do on A-41 before you
exhausted it?
A. I believed that I could do all of my tests that I
can do in a laboratory, and that would be essentially probably
nine tests at least.
Q. Well, you'd already done five of them?
A. Oh, excuse me. At that pOint in time? Excuse me.
Q. Yeah.
A. What I'm saying is that at the beginning I believed
that I could do all of the tests.
Q. Okay. Well, at that pOint in time you had done
27 five different tests, right?
28 A. Well. I wouldn't count the ortho-tolidine. The
COMPUTERIZED TRANSCRIPT
n u , , o (J
" U o :J .J
, > --
4520
1 precipitin, the absorptio~-elution, the Lattes, that's three,
2 Group I, that's four.
3 Q. So, you thought you could get five more tests out
4 of it at that point in time?
5 A. Essentially. yes.
6 Q. Now, in your -- in your particular laboratory --
7 Well. let me just backup.
8 If a sample of blood were to come from somebody
9 whose genetic profile is close to that of a piece of evidence
10 but differs in some, you know, in one or -- or in just a few
11 number of enzymes, the more tests that you do is generally to
12 the benefit of that particular person, is that right, because if
13 you do enough tests you maybe able to exclude them?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
MR. KOCHIS: I would object. That calls for speculation.
If it's the same source, the more tests you are going to do, you
are just going to simply reconfirm to a smaller percentage, to a
greater degree that's the person that it came from.
MR. NEGUS: The hypothetical was it was a person that is
similar but different in some respects, the more tests --
THE COURT: I will press the exclusion by further testing
I will permit it, counsel.
Overruled.
Can you answer it?
THE WITNESS: I'm not sure if I understand the question
as asked.
BY MR. NEGUS:
Q. Okay. Well, let me -- let me -- I'm having so much
28 trouble with it, probably try and figure another way to get at
COMPUTERIZED TRANSCRIPT
n u , , o o
" u o .J
.1-
.0
.' ".
-'-
---- .... ,,- --- ... -'
4521
1 it.
2 In your particular -- in your particular laboratory
3 you are unable to get satisfactory results with the Group I test
4 the way that Brian Wraxell runs it; is that right?
5 A. The way that Brian Wraxell runs it, first of all,
6 is with another enzyme in it, and 1 do not believe that the
7 other enzyme can be typed reliably, at least by myself, so 1 do
8 not do it.
9 Q. Okay. So Mr. Wraxell, for example, Mr. Blake,
10 other people who are more experienced and educated in serology
11 than yourself can get results but you can't?
12 A. There are other people that feel that they can get
13 results out of glyoxylase, yes.
14
15
16
17
18
19
20
21
22
23
24
25,
26
27
Q. And Mr. Wraxel and Mr. Blake being two examples
that come to mind?
A. I know Brian Wraxell does. I don't know if Dr.
Blake does or not.
Q. And the -- the, I guess, the manual, the cookbook,
the thing that has the recipe for the various tests that you do
in it, that was originally that was originally, came from Mr.
Wraxell; is that right?
A. That is correct, yes.
Q. And he has the -- has what's called the glyoxylase,
g-l-y-x-o-l-a-s-e, 1 believe, test as one of the components of
the Group I?
A. That's true, yes.
Q. And if you add that particular test that gives
28 somebody one additional chance to either exclude that person or
COMPUTERIZED TRANSCRIPT
" U ~ ,
., o
" U Ii ,J -I
~
r--
--
1
2
3
4522
if the blood did corne from them to include them; is that right?
A. That is true, yes.
Q. Are there other tests that can be done by persons
4 with more experience and education than yourself that you were
5 unable to do in the laboratory at that particular time?
6 A. There are other tests that could have been done,
7 yes.
8 Q. For example, PGM subtyping was never done on A-4l?
9 THE COURT: What's the relevance of going into things
10 that were not done of this witness?
11 MR. NEGUS: Because he wasted the sample, and I think
12 that goes to the weight of what he did do. He has already
13 testified he wasted some sample which --
14
15
16
17
18
19
20
21
22
23
24
25
26
MR. KOCHIS: Well, that's an argumentative statement of
what his testimony is. And it's not as if this was swept aside
under a rug or put down a toilet. He tested it in other
systems, and it's Mr. Negus pOSition as to which system should
have been tested. It's not a waste.
THE COURT: Mr. Negus, I really fail to see a great deal
of relevancy to that. By saying that there are other test that
he could have run he was therefore negligent or incompetent in
running the tests that he did, is that your argument?
MR. NEGUS: The thing is that -- I have got no quarrel
with the tests that he ran and got good results on. but he did
them in an incomplete fashion, like with the Group I, and
likewise he unnecessarily, his own testimony was, repeated some
27 tests, thus wasting sample and preventing him from doing other
28 tests.
COMPUTERIZED TRANSCRIPT
-,-, U , , ,-, CI
" U 1-' -J ·0 o
l "-
1
2
3
4523
THE COURT: I'm concerned with wasting time here.
MR. NEGUS: It's not going to take me that much longer.
THE COURT: All right. Go ahead.
4 BY MR. NEGUS:
5 Q. PGM subtyping was something else you could have
6 done; is that right?
7
8
9
10
A.
done, yes.
Q.
A.
PGM sub typing is another test that could have been
And what are the other ones?
Well, if a person felt competent to do glyoxylase
11 or felt that it was a reliable system in the first place, you
12 could do glyoxylase. There are other tests that could have been
13 on. One is called GM another one is called G6PD.
14 MR. KOCHIS: Excuse me. Your Honor, at this point I'm
15 going to interpose an objection because these tests that this
16 witness is talking about, that the crime lab did not have the
17 capability of performing back in June of '83.
18
19
20
21
22
23
24
25
26
27
28
MR. NEGUS: But they had the capability of contracting
with other people to do them like they did in subsequent -
THE COURT: Go ahead. Overruled.
THE WITNESS: And the only other one I can think of right
now would be one called G6PD.
BY MR. NEGUS:
Q. Okay. On June the 28th, June the 28th did you then
attempt to do a Group II?
A.
Q.
A.
Yes, I did.
And could you then write -6-28 Group IIR.
(Witness complied.)
COMPUTERIZED TRANSCRIPT
i ~
" o " u
" :; ·0 :J
1 ,-...... -
1
2
3
.. 5
6
7
8
9
10
11
12
13
O.
test?
A.
O •
A.
Q.
A.
4524
And on June 29th did you do the second Ab-EL Lattes
Yes, I did.
Could you put -6-29-83-.
(Witness complied.)
Now, did you also on 6-29 do the Group IV?
Yes, I did.
Q. That's with two of the four enzymes that you can
possibly do on that particular test; is that right?
A. Yes, sir.
Q. Okay. So could you put -Group IV-.
A. (Witness complied.)
Q. And you feel yourself competent only to get
14 reliable results on two out of the four; is that right?
15 A. I feel that the enzyme lends -- well, that the one
16 other enzyme that I don't do on Group IV lends itself very -- it
17
18
19
20
21
22
23
24
25
26
27
is very hard to type, or harder to type on Group IV, the G6PO,
that's why I don't do it.
Q. And basically you've never been able to get your
G6PO's to come out right; is that right?
A. I can't say I've never been able to. I've had some
success with it, definitely.
Q. But you weren't having any success and you weren't
doing it back in June of 1983; is that right?
A. No, I wasn't, plus there is other factors involved
in deciding to do it without the 6R G6PO also.
Q. Well, let's go back to the glyoxylase just for a
28 second.
COMPUTERIZED TRANSCRIPT
j , Ii a
t
1-' LI
. ,Ll
.;-...... - _._---- ~--.- ~.- . -
4525
1 If you did glyoxylase as part of Group I, would
2 that have used up any additional sample?
3
4
A.
Q.
No, it would not.
Would it have effected the reliability of the
5 results that did you get in any way?
6
1
A.
Q.
No.
So, essentially it would have been an extra freebee
8 for no extra cost and no risk?
9 A. Except for the possibility of mistyping glyoxylase
10 which I believe there is a much greater possibility, no, there
11 wouldn't have been.
12 Q. But if you photograph it and you show it to other
13 people you can reduce that?
14
15
16
17
18
19
20
21
22
23
24
A. It's possible, but the enzyme itself degrades in
such a fashion that it lends itself to mistyping errors.
Q. Does it hurt to have additional information?
A. No, it does not.
Q. On June the 29th was there a reason why you did not
proceed and do Group III and haptoglobin?
A. Yes, there is.
Q. Wha t was that.
Q. The Group III's, the biggest reason is because at
that time we were -- did not have a supply of one of the
chemicals which was needed to do Group III.
25 Haptoglobins we were simply not doing at that time
26 a standard run.
27 Q. What do you mean by a ·standard run·1 You just
28 weren't doing them in case work?
COMPUTERIZED TRANSCRIPT
•• o I ,.
f .!../
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4526
A. We weren't doing them in case work routinely.
Q. Did you note on June the 29th that you hadn't got a
good result on the Group II?
A. Yes, I did.
Q. Did you make a conscious decision at that point in
time not to rerun it to find out what it was?
A. Not to rerun it, no. I believe the opposite is
true. I made a conscious decision to rerun it.
Q. When did you do that?
A. I reran it on August the 2nd, 1983.
Q. Then let's see. about down here could you put an
8-2-83 Group II in black.
A. (Witness complied.)
Q. On 8-2-83 did you receive into your laboratory the
sample of blood that came from Kevin?
A. Yes, sir, we did.
Q. Giving you a brown marker, could you put down on
the chart 8-1-83 ·KC blood-.
A. (Witness complied.)
Q. On 8-2-83 did you attempt to Group lIon Kevin's
blood?
A. Yes, I did.
Q. Could you write in brown "Group 11-.
Q. Right next to that was that in fact pa~t of the
same plate as the A-4l?
A. Yes, it was.
Q. write in brown.
A. (Witness complied.)
COMPUTERIZED TRANSCRIPT
L
r, u , , ,-, CI , , ,-, u .J .L
4
'.
4521
1 Q. I take it then that at that point in time, on
2 August the 2nd, that you knew that Kevin was in custody?
3
4
A.
Q.
Yes.
Prior to -- Well, how many tests did you think you
5 had left when you started running A-4l on -- on August the 2nd?
6
7
A.
Q.
When I -- prior to starting it?
Yeah, before you -- before you started, how many
8 did you think that you would be able to do of the remaining
9
10
11
tests?
A. At least three.
Q. And at that point in time it was your plan to do
12 the Group II again, the Group III for the first time, and the
13 haptoglobin for the first time; is that right?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. I can't say if it was at that time or not, but it
was probably around that time, yes.
Q. NOW, recognizing the -- you recognized on, June the
28th you recognized the importance of A-4l for this particular
investigation, did you not?
A. Yes, I did.
Q. At that point in time in order to make sure that
the reading off the plate under the optimal conditions was
shared by as many serologists as possible, did you attempt to
get anybody from outside your laboratory, anybody else with more
experience than yourself. to come in and read the plate with
you?
A. Not anybody from outside the laboratory, no.
Q. Well, the only people -- only people inside your
28 laboratory at that point in time, and still I'm sure, you were
COMPUTERIZED TRANSCRIPT
Ii U
j , " o
"
~ , u .J .:1
('- "
1
2
3
4
4528
the person that in your laboratory had the most experience in
serology; is that right?
A. That is true, yes.
Q. You are the -- When usually, all else being
5 equal, you get the serology work in the lab, is that --
6
7
8
9
10
11
A.
Q.
A.
Q.
A.
Q.
Well, there's two other people doing serology, yes.
One of them is Mr. stockwell?
Yes.
And the other is Mr. Jones?
That is correct, yes.
But between -- you have more experience than both
12 of them put together, is that more or less accurate?
13 A. , I have more experience than them, yes, but I can't
14 say whether I have more than both of them put together.
15
16
17
18
19
20
21
22
23
24
25
26
THE COURT: Between now and tomorrow morning, as always,
don't talk about the case, don't let anybody else discuss it
with you, don't ~et express or form an opinion on the matter.
Drive carefully.
See you tomorrow at 9:30.
(Adjournment.)
i 27 ' ........
28
COMPUTERIZED TRANSCRIPT
", U , , ,-., o , , ,-, ,U
·U . ,
, \" .....
IN THE SUPERIOR COURT OF THE STATE OF CALIFORNIA
IN AND FOR THE COUNTY OF SAN DIEGO
DEPARTMENT NO. 30
THE PEOPLE OF THE STATE OF CALIFORNIA,
Plaintiff,
va.
KEVIN COOPER,
Defendant.
HON. RICHARD C. GARNER, JUDGE
) ) ) ) ) ) ) ) ) ) )
NO. OCR-93l9
---------------------------------)
APPEARANCES:
REPORTERS' TRANSCRIPT December 6, 1984
For the People: DENNIS KOTTMEIER
For the Defendant:
District Attorney WITH: JOHN P. KOCHIS Deputy District Attorney 1540 Mountain Avenue Ontario, California 91762
DAVID L. McKENNA Public Defender BY: DAVID E. NEGUS Deputy Public Defender 1060 West Sixth Street Ontario, California 91762
ROBERT L. ROACH, CSR .1727 DONNA D. BEARD, CSR t1874 Official Reporters
COMPUTERIZED TRANSCRIPT
I~;
. Ii U
j , 'i o
~
f.QR THE PEOPLE:
GREGONIS, DANIEL J. (Mr. Negus)
i
INDEX OF WITNESSES
Direct Cross Redirect
4529
COMPUTERIZED TRANSCRIPT
Recross
1-' U , , 0 0 , , 1-' .U .1: .0
INDEX OF EXHIBITS
Iden.
590-A Plastic Overlay 4557 For Exhibit No. 590
591 Chart EAP Banding Pattern 4562
599 Group II Run 1162 - 4539 Copy
600 Group II Run $163 - 4539 Copy
611
612
Chart - Butcher Paper Enzyme Life Span
Chart - Butcher Paper Exhausted Items
COMPUTERIZED TRANSCRIPT
4591
4616
ii
In Evd.
I-' o I ,
" U ., ,
,~,
1 1 1"" - .
f 2
3
4
5
6
7
8
9
10
11
12
13
14 /.--......\
15
16
17
18
19
20
21
22
23
24
25
26
27 '-
28
4529
SAN DIEGO. CALIFORNIA. WEDNESDAY. DECEMBER 6. 1984. 9:38 ~
--00000--
THE COURT: Mr. Negus.
DANIEL J. GREGONIS,
called as a witness on behalf of the People, having been
previously duly sworn, resumed the stand and testified further
as follows:
CROSS-EXAMINATION (Resumed)
BY MR. NEGUS:
Q. On -- just to return for a second to cigarette
butts.
As to the information that you have there on -- on
V-12, the hand-rolled cigarette, from the -- from the testing
that you and Brian were able to do on that hand-rolled cigarette
butt, basically you couldn't exclude anybody in the entire
world; is that right?
MR. KOCHIS: Objection. That was asked and answered
yesterday.
MR. NEGUS: No, it wasn't. We did J-20. I forgot to do
V-12.
THE COURT: Okay. Go ahead.
THE WITNESS: From Mr. Wraxell's report, his final
conclusions on that, that is correct.
MR. KOCHIS: Well, your Honor, I'm going to object to
hearsay statements of other people. They can testify when
COMPUTERIZED TRANSCRIPT
!"~
1-' U , , '---, o , , 1-' U ·0 o
( 1
2
4530
they're called, but not this witness.
THE COURT: Can't you testify of your own knowledge? Can
3 you exclude anybody in the whole world?
4 THE WITNESS: Well, as far as my testing, this is
5 consistent with a nonsecretor; however, it is not totally
6 conclusive of a nonsecretor.
7 BY MR. NEGUS:
8
9
Q.
A.
So it's also consistent with a secretor, right?
I would say that it's more probable that it is a
10 nonsecretor; however, you cannot totally exclude a secretor
11 also.
12 Q. Well, on this -- Mr. -- you and Mr. Wraxell did an
13 absorption-elution test on V-12; is that right?
14
15
16
17
18
19
20
21
22
23
24
25
A. That is correct.
Q. And the absorption-elution test is much, much, much
more sensitive than the absorption-inhibition test that you did;
is that right?
A. It's more sensitive, yes.
Q. But -- well, I mean, in terms of sensitivities,
you -- you normally talk in terms of how much you can dilute
something and still pick it up, is that a normal way to try and
measure sensitivities?
A.' Yes, it is.
Q. Okay. Would in terms of dilutions, would the
absorption-elution be ten times more sensitive, a hundred times,
26 thousand times?
27 A. I would say it's, depending on your system,
28 probably around a hundred times for sensitive.
COMPUTERIZED TRANSCRIPT
n u , , o o , , " U ,0 ,J
(
4531
1 o. So even if you had a nonsecretor you would have
2 expected, had there been enough saliva there, to have picked up
3 some sort of type from V-12, would you not, if there have been
4 enough saliva?
5
6
A.
o. Had there been enough saliva on those tests, yes.
And the fact -- therefore, the fact that
1 What the absorption-elution test, one of the things
8 it's used for is sort of a -- a check on your less sensitive
9 absorption-inhibition test, is that not correct?
10 That is, basically if you get a result on the
11 absorption-elution test, then in certain circumstances that's
12 the first step towards being able to make a deduction that you
13 had enough there, so that had you had a secretor it could have
14 shown up on your absorption-inhibition test?
15
16
11
18
19
20
21
22
23
24
25
26
A. Well, I wouldn't say that it's the first test or
first step, but it is a step, if you would.
O. It's one of the various systems that -- that --
that you can -- that you have to d01 is that right?
A. That you can do, yes, to detect a nonsecretor ABO
blood type, yes.
o. Well, in order to rigorously answer the question,
you have to do both that and quantify the amylase, right, and do
the absorption-inhibition?
A. In order to come up with absolute conclusions, yes.
Q. Well, as far as your tests on V-12 back in June of
'83, you have no present memory, do you, of what sort of amylase
27 reaction you got?
28 That is, you just have no -- you can't -- you don't
COMPUTERIZED TRANSCRIPT
···n u
~ , " a
~ , ~ ,
" u
"~'
1
2
3
4
5
6
7
8
9
10
11
12
13
14 ,/'
15
16
17
18
19
20
21
22
23
24
25
26
27
28
~.
4532
remember it. You didn't make any notes; is that right?
A. Well, from any notes I got a positive amylase. I
did not note whether it was a weak amylase, which I would have
in this case.
In all my notes I note whether it's weak or not.
Q. Well, the fact that -- Well, is your opinion, by
the way, about -- about your quote ·semiquantative- testing of
amylase as a method of determining whether or not somebody is a
secretor, is that shared amongst the forensic serologic
community?
A. It is shared to some extent, yes.
Q. Well, for example, of the people that you -- that
you recommended testify for the prosecution about -- about
serology in a forensic context, there was only two of them that
had any forensic experience, Dr. Sensabaugh and Mr. Wraxell; is
that right?
A. Okay. I don't remember at this point which other
ones I recommended, but I did recommend those two, yes.
Q. Neither of those agree with you?
A. Well, I think they would agree with me in part.
Q. Well, wouldn't they -- wouldn't they say that your
results and the results -- both the results that you got alone
and the results that you and Mr. Nraxell got would not exclude
anybody in the world?
MR. KOCHIS: Your Honor, I would object. It's calling
for a hearsay response what other people may say.
If Mr. Negus wants to subpoena them to come into
court, that's something else.
COMPUTERIZED TRANSCRIPT
" U ~ ,
" CI ~ , ~ , ~ ,
2
4533
1 MR. NEGUS: I no doubt will. But the thing is Mr. Kochis
2 asked Mr. Gregonis about reliability and acceptance in the
3 forensic community, so I believe that it's -- because of the
4 fact that Mr. Kochis has put that issue of acceptance in the
5 scientific community into -- into -- into issue by force you
6 have to have hearsay matters in order -- because now that's --
7
8
THE COURT: No, counsel. I'm a little concerned about
the foundation. You perhaps may lay a foundation where you can
9 get it in otherwise. Otherwise I will sustain the present
10 objection.
11 BY MR. NEGUS:
12 Q. Well, let me -- When you testified that the
13 techniques you used were accepted in the scientific community,
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
which scientific community were you talking about?
A. Talking basically the serology community, forensic
serology community.
Q. Okay. And are Mr. Wraxell and Dr. Sensabaugh
leading members of that scientific community?
A. Yes, they are.
Q. And are their opinions on these matters given great
weight in that community?
A. Well, their opinions are definitely accepted, yes.
THE COURT: Counsel, I think that's sufficient. Go
ahead.
BY MR. NEGUS:
Q. And they disagree with you?
A. Not totally, no.
Q. But they would say that your combining, the work
COMPUTERIZED TRANSCRIPT
n u
j , " a
~ , j , , ,--
1
4534
1 that you did and Mr. Wraxell's work, you can't exclude anybody
2 as being the person that smoked V-12; is that right?
3 A. Well, first of all, I don't know as our opinions
4 differ all that much.
5 What I'm saying is that the results I got when I
6 initially tested it using the larger sample, I used a much
7 larger portion than we did when Mr. Wraxell and I tested it, the
8 fact that I got a positive amylase plus no antigens present is
9
10
11
indicative of nonsecretor.
Q. It's also indicative of the opposite, right?
A. It -- given the premise if there was not enough
12 saliva there to test, since I only did a semiquantative and not
13 a quantitative, as Mr. Wraxell and I believe Mr. Sensabaugh
14 would have done, it could have also be a secretor.
15 Q. Right. So because of the imprecision of your test
16 for amylase, you have no way of knowing, other than your own
17
18
19
20
21
22
23
24
25
26
personal feelings about the matteri whether there was enough
there to get a result or not, right?
A. Well, my test indicated that I had a moderate to
large quantity of amylase present.
Q. Well, I mean that's just -- there is nothing --
there is nothing rigorous or scientific about it, that's just
your feeling, is that right? I mean, you didn't do anything to
demonstrate that.
THE COURT: Counsel, that's apparently his opinion. We
ace becoming argumentative now. You can't go beyond that. You
27 can impeach it with other witnesses perhaps. Move on.
28 MR. NEGUS: If I could read, your Honor, from motions
COMPUTERIZED TRANSCRIPT
j , " o
j , j , -j
4535
1 last summer's transcript, Page 4936 Line 16.
2 MR. KOCHIS: I'd need a volume number.
3 MR. NEGUS: I'm not at all sure of that. It looks to be
4 Volume XXXXVII and that would go to 4937 Line 2.
5
6
MR. KOCHIS: I have that.
MR. NEGUS: Okay. This was talking about, from the top
7 of page, the context, it was talking about V-12.
8
9
10
11
12
13 1. 15
16
17
18
19
20
21
22
23
24
25
26
27
28
Q.
-Question: Now when you were doing the test you
did a nonquantitative test to determine whether or
not there is amylase; is that correct?
-Answer: That is true, yes.
-Question: And even with nonquantitative tests you
can sometimes tell whether you have a lot of
amylase there or not so much?
-Answer: That is true, yes.
-Question: The only records, however, that you
took was the fact that you had it, that is right?
-Answer: That's true, yes.
-Question: And you don't remember presently
whether or not you got strong, weak, or whatever
results?
-Answer: Not really, no, not from the testing that
I did personally.-
Getting back to what we were talking about
yesterday, on August 3rd you actually read the Group II; is that
correct?
A. That is correct, yes.
Q. Could you put an -8-3-83 Read Group II parenthesis
COMPUTERIZED TRANSCRIPT
n u , , " o , , , ,
·u . ,
,~,
1 .. ~ .... •
2
3
" 5
6
7
8
9
10
11
12
13
14 r--,
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4536
A. In what color?
Q. Black. Have you got black still there?
A. (Witness complied.)
Q. And the -- at some point in time did you contact
Mr. Kochis and Mr. Kottmeier and have them come out to the lab
to discuss the work that you'd done?
A. Either I contacted them or it was the other way
around. I don't remember.
Q. Okay. And sometime that first week after -- after
Kevin was arrested they did come out to the laboratory; is that
right?
A. Again, I don't remember the specific date, but it
was around that time.
Q. Well, let's see if we can -- was it -- was it after
you had read the Group II results on A-41?
A. I don't remember.
Q. Do you know -- do you remember whether it was
before you read the Group II results on Cooper the time that you
got the answer?
A. Again, I do not remember.
Q. Well, would the date of August 4th, 1983, at least
then be a possible date.
A. That's a possibility, yes.
Q. Okay. I will put a parenthesis around that in blue
to indicate that I'm putting the date there rather than you.
When Mr. Kottmeier and Mr. Kochis came out to the
laboratory, did you essentially brief them as to what work you
COMPUTERIZED TRANSCRIPT
.' ,-, U , , I-' o , , , ,
, .~:1
;--"
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 "--
28
4537
had done up to that point in time?
A. I believe so, yes.
Q. Was that the first time that the results of your
analysis had been revealed to anyone outside of the Sheriff's
Department?
A. I don't know at this point.
Q. Was that the first time that you personally had
ever revealed the results of your analysis to anyone outside the
Sheriff's Department?
A. Again, I don't recall.
Q. Was that the first conversation you had with the
prosecutors?
A. Again, I do not recall.
Q. At that point in time did -- were you present when
Mr. Kochis made a phone call to me?
A. I was present around that time when Mr. Kochis made
a phone call, yes.
Q. Would that be at least consistent with being at
10:30 in the morning?
A. Yes, it's consistent.
Q. You have no present recollection then?
A. No, I do not.
Q. During that phone call from Mr. Kochis, did you
give him information about the testing that you done to that
point in time on A-41?
A. I believe I did, yes.
Q. Did you omit, leave out from the information that
you gave to Mr. Kochis the results of your analysis of the Group
COMPUTERIZED TRANSCRIPT
" U , , o (J , , , , ,a
'~-
4538
1 II on A-41?
2 A. Again, since I don't recall specific dates I'm not
3 even sure I had it at that time.
Q. Well, let's assume -- let's just assume that the
5 phone call was made at 10:30 a.m. on August 4th, 1983.
6 At that point in time, 10:30 a.m., August 4th,
7 1983, you had read the plate on Group II for A-4l, right?
8
9
A.
Q.
That is true, yes.
Do you recall omitting telling Mr. Kochis the
10 results of A-41 at that point in time?
11
12
A.
Q.
No, I do not.
At that point in time you did not or had not read
13 the results of the Group II Acid Phophatase of Mr. Cooper,
14 right?
15
16
17
18
19
20
21
22
23
24
25
26
A. I may have by that time. At 10:30?
Q. Well, -- let's -- the -- on 8-4 you did a second
Group II on
A. Excuse me -- Excuse me, counsel. I was thinking I
took it off at 10:05, which I did, but it was the 5th that I
took it off.
Q. Okay. So let's add that in brown to the chart if
we could. You can put on 8-4, in brown, Group II -KC- and then
8-5 in brown -Read Group II -KC·.
A. (Witness complied.)
Q. Okay. Now the -- So it's correct then to say that
at 10:30 a.m. on August the 4th, 1983, you did not have any idea
27 as to what -- you had not read Mr. Cooper's EAP type and didn't
28 know what it was?
COMPUTERIZED TRANSCRIPT
",-, U , , ,-, o , , , , ., ,
2
1
2
A.
o.
4539
That is correct, yes.
Did you make any effort to not reveal the results
3 of your A-41 analysis until such time as you knew what Kevin
" was?
5
6
A.
o. No.
Showing you Exhibit 599, is that a -- first off,
7 the front of that, is that a Xerox copy of the Group II run that
8 you did starting August 2nd, 1983, and which you read in the
9
10
11
morning of August 3rd, 1983?
A. Yes, it is.
o. And asking you to look at the -- at the back of
12 that document, there are three Poloroid photos that have been
13 pasted on the back; is that correct?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. That is correct, yes.
O. And those Poloroid photographs are, as it were,
Poloroids of Poloroids, they are copies of the -- of the
Poloroid that you took back in August of 1983?
A. That is correct, yes.
O. Basically do the copies reveal as much information
that's significant for typing purposes as do the original
photographs?
A. They seem to, yes.
O. Showing you Exhibit 600, is that a Xerox copy of
your notes and copies of the photographs prepared in the same
fashion for the run that was done on August the 3rd and read on
August the 5th?
A. Yes, it is.
Q. Now the documents that I've handed to you, those
COMPUTERIZED TRANSCRIPT
.~~
---,-, U , , .--, o , , • ,
.0
.LI
1
2
3
4
5
6
7
8
9
10
11
12
13
14 ./"'.
15
16
17
18
19
20
21
22
23
•.. 24
.25
26
27
28
4540
documents are only released to, by way of the discovery process
that Mr. Kochis mentioned yesterday, upon request of the -- of
the opposing counsel; is that correct?
A. I assume so, yes.
Q. I mean, there are certain documents that you
normally -- you normally give to the DA for release of discovery
even without request; is that right?
A. Well, I normally give them to the DA or the
investigating agency which we were dealing with.
Q. Okay. Whatever the -- the green formal reports you
normally give out without having been asked for them; is that
right?
A. Yes.
Q. But those particular documents that have been
marked as 599 and 600, people have to ask for those; is that
right?
A. Generally upon request they are available to the
defense.
Q. Now, when did you -- when did you publish, that is,
put in written form that was available to somebody outside the
laboratory, the results of your analysis on A-4l?
A. I believe the first report that I wrote was August
the 10th, 1983.
Q. So, other than any telephonic transfer of
information, that would be the first time that anybody outside
the laboratory had a chance to actually look at documents which
indicates your results; is that right?
A. Well, the documents were available inside the
COMPUTERIZED TRANSCRIPT
I
rl U , , .-., o , , , , .-, J
/~
1
2
3
4
5
6
7
8
9
10
11
12
13
14 ,~,
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4541
laboratory if somebody wanted to look at them but that's the
first report that was sent out.
Q. But they weren't made available until after the
formal report; is that correct?
MR. KOCHIS: Objection, it's not relevant.
THE COURT: It's what?
MR. KOCHIS: Not relevant.
THE COURT: Overruled.
THE WITNESS: Well, I'm not sure the your request came in
after that or not. They are obviously available in the
laboratory for anybody to look at.
BY MR. NEGUS:
Q. On -- sometime during the early part of August, did
you begin to have telephonic conversations about this particular
case with Ed Blake?
A. Yes, I did.
Q. Now, when the initial contact between the
prosecution and the defense about the serology in this
particular case was -- was instituted, did you make
recommendations as to independent serologists that could be
hired by the defense to help out in this particular case?
A. I believe I did, yes.
Q. Of those that you made, was Ed Blake the one that
you recommended the highest?
A. I would say so, yes.
Q. And is that because he's the best that's available
in the private sector, in your opinion?
A. Well, I don't know if he's the best that's
COMPUTERIZED TRANSCRIPT
,(j
.. C ,r l.
1
2
3
4
5
6
7
8
9
10
11
12
13 1
14 ('
IS
16
17
18
19
20
21
22
23
24
2S
26
27
28
4542
available. He certainly is among the best.
Q. After the telephone conversation that you had
with -- with Ed, did you eventually at some point in time mail
him some of your -- some of your Poloroids that you had done of
A-41?
A. Yes, I did.
Q. Do you have a date as to when you did that?
THE COURT: Counsel, for the benefit of the jury, the
relevancy of all of this line of testimony is either relating to
his credibility or believability or competency; is that correct?
MR. NEGUS: Yes, I think so.
THE COURT: Okay. Just so you can keep it in
perspective, ladies and gentlemen.
THE WITNESS: No, I don't have a record of that.
BY MR. NEGUS:
Q. Okay. In any event, did -- was the -- just -- was
it discussed between yourself and Mr. Blake that there would be
further testing of A-4l?
A. At sometime, yes. I'm not sure if it was in the
initial the conversations or not.
Q. At some point in time, say, August of 1983, was
that discussed?
A. Yes, it was.
Q. And had Mr. Kochis requested at any further testing
of A-4l you have a defense serologist, somebody hired by, a
consultant hired by the defense, who was a serologist, was
present whenever you did anymore testing on A-4l?
A. I am not sure if Mr. Kochis requested it. I know I
COMPUTERIZED TRANSCRIPT
" U
• , ., o
~ , , ,-.-
,-" I
1
2
requested it.
Q.
4543
In the middle of August did he tell you that
3 basically he had done whatever preparatory work he needed to do,
4 i.e., testing Kevin's blood and was prepared to go ahead with
5 testing, whenever it was convenient with you?
6 MR. KOCHIS: Objection, that is going to go call for
7 hearsay.
8 THE COURT: Well, I don't think it is to prove the truth
9 of it, whatever the actions of this witness. Overruled.
10 MR. KOCHIS: Well, your Honor, I think in this case this
11 one conversation is offered for that purpose.
12 THE COURT: Only this specific comment. You are not
13 going any further?
14
15
16
17
MR. NEGUS: That is true.
THE COURT: Overruled.
THE WITNESS: It was either towards the middle or the end
of August, I'm not sure at what point.
18 BY MR. NEGUS:
19
20
21
22
23
24
25
26
27
Q. And at that point in time was the further testing
essentially delayed until you had done further work on Kevin
Cooper's blood?
A. That is true, yes.
Q. And the further work that you wanted to do on Mr.
Cooper's blood, was it run for Group III and haptoglobin?
A. That is correct.
Q.
A.
And do you remember when you finished that work?
I believe it would have been towards the end of
28 September.
COMPUTERIZED TRANSCRIPT
">"
" U , , ,-., o , , -, ,--
.:1 L
·., ---......... ~- .
/,---.,,, , .
1 /"- .. I
2
3
4
5
6
7
8
9
10
11
12
13
(r-', 14
15
16
17
18
19
20
21
22
23
24
25
26
27 . '-
28
4544
o. Okay. You are not exactly sure of when?
A. Not exactly sure, no.
o. Let me just -- just to again, if there is no
objection, just to facilitate the witness not jumping up and
down, let me put -End of September, Dan ready to test- on the
chart.
And did the testing then actually take place within
a, within a week or 50 of your being ready to do something?
A. Yes. The testing took place on October the 3rd,
4th and 5th.
O. Now, in terms of the different tests, without
getting into all the technicalities of it at the moment, is
there, for each test, a term used called the discriminatory
power which basically is an index, a mathematical index of how
informative in the context of a particular situation a
particular serological test will be?
A. In essence, yes.
Q. And of the tests that you had not performed on, as
of the time that you made the first contact with Ed Blake, that
are reliable enough to be used in the forensic context, was
transferrin, that is, the Group III transferrin and groups of
that component, Gc, was that the most informative of the
remaining tests?
A. Of the tests that I was looking at at that time?
O. Yes.
A. Yes, it was.
O. And haptoglobin then again would be the second most
most informative?
COMPUTERIZED TRANSCRIPT
rl U
I , I-' o
I , -:,
1---:1 :;
~ ... '.. ... Ii
1
2
A.
o.
4545
As I was looking at it at that time, yes.
Well, what test that you had not performed up to
3 that point in time, would you now think would be more, would
4 have been more informative?
5 MR. KOCHIS: Objection, irrelevant. If the tests chose
6 are all in issue, what would be the relevance? It would be his
7 knowledge at that time and not two years later.
8
9
THE COURT: No, counsel, I will permit it. Overruled.
THE WITNESS: The tests that would have been most
10 informative at that time would have been, first of all, the
11 transferrin, which had a greater likelihood than a lot of the
12 tests of either eliminating or including Mr. Cooper as having
13 deposited this blood drop, and also another one would have been
14
15
16
17
18
19
20
21
22
23
24
25
a test in particular isoelectric focusing on EAP to determine 8
whether this was a test for ,R-or RB.
Q. Well, you had done the tests before. You're
talking about the two on his EAP. I'm talking about tests you
hadn't done before.
A. I had done two EAP runs, yes.
Q. At that point in time did you in any way indicate
that you had any doubt about your results?
A. At that point in time, no.
Q. And, well, let me ask you this.
Did -- after you found out what type transferrin
and haptoglobin types Mr. Cooper was, did you decide that you
26 wanted to do first of all the transferrin?
27 A. I believe it was -- we discussed it between myself
28 and Dr. Blake as to which test would go first.
COMPUTERIZED TRANSCRIPT
" U I ,
'--~ o ~ ,
J L U I
_ ...... - - .. -- .. -----.
I
2
3
4
5
6
7
8 2
9
10
11
12
13
14 1
15
16
17
18
19
20
21
22
23
24
25
26
27 ~
28
4546
Q. You told him you wanted transferrin first, right?
A. I don't recall that specific conversation. I know
that I wanted transferrin and haptoglobin.
Q. Well, did you tell him you wanted transferrin
first?
A. Again, I don't recall.
Q. Did you want transferrin first?
A. Again, at that time, that point, I don't recall.
After this point I would say, yes, because it is a better
discriminatory than the haptoglobin.
Q. And basically did you tell Dr. Blake what you
intended to do and he basically agreed with the procedures that
you suggested?
A. Essentially, yes.
Q. During all this testing on the A-4l, it was at all
times within the possession and control of the crime lab; is
that right?
A. Yes, it was.
Q. When Ed came down, did he make some suggestions to
you about how to prepare the samples that you had in order to,
in order to maximize both the number of tests that you could do .
on it and the likelihood of getting a readable run?
A.
Q.
A.
Yes, he did.
Did you learn anything from his suggestions?
Yes, I did.
Q. And did those suggestions in fact increase the
chances of getting a readable result and doing two tests?
A. I believe they would have, yes, as compar~d to
COMPUTERIZED TRANSCRIPT
" U ~ I .,
o ~ , --J L
·c -'
,/."
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 ~.
28
.~"
4547
other methods I may have used.
Q. When the sample was prepared, did you essentially
take it out of the freezer and deliver the remains, as it were,
dump them out for Mr. Blake; Dr. Blake?
A. I took the -- it was in a small pillbox, a metal
pillbox. I took that out of the freezer and then I showed that
to Dr. Blake. I didn't dump them out, I just showed it to him.
Q. The way that the -- that sample that was collected,
that was essentially putting all those little plaster chips into
a test tube type thing with solution in it, to desolve the blood
into solution?
A. As far as we were going to analyze it that day?
Q. Yes.
A. Yes.
Q. And were you the one that actually did that?
A. I'm not sure if I did or Dr. Blake did, or both of
us. I am not sure.
Q. Well, were you attempting to use all the stuff that
you had there?
A. As much blood I saw at the time in the small
container, yes.
Q. Did you neglect to look at the lid of the
container?
A. I don't believe so, no.
Q. Well, after, after that test, urn, on several
different occasions did you testify that all the blood that was,
that was there, had been consumed in the analysis?
A. I believe that all the usable blood, I testified
COMPUTERIZED TRANSCRIPT
" U I ,
,-, o
I , ~I I-.-6
---",
1 (--.
2
3
4
5
6
7
8
9
10
11
12
13
14
~'. 15
16
17
18
19
20
21
22
23
24
25
26
27 , -. 28
4548
that all the usable blood had been consumed in the analysis,
yes.
Q. At some point in time you discovered what you
thought was more blood in the pillbox?
A. At some point in time, just out of curiousity sake,
I did open the pillbox and saw a very small quantity of blood
remaining.
THE COURT: Just answer that yes or no.
THE WITNESS: Yes, your Honor.
BY HR. NEGUS:
Q. Where did that come from?
A. I assumed that it was already in the box.
Q. How come you didn't take that out when you were
preparing the sample back in October?
A. Again, I believe I didn't see it.
Q. During the design of the test, did, did essentially
Dr. Blake try and design it so, Dr. Blake design it so that for
sure you'd get a transferrin result and then you'd hope you had
enough left over to get a haptoglobin result?
A. That is essentially correct, yes.
Q. And was the amount that you had left over for the
haptoglobin, after you had run the transferrin first, was that
essentially a lesser than optimum amount of blood for testing?
A. After we had run the haptoglobin?
Q. After you had run the transferrin, the amount of
what you had left was a little bit of solution, right?
A. That is correct, yes.
Q. And was that, was the amount of blood in that
COMPUTERIZED TRANSCRIPT
:", U , , .-, o , , -:, ,-.
. -. -, ,
4549
1 solution less than optimum for running the haptoglobin?
2 A. I would say it is less than I would normally use,
3 yes. So, yes.
4
5
6
Q.
A.
Q.
And was the haptoglobin result not very strong?
It wasn't very strong, that is correct.
In the literature about the testing of blood, in a
7 forensic context, is it a general idea that an analyst, in order
8 to avoid miscalling something, has to be very careful in
9 situations where the results are weak or positively ambiguous,
10 just say I make no call?
11
12
A.
Q.
That is true, yes.
Was there a particular reason that you wanted to
13 have a serologist chosen by the defense present when you did
14 additional testing on A-4l after August the 5th?
15
16
17
18
19
20
21
22
23
24
25
26
A. Yes, there is.
Q. What was that?
A. Basically, there was a couple of reasons.
One is to make sure that they did see my results
firsthand rather than through photographs, which are not always
as good as seen at firsthand.
And basically out of courtesy to the defense.
Q. Were those, were those reasons any less compelling
on August the 2nd when you, when you did the second EAP test?
A. I would say no.
O. Let's just -- just for A-41, of these various
different tests that you can do on A-4l, that you did in fact
27 do, would it be the ABO, EsD, PGM, EAP, ADA, AK, Gc, Tf, PEPA,
28 and Bb.
COMPUTERIZED TRANSCRIPT
n u , , ,-, o , , ~, ,-.-
··0 .0
/'---...
1 -" f 2
3
4 2
5
6
7
8
9
10
11
12
13
;~ 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
~"
4550
How many of those did you attempt to use blind
testing on?
A. The ABO, the EsD, the PGM, the CA II and the
Peptidase A.
o. Well, you can't say for sure that you attempted to
do blind testing on the PGM, because you donlt know whether you
got information about Mr. Cooperls PGM type before, after you
read that test.
A. First of all, without having a standard for Mr.
Cooper I don't, didn't really consider that as a standard
anyway.
o. It was information that you had.
A. It was information, yes.
Q. What's the purpose of blind testing?
A. To make the calls as unbiased as possible.
Q. So, if you had the information about a personls
type, the thought is that maybe the result that you want in a
particular case will influence your call?
A. That is the thinking, yes.
Q. And at least you had some information also about
Mr. Cooper's Peptidase A type before you read A-41; is that
correct?
MR. KOCHIS: Your Honor, I'm going to object as lack of
foundation. If I am permitted to go into the nature of the
information Mr. Gregonis had, I am not going to have an
objection. But I would like to be heard further, out of the
presence of the jury on this area. I think we had a rUling on
it before outside the presence.
COMPUTERIZED TRANSCRIPT
I
r l
,.. C
• (
.(
"--;-'''''' . --- '~---. ..
/~
1 (--
2
3
4
5
6
7
8
9
10
11
12
13
14 ~
15
16
17
18
19
20
21
22
23
24
25
26
27
'--- 28
4551
THE COURT: Take an early recess. Any objection?
M.R. NEGUS: No.
THE COURT: All right, let's take a early recess.
Court will remain in session though. Remember the
admonition.
This is an in-chamber matter. We will take it up
in chambers.
(Chambers conference reported.)
THE COURT: On the record. The defendant and all counsel
are in chambers out of the presence jury.
While M.r. Negus is looking for something in the
Court's copies of transcripts, Mr. Kochis, Mr. Kottmeier, do you
have any revised estimates on when you might be able to rest
based upon the speed we're going?
MR. KOCHIS: No. It is still possible, in my opinion,
that the week of the 17th of December would be a week in which
we may rest.
THE COURT: Well, that is wonderful.
MR. KOCHIS: If not that week, I would say almost for
sure the first week in January when we come back for those three
days.
THE COURT: Okay.
MR. KOTTMEIER: One other thing that we can discuss
briefly while the jury is not here.
This afternoon I would request a few items from
evidence to be released to myself for this weekend. We have
~ade arrangements with Dr. Mary Howell for a conversation at the
COMPUTERIZED TRANSCRIPT
:0 U , , o (J , , J .J .. , U
-. (
4552
1 home of Josh Ryen that we will video tape, to offer as a
2 foundation for Josh's statements. And what we were going to do,
3 with the Court's indulgence and consent, would be for Mr. Negus
4 and I to go to Josh's house, ask him questions on video tape,
5 bring this tape back to court to offer as the basis for a
6 foundational evaluation of his testimony and/or the possible
7 introduction of the tape if both sides find it usable.
8
9
THE COURT: What do you need from evidence?
MR. KOTTMEIER: A couple of photographs. It must be
10 contageous, Kochis. A couple of photographs such as the
11 interior of the laundry room and in particular the Star Trek
12 towel that we have been discussing.
13 THE COURT: Okay. We'll take them out at some point.
14 Show it to Mr. Negus.
15
16
17
18
19
20
21
22
23
24
25
MR. NEGUS: I have no objection.
THE COURT: Perhaps there will be no objection.
MR. KOTTMEIER: And we need to set some time aside when
the Court can review Josh's tape, assuming it comes out, and
make some -
THE COURT: You are going to have a tape? Okay. The
video tape.
MR. KOTTMEIER: A video tape. We are hoping to have a
very relaxed atmosphere with Joshua, with just his grandmother,
~r. Negus and myself and Josh present, and then the camera to
video tape him in his own home. And both sides I think are
26 hoping
27 THE COURT: I can conceive of it not being necessary at
28 all. I mean, after your conversation, interview or deposition,
COMPUTERIZED TRANSCRIPT
: ,-, U , , ,-, o , , :I .:1 , ,
3
1
2
3
4
4553
whatever you want to call it, you both may agree that the tape
be used, that it not be used, that it is necessary to have the
live body, any number of things.
MR. NEGUS: I think the probability is we will agree. I
5 would like to be able to arrange somehow before it is played to
6 the jury, you know, just because of confrontation rights that
7 are involved, I need to have Mr. Cooper be able to see it before
8
9
it is played to the jury.
THE COURT: I will -- certainly we can arrange a time,
10 that is not important.
11 MR. KOTTMEIER: But that is on the horizon for this
12 Sunday.
13
14
15
16
17
18
19
20
21
22
23
24
25
THE COURT: Okay.
MR. NEGUS: Well, I can't find it.
MR. KOCHIS: Your Honor, the nature of my objection, what
he is attempting to get into in front of the jury, is that Mr.
Gregonis received a phone call from Mr. Lorenz, whose with the
Allegheny Crime Department in Pennsylvania, and some information
was passed. However, what happened is Mr. Lorenz says, ·We have
a case in which Mr. Cooper is a suspect.-
The assailant, whether it be Mr. Cooper or someone
else, left some seminal fluid behind at·a scene of a rape and
this is the type of that person.
Now, provided I can go into that, I don't care.
THE COURT: I can't conceive of the relevancy of that
26 information, but the fact that he -- is that what you are trying
27 to go into?
28 MR. NEGUS: I have gone into it, that Mr. Lorenz called
COMPUTERIZED TRANSCRIPT
I-' U , , I-' 'J
I , -, :I
.:1 .L
/~ -"
1
2
3
" 5
6
7
8
9
10
11
12
13
14 r-'.
15
16
17
18
19
20
21
22
23
24
25
26
27 -......
28
.~
4554
Mr. Gregonis and told him that it -- that based upon -- the
blood type basically is all I care about. He told him he's 1+
and PEPA 2-1, and the fact that, how did Mr. Lorenz know that,
because they had Mr. Cooper's fingerprints on a vehicle that was
used and he was identified positively by the victim, and they
got, they had that particular information. I don't see that
that is particularly relevant. All that is relevant is that he
had the information and it was was passed.
MR. KOCHIS: Well, on the contrary. All the things Mr.
Negus articulated weren't passed on to Mr. Gregonis, the
positive 1.0., photo lineup and fingerprints, and my position
and Mr. Gregonis' point is, I didn't have a positive sample.
This was not like a standard. It wasn't as if someone from
Pennsylvania called me up and said, we've got a blood bank here,
we have got a sample of Cooper's blood, and this is his profile.
They had some stains that were left behind by an
assailant and Mr. Gregonis felt it was not a standard, and he
was doing blind testing because he was not sure that was left
behind by Mr. Cooper, and I intend to at least, now that Mr.
Negus has made an issue on this in front of the jury, to go into
it in front of the jury; that Mr. Lorenz is not employed by San
Bernardino, that he's employed by a crime lab in another part of
the country,
THE.COURT: That is whose not employed?
MR. KOCHIS: Mr. Lorenz. He works for the crime lab in
Allegheny County.
THE COURT: Okay.
MR. KOCHIS: If Mr. Negus continues to push this argument
COMPUTERIZED TRANSCRIPT
n IJ , , o o , , -,
.:1 '.~
.=-
1
2
3
4
5
6
7
8
9
10
11
12
13
14 f'
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4555
that he had a standard, that it wasn't blind testing, I feel I
should be allowed to go into the fact that you really have an
unknown quantity. Mr. Cooper hasn't been convicted in
Pennsylvania. There is a lot of things which have to be
established before it is shown that the results that Mr. Lorenz
read over the phone had anything to do with this defendant.
THE COURT: How can we do that in a nonprejudiclal
manner?
MR. NEGUS: I think that the fact that Dan's already
done, it -- I mean, he said he didn't have a standard, I am not
disputing that, what I was, the actual direction I was going in
at this point in time was that the tip that he got from
Pennsylvania, as far as the PEPA was concerned, was confirmed by
his semen analysis of the green blanket, prior to his doing
testing on A-41. That was in fact where I was going with it at
this point in time.
MR. KOCHIS: My problem is when he says you have some
information, if that question is going to be asked and answered,
then I have a right to go into what some information consists.
If it is not, we have that profile back there.
THE COURT: Mr. Kochis, I simply can't permit the prior
act back there, bringing in the rape and suspect's status, all
of that to come in. I can't see any justification for that at
all.
You can bring in the nebulous quality of it in some
manner, this was simply a phone call from back there intitiated
perhaps by that office without any varification of this witness
in some manner, but you are going to have to do it in a
COMPUTERIZED TRANSCRIPT
" U , , ,-, o , , -, :; U ,
·-.· ...... ·.·"w.~. __ ~. __ _ .'
1 (" '.
2
3
4
5
6
7
8
9
10
11
12
13
14 ~
15
16
17
18
19
20
21
22
23
24
25 1
26
, 27 ~ ... ~-.
28
4556
nonprejudicial manner.
MR. KOCHIS: But I am -- what I am saying, he should not
be allowed to have it both ways, to push this information
aspect. I am not' the one that brought it up, I didn't mention
any of this on direct. If he wants to bring it up he's opening
up a number of doors that we completely stayed away from.
You can't close the examination down once he
chooses, for whatever reason is in his mind, to waive that and
go into that. That's what he's done.
MR. NEGUS: I don't think I have waived it. Let me
just if the issue is -- I am not going to push it anymore,
and the only other point I was going to make was that the tip he
had was confirmed by the green blanket, and before he, before he
looked at the PEPA on A-41, that's was the other thing, anymore
than I have already done.
THE COURT: We are accustomed to editing matters, to
excising prejudicial parts of it; we do it all the time. And we
will have to continue to do so with reference to the
Pennsylvania information.
MR. KOCHIS: Well, I will attempt to be as tactful and as
artful as I can in my question.
THE COURT: I will jump allover you if you are not.
MR. KOCHIS: That is what you're in the courtroom for?
THE COURT: All right, thank you. Take a recess.
(Recess)
THE COURT: You may continue, counsel.
BY MR. NEGUS:
COMPUTERIZED TRANSCRIPT
"',-, U , , ,--, o , , -, J
5
roo
0,-
4557
1 Q. To finish up briefly with where we were before, at
2 one point in time you testified, did you not, that you were
3 attempting to blind type Group lIon A-41?
A. I believe I testified that in essence that's the
5 way it looked for Group II.
6 Q. Didn't you also testify that you attempted to and
7 then changed your mind when you found out that you had [un
8
9
Cooper's blood at the same time and admitted that you didn't?
A. Well, the first time I tested it, it was a blind
10 trial on the 28th. And then I believe that I said that
11 essentially that I was trying to blind type it but when I ran it
12 on Group -- Group II on the 2nd of August, I believe, ~hatI wa
13 still trying to blind type it~ however, obviously it was not a
14
15
16
17
18
19
20
21
22
23
24
25
26
27
blind trial because Mr. Cooper's blood was on the same plate.
Q. Well, first of all, you testified that yoU
didn't that -- wasn't your first testimony that you didn't
run Mr. Cooper's blood on the same plate as A-4l and then I
showed you the thing and you changed your mind and said you did,
and said, -I stand corrected.-?
A. I may have for the run on August the 2nd.
Q. On this Exhibit 590 I've also placed a plastiC
overlay, 590-A so that we can -- that we can draw on it.
This -- the actual area where you where you're
looking at these patterns that you get is like about yea big,
less than a foot in each dimension?
A. I would say the actual area is somewhere around
nine inches by four inches, something like that, for each
28 enzyme.
COMPUTERIZED TRANSCRIPT
0 •• ,_,
U , , I-' Q
I , -:, J ,-a
• .... 1> •••• ___ ._._. __ •••
(-"" 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4558
o. Okay. So you basically -- what -- the terminology
that you use is, is that when you -- when you set up one
particular test, one particular test
You called that a run, is that is that the
terminology you use?
A. Yes, I do.
O. I'm putting up on the board 599.
And the -- for most runs that you do, you'll use
somewhere between eight and twelve samples of blood?
A. Depending on the system and the size plate that 1'm
using, that's correct.
O. And also sometimes, not in this particular case too
much, but sometimes just, you know, how much you have left to
do, is that right?
I mean, if you -- if you -- you will -- between
nine and twelve -- if you only have six samples you won't use
twelve, you will use the nine?
A. Well, I will probably use at this point I will
probably use the twelve and just stick on some samples for
population studies.
O. Back when you were doing it in June of '83 and
August of '83, you'd use nine or twelve.
There's no real significance
What, I guess what I'm saying is there is no
significance as far as the test is concerned as to whether or
not you use nine or twelve; is that right?
A. That is correct, yes.
O. Now, the particular test that you did on August
COMPUTERIZED TRANSCRIPT
,,.., U , , I-' o • , ,
J , ,
', ......... -_ .. , .. -
~,
1
2
3
" 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
~,
4559
2nd, 1983, that involved nine different slots, is that right, of
the Group II?
A. Yes.
Q. That was what you referred to in your run number as
Run 162?
A. That is correct, yes.
Q. Does that mean essentially that that was the
hundred sixty-second time that you had run a Group II in your
laboratory in a case context?
A. As far as Group II's, that's the hundred
sixty-second time that I had run a Group II after I started
keeping records in this method.
Q. Okay. How long were you doing Group II's before
that, just a short period of time?
A. Probably six months prior to the beginning of this
way of numbering.
Q. And then at that pOint in time you were also in the
250's and 260's as far as Group I's are concerned; is that
eight?
A. That is correct, yes.
Q. So of the -- of the particular tests that you --
that you performed in your laboratory when you started working
for them they basically were just doing ABO, right?
A. Basically, yes.
Q. And then after a period of time you added the Group
I, and then after another period of time you added the Group II?
A. 3asically I started the Group I right away and then
probably about three months later, four months later possibly, I
COMPUTERIZED TRANSCRIPT
" U , , o o • ,
J :J
·0 .0
2
1
2
4560
started the Group II's.
o. And then the other stuff was -- was just beginning
3 at the time that this case occurred; is that right?
" A. As far as routinely, yes. The peptidase A's were
5 being -- or the Group IV's were being run somewhat routinely,
6 depending on the case, prior to this.
7
8
9
10 of the
o. A.
o.
If you had a black defendant, is that -
Either suspected black assailant or victim.
Okay. So this was basically then, Group II was one
was one of the tests that you had more experience on
11 than some of the others?
12
13
A.
Q.
That is true, yes.
Now, just on this -- on the actual, I guess,
14 machine, or whatever you wish to call this that you run it on,
15
16
17
18
19
20
21
22
23
24
25
26
27
just so that we -- the negative side on that is called the
cathode~ is that right?
A. Yes, sir, it is.
Q. I'm going to write ·cathode· on at 590-A.
And the positive is called the anode?
A. That is correct.
Q. Now, the -- trying to be as -- not to be too
technical, what you're doing in the testing is you're attempting
to see, given a certain amount of electricity and in a certain
amount of time, how far certain parts of blood will travel; is
that right?
A. In essence, yes.
Q. So, when you have -- when you have your -- your
28 paradigms for -- this is a -- a -- a PGM that you have on the,
COMPUTERIZED TRANSCRIPT
n u
j , ., a
I ,
,~
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 '--
28
,'~
4561
set up there on the on the diagram as it exists nOW1 is that
right?
A. It could be be a ?GM, yes.
o. The -- so what you're -- the -- what you're trying
to do is you're going to measure the distance or just examine
the distance then, a certain time certain voltage will take for
certain materials to get to those particular -- those particular
slots that you have on the diagram; is that right?
A. Essentially, yes.
O. Okay. Now in -- each time that you -- that you
run, just using that example, a PGM, it doesn't turn out to be
exactly, you know, say three inches from this the place where
they started to the furthest point, it will vary, right?
A. That is correct, yes.
o. So what you do in trying to analyze it is, you're
making comparisons rather than precise measurements of distance
moved?
A. That is correct for the most part.
o. In order to -- well, both the PGM's and the acid
phophatases have more complex patterns than average, is that
true?
A. I don't know if you can say it would be more of and
average. They are more complex than other enzymes.
o. When -- after you finished doing the running the
electricity through the -- through the -- through the machine
and the proteins have finished their movement, you can't see
anything just by looking at it, right?
A. Well, you can. For instance on Group IV you can
COMPUTERIZED TRANSCRIPT
t
n u I ,
o o I ,
LI , " I-' U
,~'
1
2
3
4
5
"" 6
7
8
9
10
11
12
13
14
15
16
17
18-
19
20
21
22
23
24
25
26
27
28
~
4562
see the hemoglobin partway through the run, where it is, but
generally, you have to put something on the plate to develop it.
Q. And the way you do that is you spread another
chemical over the surface of your -- of your gel and that will
react with whatever -- whatever particular enzyme you're looking
for and make a visual pattern?
A. That is true, yes.
Q. with your
two different types of
with your Group II basically there's
two different ways that you get the
patterns to come up. One is you put on a substance which will
make the protein glow in the dark, and another one is you put on
a substance which will turn it a darker color from the gel1 is
that right?
A. That is true, yes.
Q. And the EAP is done by making it glow in the dark?
A. Or to be more specific, to floresce in ultraviolet
light.
Q. For nontechnical people glow in the dark is good
enough. I mean, that's pretty much what you see, you see a glow
and you do it in the dark?
A. With an ultraviolet light.
Q. And so with the ultraviolet light, that's a rough
approximation of what the different little patterns are going to
look like1 is that right?
A. That's what they do look like, yes.
Q. That being Exhibit 591 that I'm showing.
Now, as you were doing it back in August of 1983,
you were putting two different coatings on your acid phophata$e,
COMPUTERIZED TRANSCRIPT
" U , , l-~ o
~ , lJ ,
~ ,
/--,
.... -..••.. ~ .. ,.---. -.~
1
2
3
4563
is that right?
A. I was at times, yes, depending on the samples.
o. Well, in the case of Run 162 you put two different
4 coatings on, right?
5
6
A.
o. That is correct, yes.
And after you put on the
7 The first coating you took a reading, is that
8 right?
9
10
A.
o. That's true.
And as far as A-41, in that particular slot after
11 you put the first stain on the reading was a B, right?
12 A. Okay. I'm not sure whether I read the first or
13 A-4l on the -- well, what you call the first coating or the
14 second coating, I'm not sure at this point.
15
16
17
18
19
20
21
Q. Didn't you do both?
A. Yes, I did, but a lot of times the reason for the
second coating is that you can read things that you cannot with
the fi rst coat.
Q. Putting up on the board Exhibit 595, which is a
little chart that you prepared for Mr. Kochis of different
patterns that you look for in the -- in the enzymes, you
22 mentioned -- and you put a dotted line to indicate something
23
24
25
called a storage band, is that right, the top of that exhibit?
A. That is correct, yes.
o. Okay. Now if somehow you could analyze blood this
26 way while it was still inside a human being, you wouldn't see
27 that; is that right?
28 A. Probably not, no.
COMPUTERIZED TRANSCRIPT
-'n u , , ,-, o
~ , LJ I
.;.- ......... ,.,.
f -'--
. /-.
/~.
4564
1 Q. What -- what the storage band is, is it's a
2 after blood is shed it starts to change immediately; Is that
3 right?
" A. That is true, yes.
5 o. And one of the things that forensic -- forensic
6 ser010gists have to be careful about is to be sure and analyze
7 the blood before it changes too much to either be not readable
8 or to give false results; is that correct?
9 A. That is correct, yes.
10 o. And with acid phophatase there's been a fair amount
11 of controversy in the forensic community over the last ten years
12 or so about what happens to it as it gets older; is that
13 correct?
14
15
16
17
18
19
20
21
22
23
24
25
A • There's been discussion about it, yes.
Q. One of the things that you have to do with acid
phophatase is to check to make sure it hasn't gotten too old so
that its patterns will alter; is that right?
A. That is part of it, yes.
O. One of the -- one of the diagnostic clues that
people use is to check the storage bands, right?
A. That is part of it, yes.
O. And basically what you want to make sure is that
you don't have too much activity up here as would indicate a
sample that was too old to be reliable, true?
A. I don't know about too old, but too degraded. But
26 that is mostly prevented by one of the chemicals that you add to
27
28
the stain before you run it.
Q. Okay. But you can -- you can sort of freshen up
COMPUTERIZED TRANSCRIPT
"" U I ,
o o I ,
.'-1 -. :1 .J
..• > ....... _._"._. - -- --
4565
1 the stain by adding a chemical called mercaptoetanol,
2 m-e-r-c-a-p-t-o-e-t-h-a-n-o-l; is that correct?
3
4
5
A.
Q.
A.
Sounds good to me.
And you use that to freshen its up, as it were?
To reconvert some of the degraded product into the
6 original product, if you will.
7 Q. Is that the same thing as in technical language,
8 that's freshening it up?
9
10
A.
Q.
I would say so, yes. ---. ----------
You still, however, even after you after you add
11 the freshener upper, you still have to check to make sure that
12 the freshener upper worked, right?
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. Exceptionally, yes.
Q. So, when you're reading the plate you have to first
check up in the storage band area to make sure that you don't
have a degraded sample, that's one of the first things you have
to do; is that right?
A. That's part of the diagnosis, yes.
Q. Now, if -- if you were looking -- if we were to
convert these little lines on the -- I will take a red marker on
Exhibit 590-A and just for convenience taking 1, 2, 3, 4, 5, 6.
As to the EAP, just realizing it's not to scale or
anything like that, but the different spots that you would look
for your for a reaction would be like 1, 2, 3, 4, skipping 5
and then 6; is that basically correct?
A. Essentially, yes.
Q. And so the storage bands would be up around the 6
28 area?
COMPUTERIZED TRANSCRIPT
" U , , l-~ o
~ , U , ·u I
,~
(-. 1
2
3
4
5
6
7
8
9
10
11
12
13
14 /"--.."
15
16
17
18
19
20
21
22
23
24
25
26
27 .... ,..,...-
28
,c-----,
4566
A. Using those diagrams, yes.
O. When you put your -- giving you a green marker,
when you -- when you put your stain on the Run 162, the first
stain, that is, not the one that makes it go brighter, but the
first, what area of the plate did you cover with the stain?
Could you circle that in green?
A. The first part that I covered was approximately
from
It's not marking very well.
O. Let me find see if I can find another one here.
Well, let's switch from -- I can't find green.
Let's switch from green to brown.
Giving you the brown marker, could you then mark it
in brown, the area -- you've drawn a line along it.
Now when you did -- when you did this particular
Run 162 then, the first thing you did was to check the general
overall patterns to see whether or not, you know, what you had.
And do you actually sort of sit there and go down
them and write down your calls, you know, from just the first
stain?
A. If I can call them out of the first stain, yes.
Q. Okay. So when you -- when you -- as far as what
you understood about A-41 was concerned, it appeared to be a
fresh stain; is that right?
A. From my other analysis, yes, it did.
Q. Okay. And had there been any signs present when
you were, when you were looking at it on August the 3rd, that
would have stood out in your mind, would it not, that, oh,
COMPUTERIZED TRANSCRIPT
" U I I. ,-,
o I I
U , ·C .:1
1 f-
2
3
4
5
6
7
8
9
10
11
12
13
(~ 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4567
here's something that it may be not as fresh as I thought it
was?
A. That's true, yes.
O. You didn't see any activity, any significant
activity up in the storage band area when you stained A-4l7 1s
that right?
A. Not that I can recall, no.
Q. In this particular -- in the particular Run 162,
using the blue marker on Exhibit 590-A, could you indicate the
spot where -- where you put the second stain, the one to make it
what you had already seen brighter?
A. Okay. As far as what are you considering No.5,
just nothing there.
Q. Basically just to get the spacings right, in an EAP
sample there would be nothing normally that would pick up in the
No. 5 spot; is t~at right?
A. Not normally, no.
Q. Okay. So let's consider No.5 to be normally
blank.
A. Basically the area where I put the second overlay
was below, or I guess through 5, somewhere between the storage
band area and the first diagnosis band, and I put it down to the
origin.
Q. Was that basically negligence on your part?
A. Well, there's a reason why I did not put it up any
further. That is because there is another enzyme up above that
which can be very much effected and cause false results due to
the chemical that's put on on the second overlay.
COMPUTERIZED TRANSCRIP'l'
" U , , .-., o , , U ,
4
1
4568
1 Q. Is that -- is that the way that Mr. Wraxell
2 recommends that you do it?
3
4
S
6
A.
Q.
A.
Q.
As far as the second overlay?
Yeah.
I'm not sure what Mr. Wraxell recommends.
In the -- in the pattern that you get with a --
7 with an RB, the middle band is slightly more intense than either
8 the top band or the bottom band; is that right?
9
10
A.
Q.
That is true, yes.
But the top band is of the same intensity as the
11 bottom band; is that right?
12
13
A.
Q.
Approximately, yes.
Now, as -- because there exists these -- these
14 problems in interpretation sometimes of acid phophatase, there
15
16
17
18
19
20
21
22
23
24
2S
26
27
are certain rules, are there not, about when you make a call and
when you don't?
A. Yes, there are.
Q. So, basically one of the rules is that unless you
can see bands in both either No. 1 and 3, 2 and 4 positions,
that is, those would be of those two pairs, you wouldn't make a
call, right?
A. Essentially, yes.
Q. And so you would not have called the A-4l a type B
unless you had a clearly visible band right here.
A. That is true, yes. That's what the problem was on
my first run.
Q. So, if in fact A-41 had been an RB rather than the
28 B that you saw on the plate when you looked at that particular
COMPUTERIZED TRANSCRIPT
." U , , o o , , .'-1 , ,
1 f . ,
2
3
4
5
6
7
8
9
10
11
12
13
14
~. 15
16
17
18
19
20
21
22
23
24
25
26
27 ............
28
4569
area, you would have seen an equal area up there, right?
A. Had I put the second overlay up that far, yes.
Q. Even with the first overlay, when you saw it on the
first -- on the first -- when you first spread the thing over
there, you would have seen it at that point in time, would you
not?
A. Not necessarily, no.
Q. Is the other, the other, the other EAP runs that
you were doing in the same general time as you had run 162, did
they show the areas stained with both stains where the overlay
was?
A. Excuse me, I don't understand your question.
Q. You have the pictures there before you, do you not
have? Of the other Group II runs that you were doing at the
same period of time.
A. Yes, I do.
Q. And, do they show the same staining procedures that
you used on Run l62?
A. Essentially, yes.
Q. Don't they, for example, show right up into the
other ones, show right up into the storage band area that had
been sustained with both the first and the second stain?
A. I would say they all seemed to show that I stained
with the second stain below where I stained the first stain.
Q. Okay. But you -- the other ones are stains in the
storage band area, right?
A. Some of the them are, yesl some of them cut right
through it.
COMPUTERIZED TRANSCRIPT
",-, U
I , .-:1 o
I , U . , .0 .0
~ .. r
4570
1 Q. On this -- on this particular Run 162, basically
2 the only Ryen case samples that you were actually running were
3 Kevin's blood and A-41; is that right?
4
5
6
7
8
9
10
was.
A.
Q.
A.
o. A.
o.
That is true, yes.
And Kevin's blood was obviously quite fresh.
Yes, it was.
And the A-41 at least was appearing quite fresh?
From -- again, from my previous results, yes, it
So, isn't the reason why you didn't bother staining
11 in the storage band area, which is something you normally would
12 want to know, was because they were fresh and so that you could
13 see that there wasn't any activity up there?
14 A. That is part of it, along with that the storage
15 band area is usually -- although I know different now, I did not
16 believe at that time that it was a diagnosis or a diagnostic
17 area for this enzyme.
18
19
20
21
22
23
24
25
26
27
28
o. Well, didn't you tell me, when we went into this
EAP problem at great length at previous hearings, that you
always made it clear to make sure that there wasn't much
activity in the storage band area?
A. Yes, I did.
Q. And that is what you did in this particular, this
particular case with A-41; is that right?
A. On my initial overlay, yes.
Q. Okay. And there wasn't.
A. Not that I saw, no. Or not that I recall.
Q. So that would not have been consistent with an RB
COMPUTERIZED TRANSCRIPT
o o I ,
LI , ·0 :J
4571
and that's why you didn't call an RB, right?
A. Again, I disagree with that. I mean, I was looking
for a storage band, not necessarily an R band up there. I did
not know that you could get at least an indication of an RB on
this system.
O. Let's just back-up.
Again, the same sort of nomenclature, a type B is
in fact two BB alleles, it is a BB, just shortened to a -B-,
leaving aside the allele.
A. Yes, sir.
O. What you get is when you are analyzing it, is that
whether or not you have a BB, RB, AB, CB, your B protein is
always going to end up on the same spot; is that right?
A. Yes.
Q. Ditto, whether or not you have an RR, RA, RB, RC,
or RD, the R bands are always going to show up in the same spot,
right?
A. That is true, yes.
Q. And the R bands essentially will show up in, as
with all the things, in EAP, in the same spot as the B's and
also beyond it, right?
A. Yes.
Q. True. Or RR, RC, RA, RB, whatever.
A. That is true, yes.
O. You certainly were aware that the system you were
using could be used to detect R's at that point in time, weren't
you?
A. I was aware that it could be used to detect R's and
COMPUTERIZED TRANSCRIPT
I-' U , , ,-, o , , ,.J .1-' U
1 (0 _,
2
3 2
4
5
6
7
8
9
10
11
12
13
!~" 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
:~ ....
4572
RA's, I did not -- I was not aware that you could differentiate
the B and the RB on this system.
Q. Well, you knew like for an R -- to tell an RA you
had to look up there, right?
A.
Q.
A.
That is true, yes.
And so you are saying
And below, too; you have to look at the whole
pattern.
Q. All right. So, you know at least one of the places
you had to look was up him here.
A. Yes, sir.
Q. You also knew for an R you had to look up there,
right?
spot
bands
band
that
A. That is true.
Q. But it never occurred to you to look in the same
for an RB?
A. Well, it occurred to me that I knew where the R
occurred, since they are very close to where the storage
of B band or the B type is. I did not believe at that time
you could get an indication of whether it was a B or an RB.
Q.
A.
Well, at what point did you learn that you could?
That 'I could?
Q. Yeah. Become part.
A. After I did some research into the RB, and this was
after the impetus for the research was learned that Dr. Blake
called Kevin Cooper's blood an RB.
Q. SO, your basic RB research has all been done since
you learned that if your call was correct, then A-41 couldn't
COMPUTERIZED TRANSCRIPT
" o ~ ,
,-J
r--
---
1
2
3
4573
have come from Kevin cooper.
A. Could you repeat the question.
Q. Your RB research has all come after you learned
4 that if your A-41 call was correct, A-41 could not have come
5 from Kevin; is that right?
6
7
8
9
A. My basic research is after I found out Mr. Cooper
was an RB.
Q. Was the impetus to your research the fact that if
your original call of a B was correct, based upon what you saw
10 on the plate, then A-41 could not have come from Kevin?
11 A. Along with learning that my calIon VV-2, the blood
12 sample from Mr. Cooper, was also wrong.
13 Q. Did -- basically, as far as A-41 is concerned, are
14 you using the photographs now to say that you can see more in
15
16
17
18
19
20
21
22
23
24
25
the photographs than you could see in the plate when you were
looking at it back in August?
A. Well, with what I know now, I would say the
photographs of the runs, where you can see the bands, it, you
know, will have more meaning to me.
Q. Do you remember at one of our prior hearings
testifying that it was hard to tell the difference between a B
and an RB?
A. I don't remember, no. But I could have.
Q. If that occurred prior to your learning that Kevin
was an RB, at least at that point in time you would have had
26 some idea that you -- it'd be hard, it could be done; is that
27 correct?
28 A. I believe I also stated that in order to really
COMPUTERIZED TRANSCRIPT
L
r, u , , ,-, o , , ,-:I
-:I L
........
"~ ... ~ ........ --.-
4574
I tell whether it was an RB you have to put it on another system
2 to confirm it.
3 Q. Well, then at that point in time were you looking
4 for information that would say, hey, put it on another system
5 and let's check it out?
6 A. Basically, I didn't know of information that would
7 tell me that at that time, so, no, I would not.
8 MR. NEGUS: I would like to read from the preliminary
9 hearing transcript, Volume XI, Page 30, Lines 2 through -- 2
10 through 13,
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
MR. KOCHIS: I have that.
MR. NEGUS: (Reading)
-Question: Do you test your reducing agents to
determine their effectiveness before you use them?
-Answer: By the use of standards, yes.
-Question: So, essentially your test, then, is if
the standard comes out the way it should, then
it's working okay?
-Answer: Essentially, yes, as long as I don't
have in the particular PGM and EAP if I don't
have a lot of storage bands and such.
-Question: Do you stain on the on the EAP so
you can see the storage bands, or overlay?
-Answer: I stain above where the EAP would
normally be. So just -- I would expect to pick up
the storage bands if they are there.-
Then same volume, Page 34, line 6, through 35, 2.
28 And the photograph that was referring to is the photograph of
COMPUTERIZED TRANSCRIPT
'n u , , o o , , ,:I J :J
1 A-41.
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 3
23
24
25
26
27 ,-.
28
4575
MR. KOCHIS: I have that.
MR. NEGUS: (Reading)
-Question: Where would the storage bands be on
that particular photograph?
-Answer: They would be present up more anodally
of the sample, up in this area.
-Question: Would they -- there appears to be like
an area where you stop staining or overlaying on
that photograph.
-Answer: No. That's -- there's overlay, secondary
overlay, after you initially develop the sample
you develop or put an overlay of approximately
one percent sodium hydroxide on there. It brings
up the bands, and what it does is makes the
chemical -- brings it from a -- what would be
called an alcohol stain into a feron state, and
that's it essentially fluoresces brighter.
-Question: So that band across the top there
-Answer: This line across the top is where I
stopped putting on the one percent sodium
hydroxide.
-Question: To make it glow in the dark?
-Answer: Make it brighter.
-Question: All right.
-So are there storage bands above where you
stopped putting on the one percent?
-Answer: There doesn't appear to be. There may be
COMPUTERIZED TRANSCRIPT
" U , I
,--, CI ,
I ,-.:1 ·L' ,
I ... - _ ~'''''_ • _ ~ _ .. _
\ ......
I
2
3
4
5
6
7
8
some faint ones that I didn't pick up with my
initial overlay.
4576
"Question: Okay. Well, do you -- do you put that
second overlay on routinely, or is that just when
you have faint results?
"Answer: I pretty much do it routinely. I read
the plate before and after putting the overlay on
it."
9 And then could we go on actually with the next
10 line, 7 through 10.
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
MR. KOCHIS: I have seen that as well.
MR. NEGUS: (Reading)
"Question: Looking at that photograph -- well,
first, do you believe that that -- I mean, are you
sure, same degree of certainty with the other
ones, that that is a B and no other type?
"Answer: Yes, sir,
And then on Page 36, Lines 4 through 12.
MR. KOCHIS: I have that.
MR. NEGUS: (Reading)
"BY THE COURT: If you just read off the
photograph, not having read off the plate, would
you read it only as a B?
"THE WITNESS: Yes, I would.
"Question BY MR. NEGUS: And no other type?
"Answer: Yes, sir.
"Question: So, you are sure of that just from the
photograph?
COMPUTERIZED TRANSCRIPT
':r, U
I , I-' o , , ,J
··C .J
~ ( ,
-.
1
2
3
o.
4511
-Answer: From the photograph I would call it a B.
-Question: And you are sure?
-Answer: Yes, sic.-
At the time that you gave that particular testimony
5 at the preliminary hearing, did you believe that the pOint I was
6 trying to make about the EAP was that it might have been
7 degraded?
8
9
MR. KOCHIS: Objection, that would be irrelevant.
MR. NEGUS: It goes to his attitude towards testifying at
10 that point, the particular opinion that he is testifying.
11
12
MR. KOCHIS: It calls for speculation as to --
THE COURT: Well, if you know what you think, go ahead.
13 If you can explain your answer. Overruled.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
THE WITNESS: I believe at that time I was thinking as to
whether another expert could come in and read my photographs and
tell what type it is.
BY MR. NEGUS:
O. Were you also -- were you also thinking that I was
trying to make a point about the sample being degraded?
A. I don't know.
MR. NEGUS: That's probably as good time as any.
THE COURT: Take the noon recess. Remember the
admonition. Return at 1:30, please.
(Noon recess)
COMPUTERIZED TRANSCRIPT
rl U
I , I-' o
I , 1-:I
6
/--.~~"\
1 1 (-. 2
3
4
5
6
7
8
9
10
11
12
13
14
r 15
16
17
18
19
20
21
22
23
24
25
26
27 , ....... 28
4578
SAN DIEGO. CALIFORNIA. THURSDAY. DECEMBER 6. 1984. 1:35 ~
DANIEL J. GREGONIS,
called as a witness on behalf of the People, having been
previously duly sworn, resumed the stand and testified further
as follows:
CROSS-EXAMINATION (Resumed)
BY MR. NEGUS:
Q. Mr. Gregonis, behind on you on the board is Exhibit
206, a chart which we need not go into in great detail at this
point in time, but involves the reactions of ortho-tolidine and
luminol.
I just wanted to direct your attention to certain
of the substances which I have listed on the board, to wit,
algae, fungi, and some types of bacteria.·
Do those particular -- to algae, fungi, and aerobic
bacteria contain a chemical called -- called catalase?
A. Yes, they do.
Q. And if -- when you do the -- do the second step of
an ortho-tolidine will that catalase react with the
ortho-tolidine and the hydrogen peroxide and produce a color
change?
A. If there's sufficient quantity there, yes.
Q. Generally as far as in a laboratory setting is
concerned if you're using the ortho-tolidine test -- well, in
your particular -- the particular testing techniques that you
COMPUTERIZED TRANSCRIPT
·n u , , ,-, o , , ,J , ,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
,~, 15 (
16
17
18
19
20
21
22
23
24
25
26
27 "-
28
4579
use as far as determining whether a substance is blood or not,
basically you use the combination of the ortho-tolidine test and
then the precipitin test to come to your opinion as to whether
or not a substance is in fact blood1 is that correct?
A. That is true, yes.
THE COURT: Did you go into this at all on direct, Mr.
Kochis?
MR. NEGUS: Yes.
MR. KOCHIS: The method that he uses to test a stain.
THE COURT: All right. Go ahead.
BY MR. NEGUS:
Q. The particular combination if -- the fact that only
human blood will -- will give you a positive reaction on the
precipitin test, that also answers for you more conclusively
than the ortho-tolidine test does the question of is the
substance blood; is that right?
A. That's true, yes.
Q. So if you were -- if you were just relying on
the -- the ortho-tolidine test alone, in order to exclude out
various vegetable substances which will produce a color change
with ortho-tolidine and hydrogen peroxide you essentially cook
them, right, boil them?
A. That's one way of doing it, plus letting it sit for
perhaps a week will also do it with most of those materials.
Q. But like the standard quick procedure is, just is
to cook it?
A. That is one possibility, yes.
Q. SO, for example, when Mr. Kochis was asking you
COMPUTERIZED TRANSCRIPT
" U , , ,-, o , , ,J
8
/---
1 I . t
2
3
" 5
6
1
8
9
10
11
12
13
14 .~
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4580
about distinguishing between tomato paste and blood, the fact
that tomatoes and tomato paste have been cooked, that's one of
the reasons why you wouldn't get a positive reaction on a tomato
paste; is that right?
A. If indeed they have been cooked, yes, that is true.
Q. Tomato paste generally has been cooked, right?
A. I don't know.
Q. Similarly, if you want to distinguish in the
laboratory various animal substances which might cause a
positive reaction with the ortho-tolidine, the easiest way to do
that is just to look at it under a microscope, right?
A. As to what type of cells and things they are, yes.
Q. I mean, if you're getting a positive reaction,
various times animal cellular material can cause a positive
reaction, but if you look at blood under a microscope you can
you can recognize the shape of a blood cell as opposed to other
kinds of cells from animals, right?
A. When you're talking about tissues, say, you give a
lung tissue or intestine or something like that, if they are
giving a positive result I'm not so sure that's not from
residual blood that's in there.
Q. Those substances I have listed under animal, those
are substances basically, are they not, that in the literature
are defined as giving positive reactions to the ortho-tolidine?
A. That is true, yes.
Q. And to distinguish whether you're getting one of
those other things or blood, the way to do it, the easiest way
to do it in the laboratory is just to look under a microscope,
COMPUTERIZED TRANSCRIPT
.~, o , , ,-.:1 o :J
!~ 4581
1 right?
2 A. Well, first of all you're looking at a dried stain,
3 I assume, because that's what we deal with.
4 o. True.
5 A. So the red blood cells would essentially be lysed
6 so you're not going to be able to see the red blood cell as it
7 is.
8
9
10
o. Can you recognize a lysed red blood cell under a
microscope?
A. Not different from other things, not really, unless
11 it's all together still.
12 o. Does are you familiar with a chapter by a man
13 named Henry Lee in a book by Richard Saferstein entitled
14
15
16
17
18
19
20
21
22
23
24
25
-Handbook of Forensic Science- I think it is?
A. Yes, I am.
Q. And is microscopic examination the method he
recommends to distinguish amongst the various animal substances?
A. I don't recall. He may.
Q. The catalase also will react with luminol to
produce a reaction; is that right?
A. That is true, yes.
O. From the -- from the Lease house --
Now with respect to the -- just the general idea
that you were doing with Mr. Kochis about what's consistent with
what, some of the stains that you analyzed the only thing that
26 you were able to get out of them was there ABO type; is that
27 right?
28 A. I believe so, yes.
COMPUTERIZED TRANSCRIPT
n u , , ,-, o , , ,o
.1-' U
2
1
f-'
4582
1 o. And in this particular case if you get an ABO type
2 there is no stain in the world, using the technology that you
3 do, that's not going to be consistent with at least one of the
4 victims; is that right?
A. That is true, yes. -------------
5
6 o. Now in the Lease house did -- where -- were any of
7 the bloodstains that you obtained out of the Lease House of
8 sufficient size and quality that you were able to obtain results
9 from all the tests that you normally do in your laboratory as we
10 find it here?
11
12
A.
o. No, sir.
with respect to the piece of rope that was in the
13 closet, I believe it was J-9, did that come to you packaged in a
14
15
16
17
18
19
20
21
22
23
24
25
plastic bag?
A. Yes, it did.
Q. Was there -- there was -- was there enough blood
there to run all the -- all the different tests that you do?
A. Yes, there was.
Q. So the lack of results was due to something other
than -- than quantity on that particular item; is that right?
A. I would say so, yes.
O. In general, is it considered to be not a good idea
to package blood stains in plastic?
A. In general, yes.
O. And that's because if you get any moisture in there
26 with them, that can cause them to degrade and so you'll end up
27 having results which aren't typeable?
28 A. That's true.
COMPUTERIZED TRANSCRIPT
." U I ,
I-' o I ,
1-o
I ,
, ... ~ .. -.~ . __ ...... - .. '._-
-'-
4583
1 o. The axe sheath that was -- that was submitted to
2 you, I think it was J --
3
4
A.
o. 5.
5. That likewise -- that likewise came in a
5 plastic bag?
6
7
A.
o. That is true, yes.
When you -- when you got this sheath in the
8 laboratory, did it come with you -- with some sort of writing
9 indicating that one of the people who had -- who had collected
10 it thought that there was a bloodstain on it?
11 A. I don't recall whether it did or did not. It
12 doesn't -- he doesn't seem to have it in his notes.
13
14
15
16
17
18
19
20
21
2·2
23
24
25
26
27
Q. Showing you Exhibit 496, does this appear to be a
Xerox copy of what's called -- previously been identified as a
laboratory pink slip for the items that were taken from the
Lease house by Mr. Stockwell and Ogino on June the 7th, 1983?
A. Yes, it does.
MR. KOCHIS: Your Honor, to that exhibit I believe I
would interpose an objection to the narrative portions of it.
The portions at the bottom are evidence tags, but
the top is simply a written narative, and it's hearsay.
MR. NEGUS: Well, it's been previously identified
THE COURT: Let me see it.
MR. NEGUS: as something that Mr. Stockwell refreshed
his recollection with and may have some admissibility for that
purpose.
It also was -- was used by Mr. Stockwell to
28 indicate that it was a piece of paper that he gave indications
COMPUTERIZED TRANSCRIPT
',-, U , , I-' o , , Ie .:1 .l.
1
2
3
4
5
6
7
8
9
10
11
12
13 ,""~-'-
14
15
16
17
18
19
20
21
22
23
24
25
26
27 ,--.,
28 ,~,
4584
to other criminalists.
THE COURT: What's that got to do with this witness?
MR. NEGUS: Well, I think it says there, if you read one
of the underlined portions there, just the question that we were
just -- I was just asking.
THE COURT: What is your question? State it again,
please.
MR. NEGUS: The original question was: Did you get any
indication from the criminalists that they thought there was
blood on the -- on the scabbard? And he said he couldn't find
any notes about it, so I was going do show him the notes.
THE COURT: What's the relevancy of his getting
information with reference to blood on the scabbard?
MR. KOCHIS: Your Honor, my additional objection would be
there's no foundation that Mr. Gregonis was going through and
reading other people's notes before he did any analysis.
MR. NEGUS: Well there was some foundation from that with
Mr. Stockwell.
THE COURT: That's what I was getting at, counsel.
Without the foundation and everything I will sustain the
objection. You are going to have to start from scratch if you
wish to pursue it.
BY MR. NEGUS:
Q. Mr. Gregonis, did you in fact look over the
information that Mr. Ogino and Mr. Stockwell sent to you about
the items to be analyzed from the Lease house?
A. I don't recall whether I did or did not.
Q. You did decide for some reason or other to analyze
COMPUTERIZED TRANSCRIPT
" U , , o (} , , ,-a J J
f 1
2
3
4585
the scabbard; is that right?
A. Yes, I did.
Q. Was that on the basis of information submitted to
4 you by Mr. Ogino and Mr. Stockwell?
5
6
7
8
9
10
A. I believe that it was probably on verbal
information rather than from written information.
Q. Well, then, did they tell you that they thought
there was blood on the scabbard?
A. As I recall, yes.
Q. Okay. Now next question: Did they tell you where
11 they thought there was blood on the scabbard?
12
13
A.
Q.
No, sir.
Where -- did you keep any notes of where you tested
14 the scabbard with ortho-tolidine?
15
16
17
18
19
20
21
22
23
24
25
26
27
A. I did a general ortho-tolidine throughout the
entire axe sheath.
Q. Showing you Exhibit 50, a picture of the scabbard,
does there'S a couple of circles that have been placed on'
there. Do you -- did you place either of those on there
yourself?
A. I may have. I don't remember.
Q.
you to be
A.
Did you see anything on the scabbard that looked to
that it might be a possible bloodstain?
I saw stains on the scabbard that I tested with the
thought they could be blood, yes.
Q. Where were those stains?
A. Specifically as I tested them then I don't
28 remember. I can see stains now that I would have tested
COMPUTERIZED TRANSCRIPT
L
--'r, u , , ,-, I:' , , ,a ·u ,
(' 1
2
specifically.
Q.
4586
So, you don't have any specific recollection though
3 at the present time?
" 5
A.
Q.
No, I do not.
Did you also receive from the -- from the Lease
6 house some -- some knobs?
7
8
9
10
A.
Q.
A.
Q.
Yes, I did.
And they likewise had suspected blood on them?
Yes, they did.
Did that blood turn out to be in fact blood, but
11 not from a human being?
12 A. Okay. As far as whether it was from a human being
13 or not, I don't know. My test tor human blood were negative.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Q. That meant that -- that the substance, whatever it
was, did not did not react the way that human blood would
when you put it in the little bowls in the precipitin test; is
that right.
A. With a nice fresh blood stain, assuming there's
enough quantity of material there, yes.
Q. Okay. But basically -- well, there was enough
quantity in this particular situation, right, because you did
some additional tests?
A. Yes, there was.
Q. And precipitin tests will give you positive results
with a stain that's years old, right?
A. That's true it does.
Q. So, assuming that the stain was less than years
28 old, it was not human; is that right?
COMPUTERIZED TRANSCRIPT
r, u , , ,--, o , , ,-a ·c .J
4587
1 A. I can't say for in fact that it's not hUman. All I
2 can say is that my tests were negative for human blood.
3 Q. And if it were less than years old you would expect
" human blood to be positive, ri9ht?
S
6
A.
Q.
Yes, I would.
Did you also test some stains that, J-17 and K-1
7 and 2 I believe, that were taken labeled as havin9 come from the
8 driveway of the Lease House?
9
10
A.
Q.
Yes, I did.
The stain from the knob, that was J-26; is that
11 correct?
12
13
A.
Q.
Yes.
The stain from the knob after two or three tests,
14 there wasn't enough there to do anything more with, is that
15
16
17
right, you just sort of used it all up?
A. That is correct, yes.
Q. But the ones from outside, J-17, K- 1, and K-2
18 there was essentially sufficient quantity there to do any kind
19
20
21
22
23
24
2S
26
27
28
of test that you wanted, ri9ht?
A.
Q.
A.
Q.
right?
A.
Q.
ri9ht?
A.
Yes, there was.
And you in fact did that, right?
Yes, I did.
Now, with respect to those stains they were blood,
Yes, they are.
But you can positively say that they weren't human,
That is true, they are not human blood.
COMPUTERIZED TRANSCRIPT
,-, (I
I , ,-o 6
1 (-,
2
3
.. 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22 1
23
24
25
26
27
28
4588
O. And that's not only because it didn't react with
the precipitin test, but when you did various enzymes you got
patterns that don't exist in human beings?
A. That is correct, yes. Excuse me, but J-11, I did
not get my patterns -- I did not get any enzyme typing, but that
would certainly be true for K-l and K-2.
O. And were you able to determine what kind of animal
it was from which that blood came?
A. No, I was not.
O. Were you able to rule out certain animals?
A. BaSically, yes.
Q. Which animals did it not come from?
A. I tested these stains, J-17 and K-l and K-2,
against human and anti-swine, anti-bovine, anti-foul,
anti-rabbit, anti-cat, anti-goat, anti-horse, and anti-dog.
Q. Is that essentially the different antiserums that
you had there in the laboratory available to you?
A. Yes, it is.
Q. Now the anti-foul one, do you know what particular
type of bird that would be?
A. It was basically oriented towards chickens, I
believe.
Q. Some other bird, other than a chicken, it still is
a possibility; is that right?
A. It is still a possibility as long as they aren't --
as long as they aren't related or ~- as long as they are related
in a very close fashion.
Q. SO, essentially, for example, with the humans you
COMPUTERIZED TRANSCRIPT
~. " . .""
~~< ....
,.-, U , , o o , , fa , ,
-1589
1 have problems with some of the -- certain kinds of monkeys that
2 don't normally exist in the Chino Hills. The same way would be
3 of the chickens, like it might get -- be mixed up with a turkey
4 or something like that.
5
6
7
8
9
10
11
12
A.
Q.
A.
Q.
That is true, yes.
What about peacocks? Can you rule out a peacock?
That, I do not know.
When you were up at the -- you were up at the
residence at various times; is that right?
A. I was up at the Ryen house, yes.
Q. Did you see any peacocks in the area?
A. l saw some peacocks driving in and driving out,
13 yes.
14
15
16
17
18
19
20
21
22
23
24
25
26
Q. The button, J-6. Did that have a peculiar odor to
it when you took it out of the pillbox?
A. Odor?
Q. Yes.
A. Not that I recall, no.
Q. Did you the stains that you, that you testified
with Mr. Kochis were from the Ryen house, were those all the
stains that you analyzed from the Ryen house or just some of
them?
A. I don't know whether they were all of them or not.
I don't recall at this time. I believe -- I believe they are
all of the -A- items.
Q. Well, there was many other blood samples whose
27 origin was in the Ryen house other than the -A- series, is that
28 right?
COMPUTERIZED TRANSCRIPT
':" U , , ,~,
o I ,
,a ·0 .0
.-~
1 (-"
2
3
4
5
6
7
8
9
10
11
12
13
14 ~.
15
16
17
18
19 •
20
21
22
23
24
25
26
27
28
.---~
4590
A. Yes, there is.
O. Now, you said that certain of the -- of the samples
that you obtained from the -- certain of the results of the
samples that you did analyze from the Ryen house appeared to you
to be mixed blood.
A. That is true,.yes.
O. Were those the ones that the genetic profile didn't
fit either Mr. Cooper or any of the five victims?
A. That is part of the reason, yes.
O. Let's focus in on A-36, I believe it was. Was that
one of the ones that you thought might be mixed?
A. Yes, it is.
O. Now, what form did that, did that come to you in?
I mean, what form was the blood in when you got it?
A. It was identified as being one metal pillbox,
identified as being blood from dresser, so I don't know whether
it was on a thread or whether it was powder.
O. Did you -'- well, sene of the items you took
pictures of before you analyzed them.
Did you do it with all of the items?
A. No, I did not.
O. Did you do it with A-36?
A. No, I did not.
O. And with -- were so~e of the items in the -A-
series that you received from Mr. Stockwell, did they have like
a series of flakes of blood in them?
A. They did have flakes of blood, yes.
O. When you were preparing your sample, did you take
COMPUTERIZED TRANSCRIPT
r l.
f r -
" f •
" <II
"-.
I
2
3
4591
care to do all of the -- all of your work from just one flake?
A.
Q.
No. The flakes were much too small to do that.
Did -- for example, on a Group II test, could you
4 have mixed several flakes, little flakes to do a Group II test?
5
6
A.
Q.
That is true, yes.
Was there any indication provided to you by Mr.
7 Stockwell that he had mixed up blood from a bunch of different
8
9
10
sources and put it in the same pillbox?
A. No, there was not.
Q. In the -- in the months amongst the various
11 enzymes that you analyzed, some of them will last longer at room
12 temperature than others; is that right?
13
14
15
16
17
18
19
20
21
22·
23
24
25
A. That is true, yes.
Q. Every enzyme will last longer in a, in a frozen
state than it would just a dry state; is that right?
A. That is true.
Q. And all of the enzymes, if they get wet they're
going to disintegrate very quickly; is that right, if they stay
with it?
A. Basically, yes.
Q. Now, looking at the chart behind you, Exhibit 611,
there appears to be various times given for -- ·W· being weeks,
months, for the various enzymes given, looks to be blue crayon.
Do those appear to be accurate figures for how long
the various enzymes will last and still be typeable in a dry
26 state?
27
28
A.
Q.
Yes, they do.
And would all of the ones that are marked with a
COMPUTERIZED TRANSCRIPT
.'" U , , .-, o , , -, ,
. ,-, U
.,,---..
1
2
3
4
5
6
7
8
9
10
11
12 2
13
f~ 14
15
16
17
18
19
20
21
22
23
24
25
26
27 ',,--.
28
-,
4592
black -Y- still be typeable after a period of a year, or years,
if they were kept, from the time that they were threaded, in a
frozen state and drawn?
A. With the exception of Gc, yes.
O. You would disagree with the Gc then?
A. You may get the Gc, but I don't -- most of the time
I don't think you would.
o. How long would you -- would Gc normally last in a
frozen state?
A. I would say probably six months.
o. And as far as the column in green in the right-hand
side, with -E- meaning easy, -M- meaning medium, and -H- meaning
hard, would those be fair approximations for the ones that are
given of how easy it is to essentially detect, using
electrophoretic means, the various enzymes?
A. Well, again, with the exception of Hp, or the
haptoglobin on the bottom, I believe, I believe that would be
rather normally easy to detect because it is pretty hearty.
o. Okay. With the exception of haptoglobin you would
agree then with the other ones that are in fact characterized.
A. Yes, I WOUld.
o. Turning your attention then to the various samples
from the Ryen house that were submitted to you, that -- were
there any of them that would have appeared to be -- of the
results you got on them, would have been consistent with them
having not been quickly frozen and properly preserved?
A. On the -A- series?
O. Now, any of the different ones you got.
COMPUTERIZED TRANSCRIPT
-" U , , ,-, o , , -, , , ,
........ "--- .
~
(- I
2
3
4
5
6
7
8
9
10
11
12
13
r---. 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
/----, ,
4593
A. Well, on the A-5, A-8 and A-IO series, I would say
those are consistent with not being quickly frozen and
preserved.
Q. Those would be the various items of bedding?
A. That is true, yes.
Q. What about any of the other, any of the other items
from the Ryen house. I believe there was some things taken from
some furniture, NNN through RRR,
A. Yes. The NNN, 000, QQQ, RRR, and the SSS stains
are all consistent with not being frozen right away.
Q. And you, yourself, collected in the laboratory,
some stains from the wall that was taken out of the, out of the
Ryen house and labeled them SSS-l through whatever; is that
right?
A. That is true.
Q. And do you know for a fact that those were -- those
stains were not particularly well preserved up until the spring
of '84; is that right?
A. That is true.
Q. And the results you got were consistent with that.
A. Yes.
Q. Now, in addition to wetness, and time, will just
heat destroy the usefulness of certain blood samples?
A. Yes, it will.
Q. Por example, if you were to take blood samples and
put them in a closed attic where, in San Bernardino during the
summer months without any air-conditioning, where temperatures
would get up to 120 or so degrees, would that have the effect of
COMPUTERIZED TRANSCRIPT
n u , , (I 1:1 , , , . ,
.. :I l.
1
4594
1 hastening the demise of the enzymes even in a dry state?
2
3
A.
Q.
Yes, it would.
And the NNN through RRR series that you tested --
4 well, first of all, the ABO type, the antigens, they'll last for
5 years sometimes just in a dried state; is that right?
6
7
8
A. Yes.
Q. Antibodies that are from the serum that you
likewise test go rather quickly. I mean, within a month or SOl
9 is that right?
10
11
A.
Q.
Yes, they do.
But the antigens, it would not be unusual, if it
12 was just kept in dry climate at room temperature, two or three
13 days, years later, still be to able to get ABO type off of it?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
A. That is true, yes.
Q. The items that were removed from -- various items
what were labeled as items of furniture from the, from the NNN
through RRR series, you were unable on some of those to even
obtain ABO results1 is that correct?
A. Yes.
Q. You weren't able to get any enzyme results off of
them; is that right?
A. That is correct.
Q. And had they been just kept in a dry attic, without
excessive temperature, would you expect to get, at least get ABO
after eight months; is that right?
A. Yes, I would.
Q. In the testimony that you -- when you were talking
28 with Mr. Kochis, both of you I believe used the word -deposited-
COMPUTERIZED TRANSCRIPT
rl U , , ,-, o , , -,
. , .;:, .::1
f'
.... -4
4595
1 as a description of how the blood got to the spot where it was
2 found.
3 What did you mean by that?
4 A. Well, there was a number of ways that you can have
5 blood placed on an item?
6 o. I take it then that what you are saying then is
7 your particular tests don't give you any real information about
8 how the blood got there, merely whether it was consistent with
9
10
11
coming from one person or another; is that right?
A. That is true, yes.
o. So when you, for example, used the phrase
12 -deposited by Mr. Cooper-, all that meant really was that the
13 blood could have come from Mr. Cooper, not Mr. Cooper shed it or
14 put it there; is that correct?
15
16
17
18
19
20
21
22
23
24
25
A. That is correct, yes.
Q. In doing your analyses, did you attempt to come up
with a more definitive idea of how individual items that you
analyzed were in fact deposited or got to the place where they
were found? That is, just it could have come from a certain
person?
A. As far as the serological examination?
O. Well, as far as the examination that you were doing
of these particular samples.
A.
Q.
Of which samples are you talking about, Mr. Negus?
All the different samples that you analyzed
26 serologically that came from the Ryen house.
27 A. Well, as far as the -A- items, since I did not
28 collect those I do not know really where they came from so I
COMPUTERIZED TRANSCRIPT
,'-, U , , .-., o , , -, ,
·U ,
/ "-..,
1
2
3
4
5
6
7
8
9
10
11
12
13
14 /',
15
16
17
18
19
20
21
22
23
24
25
26
27 '-
28
/-',
4596
couldn't do that analysis.
As far as the S, or triple S items, yes, I tried to
document by photographs and such as to where the blood actually
came from on the wall.
Q. Of the blood on the wall, you took what, thirteen,
thirteen, I think, samples of blood, and one sample of wall that
appeared not to have blood on it, as a control.
A. Yes, I did.
Q. Of those thirteen, three of them you couldn't get
any ABO type on; is that right?
A. Two of them actually. One I tested twice and got
it the second time.
Q. That particular wallboard that was being stored
actually in the laboratory, not in an air-conditioned building;
is that right?
A. That is correct, yes.
Q. Do you have an explanation as to why you weren't
able to get the ABO off the two that you didn't?
A. Possibly just the age of the -- age or the size of
the sample.
Q. Okay. Well, age, it was approximately eight months
old when you decided to collect it, right?
A. Eight, nine months old, yes.
Q. Were you able to get any of the -- on any of those
samples were you able to get any information other than just ABO
type?
A. Okay. I did not try any other examinations.
Q. Didn't you do -- forgive me, if I might.
COMPUTERIZED TRANSCRIPT
" U , , CI o , , , , , ',:J
1 f~-'
2
3
.. 5
6
7
8
9
10
11
12
13
14
r"'- 15
16
17
18
19
20
21
22
23
24
25
26
27
28
4597
A. That was according to my summary.
O. All of those that you got a result on were type A,
right?
A. That is correct, yes.
O. Were you able to -- were you able to determine that
all but two of the samples that you got from the NNN through RRR
series were in fact human blood?
A. That is correct, yes.
O. And of the two that you were not able to determine
that, after you had done some other tests on it, there was not
enough, enough left to get a result on; is that right?
A. That is true, yes.
Q. Is it also correct that in general, you would
expect transferrin to be the easiest enzyme, or in this
particular case, serum protein, to get an answer back from?
That is, it would survive the most abuse; is that right?
A. Yes, it would.
Q. And, so, you attempted on some of the, on some of
the samples in that particular series to get transferrin and you
were unable to get it; is that right?
A. That is correct, yes.
Q. Of the, of the two, of the two samples that you
were able to get ABO types on, both of those were labeled as
having come from this dresser that's between A-2 and A-3l on the
diagram; is that right?
A. Okay. As to which dresser they're talking about, I
don't know. But they're labeled as -metal pillbox containing
---, -metal pillbox identified as containing blood from sliding
COMPUTERIZED TRANSCRIPT
" U , , ,-, o , , , , , ,'0
! /' ''',
1
2
3
4
5
6
7
8
9
10
11
12
13
14 !~,
15
16
17 2
18
19
20
21
22
23
24
25
26
27 '-~
28
r-'
4598
door from dresser.-
Q. Oh. Sliding door. Okay.
Well, that's possible that could have come -- you
actually saw the furniture in place at the Ryen house, right?
A. Yes, I did.
Q. And there was then on this particular item no
sliding door but there was a sliding door over in the area where
A-36 was: is that right?
A. That is correct, yes.
Q. And as to that particular test you got a -- the
reaction you got was -- could have been from an A antigen: is
that right?
A. On one of them, yes.
Q. NNN-l. NNN-I, Nancy, Nancy, Nancy 1 and 3.
A. I believe NNN is a type B, but let me check my
original notes.
Q. You are looking at different charts.
A. NNN-I is consistent with the type B, NNN-3 is
consistent with a type A.
Q. You can't say for sure because you couldn't do the
antibody reverse; is that right?
A. Well, it indicates a type B and type A. To
absolutely confirm it you would have to do the reverse.
Q. Wouldn't that change an opinion, some opinion at
some pOint in time?
A. That's an A to a B. I made a transfer error fr02
my original worksheet to my summary sheet.
Q. Now, before you -- any of those in the NNN, Nancy,
COMPUTERIZED T~~SCRIPr
"'n u , , ,-, Q , , -, , -, ,
('
---
1
2
3
4
4599
Nancy, Nancy through Robert, Robert, Robert series that you
noted yourself or took pictures of, or made any sort of notes,
as to what type of blood they were before' you analyzed them?
A. No, sir. Again, I did not collect those, so I
5 wouldn't have.
6 Q. So, you are telling me that you don't ever try and
7 figure out what you have back in the laboratory, it is up to the
8
9
guy that collects it. Is that the way it works?
A. Well, I don't -- I can't do the analysis as to
10 where it came from if I don't collect it myself.
11 Q. No. I'm just asking you about, noting, you know,
12 was it flakes, what shape of flakes, that sort of thing?
13
14
15
16
17
18
19
20
21
22
23
24
25
A. I don't note that, no.
Q. And after you've done the analysis, essentially the
sample is transformed so that you can't go back later and check,
is that right?
A. That is true, yes, I would say far as what it is,
flakes or something like that, that's true.
Q. Now, as to the ones that you collected yourself and
analyzed, not only --
You took, what, 15, 20 different photographs during
the process?
A. I took a few. I don't know if it was 15 or 20.
Q. But, you actually also labeled right on the, right
on the surface of the -- of the item, you know, what you were
26 taking, where you were taking it from, right?
27
28
A. That is correct.
MR. KOCHIS: Your Honor, I'm going to object. This is
COMPUTERIZED TPANSCRIPT
I
" U , , '-~, o , , ,
, , ',CI o
1 f •
2
3
4
5
6
7
8
9
10
11
12
13
14 ('
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4600
beyond the scope of any direct, has been for some period of
time.
THE COURT: Mr. Negus.
MR. NEGUS: It would seem that it would be -- that if he
opens up the subject of blood taken from the Ryen bedroom that
we can't just pick and chose as to which ones he wants and which
ones he doesn't want, that the whole Ryen bedroom is opened up
as far as analysis of blood is concerned.
MR. KOCHIS: Well, maybe as to analysis, but I didn't ask
any questions about collection or his presence at that location.
MR. NEGUSr He used several times -deposited-, they were
various -- I think he used -- they used those particular phrases
of -it got there-, where it came from.
THE COURT: Ask your question again, Mr. Negus. I have
forgotten what's pending specifically now.
MR. NEGUS: I was just asking -- The question is
basically:
In collecting from the wallboards that were removed
from the house from the south wall, you made sure to take
photographs of the drops of blood as they were in place before
you collected them, and you also marked on the wallboard itself
for anybody to see where they came from; is that right?
MR. KOCHIS: And that was the question I object to
because that's certainly beyond the scope of any direct or any
issue.
THE COURT: If you want to finish your cross, I will let
you go back to it on direct.
MR. NEGUS: I can wait a couple months, that's fine. It
COMPUTERIZED TRANSCRIPT
: ,-, LI , , I-' a
I , -,
. , ·0 J
1
2
3
4
5
6
7
8
9
10
11
12
13
:- 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28 /~-
4601
doesn't -- it's not of great moment at the moment. I can come
back to it. I would submit it is within the scope.
O. As to -- as to the the various items of bedding
that you removed, you ran at least most of those for
transferrin; is that right?
A. That is correct, yes.
Q. Some of those you got a result that you labeled as
a -CB-?-; is that right?
A. That's essentially an inconclusive result, yes.
Q. What does -CB-?-?
A. Well, to me I got some patterns that could be a CB.
However, it could be anything because it isn't inconclusive,
it's not strong enough or clear enough to call it.
Q. So, you have a separate category then of it looks
like it might be but you can't be sure?
A. That's an inconclusive essentially.
Q. Did you do anything with those particular stains to
try and and retest it, do anything to treat the stains to try
and sort it out?
A. I retested many of them for transferrin to try to
sort it out.
o. Well, did you treat the samples, I mean -- well, if
you have -- if you have something that looks like a CB but maybe
isn't, is there things that you can do to the samples, as we
said before, to freshen it up?
A. It's possible, yes.
O. Did you do that?
A. ~o, sir, I did not.
COMPUTERIZED TRANSCRIPT
n u , , .~, o , , l~' CI
.1-' U
f~" 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25.
26
27
28
'-.
4602
O. Did -- did A-37 appear to you to be a mixed stain?
A. It could be because of a weaker A antigen present.
O. And didn't get any antibodies?
A. That's a possibility, but that's not my -- plain --
what I'm looking at plainly to do that.
THE COURT: We can take a recess any time.
MR. NEGUS: Okay, fine. I'm about to shift gears.
THE COURT: Let's take the afternoon recess.
(Recess taken.)
BY MR. NEGUS:
O. The in your laboratory you received at some
point in time an item No. CC; is that right?
A. That is correct, yes.
O. And item No. CC is this Fruit of the Loom T-shirt
which I have in my hand; is that right?
A. Yes, it is.
O. On June the 22nd, 1983, did you take that T-shirt
and clip some samples from it?
A. Yes, I did.
Q. Okay. There -- First off, there appears to be some
stains on the front of that particular T-shirt.
Did you -- did you test those stains with
ortho-tolidine?
A. Yes, I did.
O.
different
And you got, I guess -- looks like there is three
there's three different areas that are labeled
on -- on the T-shirt; one here, one where you've cut something
COMPUTERIZED TRANSCRIPT
,-, o , , ,-, a , ,
1
2
3
" 5
6
7
8
9
10
11
12
13
14 r-. 15
16
17 2
18
19
20
21
22
23
24
25
26
27 '--,
28
~"
4603
out of, and another one you have -control-.
Did you test each of the stains in those three
areas for with the ortho-tolldine?
A. Yes, I did.
o. With respect to the control section, was that a
negative result?
A. Yes, it was.
O. Did you test the stains that you can still see
there on the T-shirt with the ortho-tolidine?
A. I believe so. I believe I did, yes.
O. Did they give a positive reaction?
A. Yes, they did.
O. And you also apparently cut certain parts of them
out for further analysis: is that right?
A. That's correct.
Q. And did the parts that you cut out likewise give a
positive reaction with the ortho-tolidine?
A. Yes, they did.
Q. Now, did you then go ahead and on the hard parts
that you cut out did you go ahead and do some further -- some
further tests?
A. Yes, I did.
Q. The stains that you had, when you tested them could
you tell if they appeared to be relatively fresh?
A. To begin with?
O. Yeah, when you clipped them out and started testing
them.
A. Well, there -- As far as what stage in my test?
COMPUTERIZED TRANSCRIPT
I
",,-, U
I , I-' o
I , I-' o
.:1 L
1
2
Q.
A.
4604
In the beginning.
At the beginning I couldn't tell whether they were
3 fresh or not.
Q. Okay. Well, you tested that T-shirt in a series of
5 tests from June the 2nd to June the 24th; is that right?
6 A. I also did some testing on it I believe through
7 this year also, so
8
9
Q. Okay. Well, back in -- the testing you did back in
June of 1983, was there enough sample in that area you cut-out
10 right there where your initials are to do a full range of tests?
11
12
A.
Q.
Yes, there were.
If -- Well, did you get results on all the tests
13 that you did?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. No, I did not.
Q. You got results on some of them though; is that
right?
A. Yes, I did.
Q. The you got results on your, basically on Group
II and Group IV?
A. That is correct, yes.
Q. And also ABO antigens?
A. That is correct.
Q. The results that you -- that you got, were they
consistent with the blood of Kevin Cooper?
A. No, they are not.
Q. Were they consistent with the blood of any of the
27 victims?
28 A. Yes, they are.
COMPUTERIZED TRANSCRIPT
,-, U
I , I-' o
I , CI (J
.:1 :I
1
2
3
Q.
A.
Q.
4605
Which victim or victims?
They are consistent with Doug Ryen.
One can -- Well, if that shirt were discovered at a
4 roadside approximately three, two to three days after the
5 murders, and if the spot where it was found was a spot that at
6 least at nighttime got somewhat damp, would the results that you
7 got have been consistent with that having been thrown out there
8
9
10
on the night of the murders?
A. I believe so, yes.
Q. That is, you could have seen the same kind of
11 sample degradation that you saw in a damp spot even if the thing
12 was collected only three days after the murders?
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A. That is true, yes.
Q. Obviously as far as just -- as far as the types of
lives of the enzymes and proteins that we were talking about
earlier, anything less than sort of indoors, room temperature,
in optimal conditions can significantly lessen the life of those
particular enzymes; is that right?
A. Yes, it can.
Q. And particularly like being outside can do that as
well; is that right?
A.· Yes, it can.
Q. The results then that you got were -- you got a
positive reaction to both A and H antigens; is that correct?
A. That is correct, yes.
Q. The H antigens, a positive reaction on that is not
27 inconsistent with the blood coming from a person who is a type
28 A; is that right?
COMPUTERIZED TRANSCRIPT
,-, U
I , '~I o , , I-' .0 ·LI ,
c~,
(
I/~'"
.~::;.;:-. .. ... -.. - .... -.-.
I (-'
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27 '-. ..
28
4606
A. No, it is not.
o. That is, the particular serums that you use will
to determine the A will sometimes also react with -- give a
reaction for H; is that right? It's got to do with the
specificity of the serums?
A. Well, the anti-H will sometimes react with an A or
B blood.
o. So, the mere fact that you got both the reaction
with the A and the H doesn't necessarily indicate that there is
any mixed blood involved?
A. No, sir, it does not.
o. You also got the EAP type of BA, ADA type of 1, AX
type of 1, the peptidase A type of 1, and the CA II type of 11
is that correct?
A. That is correct, yes.
o. And all of those were consistent, among other
folks, with Doug Ryen?
A. That is true, yes.
O. At the -- the laboratory number before that, an
item BB, was that -- was that a towel?
A. Yes, sir, it is.
Q. On that -- on that particular towel, was that
labeled as having come from the same spot that CC was?
A. Well, as fa'r. as my notes reflect, it's labeled as
being a stapled sealed paper bag identified as containing a
towel from the roadway.
O. Was that particular towel, did that appear to have
some stains on it?
COMPUTERIZED TRANSCRIPT
II IJ , , D o , , 8 ,f: ,J
3
1
2
A.
o.
4607
Yes, it did.
And they gave a positive reaction with the
3 ortho-tolidine?
4
5
A.
o. Yes, it did.
You attempt -- was there -- were there a large
6 quantity of those stains, or they were just small?
7
8
9 did
A. It was -- Well, at this point I don't remember.
O. Well, apparently whatever stain it was that you
you did a test for hUman blood and a test for ABO on it
10 and then you ran out; is that right?
11
12
13
14
A.
O.
A.
Q.
That is correct, yes.
So, it couldn't have been very big?
Obviously. Yes.
The results you got with the -- with the -- with
15 the ABO and the human were essentially negative, is that so?
16 You didn't get any reactions; is that right?
17
18
19
20
21
22
23
24
25
A. That is correct, yes.
Q. So that would have been consistent with a bunch of
different things, including animal blood.
Q. I suppose it's possible that it was animal blood,
yes.
Q. Degraded human blood so that it was too degraded to
give you reactions?
A. That's a possibility, yes.
Q. And also apparently on your notes you thought that
26 there was at ,least a possibility that the reaction could have
27 been from minerals that were present there in the soil; is that
28 right?
COMPUTERIZED TRANSCRIPT
,~,
CI , , ,-., o 6
.:.- ~ .. -..
,--, 1
2
A.
Q.
4608
That is correct, yes.
But getting back to the T-shirt that's on the board
3 there, item CC, because of the positive reactions you got on
4 some of the other tests you can say for sure that at least the
5 stains that you did ABO and electrophoretic testing on, that was
6 in fact blood?
1
8
A.
Q.
Yes, sir.
Did you also receive an item of evidence that was
9 marked as NN-2, a piece of white cloth with a suspected
10 bloodstain?
11
12
A.
Q.
Yes, I did.
Did that particular bloodstain -- did it turn out
13 to be in fact a human bloodstain?
14
15
16
11
18
19
20
21
22
23
24
2S
26
21
A. Yes, it is.
Q. And was the was that particular bloodstain
consistent with having come from a type B type person?
A. I don't know if you can really make any statements
about the ABO blood type I did.
Q. Well, when you did the Lattice test on it you got a
reaction with the A antibody and none of the other one, right?
A. That is correct.
Q. So, that would be at least somewhat consistent --
that would be what you would expect if you had a B ty-pe person,
right?
A. That's what I would expect, yes.
Q. Now the reason that you hesitated was that for some
reason or other you didn't get the antigen to come out1 is that
28 right?
COMPUTERIZED TRANSCRIPT
,-, U , , o o , , o o , ,
r,,-----'-
1 f
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
r·
4609
A. There was a negative -- as far as the forward tests
go there was a negative as far as I'm concerned.
Q. So, is that like with the -- with the antigens, it
looks like it might be a B but you can't say for sure?
A. No. I would say that you can't make as strong a
statement when you only have the antiboydy as you can with you
only have the antigens.
Q. Do you know why the forward didn't work?
A. Possibly not enough antigen present. Also at this
time I was using a technique which is not as sensitive towards
the H antigen as other techniques, so it's possible the H
antigen was there as it is in NN-l.
Q. Well, you?
A. There's a number of possibilities.
Q. Yeah, but NN-l is not from the same piece of
evidence that NN-2 is, is it?
A. No, it is not.
Q. I mean you can't make inferences from separate
pieces of evidence one to the other as to what the other one
would be, can you?
A. The only thing that was related to me is that these
two pieces of evidence are somehow related, from the same person
or whatever.
Q. Did you ever attempt to go back and redo NN-2?
A. No, I did not.
Q. Did you also receive -- from the automobile an an
item V-IS, which was a plastic bag with some napkins in it?
A. Yes, I did.
COMPUTERIZED TRANSCRIPT
. ,-, U
I , ,-, o
I , ,-, o .0 .0
;'-:"::;.- .... --_ .. -._-_ .. -
4610
1 Q. And did those napkins -- there were, what, five
2 different napkins there?
3
4
A.
Q.
Yes, there were.
And they had some -- some stains on them, white
5 appearing type stains, some sort of biological stain?
6 A. I don't remember whether they were white or not,
7 but they appeared to be biological stains, yes.
8
9
10
Q.
A.
Obviously they didn't look to be blood?
That is correct, yes.
Now, in fact did -- on microscopic analysis were
11 you essentially able to exclude them as being semen stains and
12 establish that they appeared to be the type of stains that you
13 would expect if somebody blew their nose in the napkin?
14 A. Upon microscopical and chemical tests, they
15 appeared to be a mucus type material.
16 Q. Now, with respect to any sort of human tissue, it's
17 not just -- it's not just semen and blood and saliva that have
18 these various proteins and enzymes; all different kinds of human
19 tissue has some different kinds of enzymes and proteins in it;
20 right?
21
22
A.
Q.
That is correct, yes.
And using some of the same techniques one can
23 one can make some -- come to some knowledge excluding some
24 people, as possible knowledge even from something like when you
25 blow your nose, right?
26
27
A.
Q.
That is true, yes.
When well, what kind of -- what kind of -- which
28 enzymes can you get from the sort of cells that come from --
COMPGTERIZED TRANSCRIPT
.p.=
rl U , , 0 0 , , 0 CI ·0 :J
of;
1 r--2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24 4
25
26
27
28
4611
that you found in a nose blow?
A. I don't know all the enzymes that you can get. I
believe that you can, from my testing at least, you can get the
EsD the PGM and the PEPA.
Q. This particular stain came to you in a sealed
plastic bag1 is that right?
A. It was a taped sealed plastic bag containing five
napkins, white napkins.
Q. Is it just as bad practice to keep other sorts of
body tissues in sealed plastic bags as it is blood?
A. Yes, it is.
Q. Doing that can easily lead to degredation, right?
A. It can lead to degredation, yes.
Q. Now, that particular stain, you were only able to
get two out of the four enzymes that you tried, is that right?
A. That is correct, yes.
Q. Is that finding consistent with the sample having
degraded from being in a plastic bag?
A. First of all, I don't know that much about the
level of the enzymes that I didn't get in mucus type materials
to be able to answer that, so I don't know.
Q. Well, you know that on other occasions you have
gotten PGM and CA II out of that type material1 is that right?
A. I believe, yes.
Q. And you weren't able to in this particular case?
A. That is correct.
Q. Does PGM in other cells last approximately the same
length of time it does in blood?
COMPUTERIZED TRANSCRIPT
"" U I ,
o o I ,
o .:J . I-' U
4612
A. It lasts usually a shorter period of time, but it's
relative to the other enzymes. I'd say it's relatively the
same.
Q. Well, how long would you expect, if it were kept
not in a plastic bag, just out in the -- out in a normal room
temperature at a dry state, would you expect a stain such as
that to last?
A. Again, I really don't know because I don't know the
levels of the enzyme to begin with.
Q. As it turned out, the particular -- your particular
analysis of that stain was not able to exclude very many people
in the world; is that right?
A. That is true, yes.
Q. That is, the -- you could exclude Mr. Cooper from
it; is that right?
A. Yes, I can.
Q. But, with respect to the white population, it could
have come from approximately 70 percent of the white population;
is that correct?
A. That is correct, yes.
Q. From the blood that you received from Mr. Ogino off
of the off of the hatchet, in fact in addition to the -- to
the ABO testing that you did, you tested for -- there was enough
there to test for all of the other enzymes and antibodies that
you normally test for; is that right?
A. There was enough material there. As to whether it
was blood or not, I don't know. But there was enough material
there to test for all those.
COMPUTERIZED TRANSCRIPT
r, u , , .~, 13 , , o .~ , ,
1 f-'
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26 1
27
28
4613
Q. Okay. Well, did the -- you did get a positive
ortho-to1idine and precipitin test on that material, is that
right?
A. Yes, I did.
Q. SO that would -- that would indicate you got blood,
is that right?
A. Blood of hUman origin, yes.
Q. But all of the other tests other than the one
-antigen test were inconclusive1 is that right?
A. That is correct.
Q. And even the --even the ABO test as it -- as it --
as it turned out is -- you can't have a great deal of confidence
in that particular result, can you?
A. I believe you can, yes.
Q. Why is that?
A. Because I have blood of human origin and I had a
very clear result as far as the ABO.
Q. Didn't get any antibodies, right?
A. That is correct.
Q. So you just got a B -- you got a reaction to the B,
the antiserum for the B antigen?
A. That is correct.
Q. Do you feel that that, given the procedures you
were doing at that point in time is, is a clear unambiguous
result?
A. Yes, I do.
Q. Were you given a history of that particular sample
to aid you in your analysis of it?
COMPUTERIZED TRANSCRIPT
:,-, U , , ,-, ;:; , , ,--, .:1 .:1 . '-
1
2
A.
Q.
4614
Yes, I was.
And that was, it was found in a field in some grass
3 next to a pasture where horses were kept on the Sunday afternoon
4 after the crime?
S
6
A.
Q.
Yes.
The results that you got on L-4, suspected blood
7 from a full Oly Gold beer can, is that result a little unusual?
8
9
A.
Q.
Not really, no.
You couldn't get ABO but you were able to get PGM.
10 I mean, is that normally what one would expect?
11
12
A.
Q.
It happens occasionally.
Why do you -- why do you suspect you didn't get ABO
13 on that?
14
15
16
17
18
19
20
21
22
23
24
2S
26
A. I don't know.
Q. Well, we will will moisture effect eventually
ABO results just like it does the various enzymes?
A. It can, yes.
Q. That particular item, you, yourself, actually
observed at the scene; is that right?
A. That is correct, yes.
Q. The L-4 came from the area that's been circled on
Court's Exhibit 195; is that right?
A. On the can itself?
Q. On the can, right.
A. Yes, I believe so. If that's the can.
Q. Well, you saw, in the Ryen refrigerator, on June
27 the 6th, some cans such as those in the refrigerator, right?
28 A. I believe so, yes.
COMPUTERIZED TRANSCRIPT
4615
1 o. Okay. And you tested them with your ortho-tolidine
2 and it turned out to be at least possibly what, blood?
3
4
A.
Q.
That is true, yes.
When you, when you saw the cans, did they appear to
5 have condensation on them?
6
7
A.
o. Yes, they did.
I take it that condensation can, on a can, if it
8 is, can be, for example, the cause of the inconclusive results
9
10
11
that you got with the ABO and the EsD.
A. That is a possibility, yes.
o. When you saw those particular, when you saw those
12 particular stains, did they appear that there was enough stain
13 on the can to do your full -- your full range of tests?
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
A. Not on the can, no.
O. If you had taken the stain that is circled on the
the side of the frig, and tested that in addition to the stains
on the cans, would you have had enough to get full tests?
A. Assuming that was blood I believe I would have.
O. Well, you tested with ortho-tolidine and that
likewise gave a positive reaction, did it not?
A. I don't believe I tested that.
O. Did you collect it?
A. No, I did not.
O. Well, when you were doing the -- when you were
examining those particular cans, was Mike Hall there?
A. I believe he was at the residence, but I don't
believe that he was there when I was examining the cans, no.
O. How about Gale Duffy, was he there?
COMPUTERIZED TRANSCRIPT
,-, U
I I ,-,
o I I
o -, ·U ,
,-' 1
2
3
..
A.
Q.
A •
o.
Yes, he was.
Did he point them out to you?
Yes, he did.
4616
Can you say for sure that Kike Hall wasn't there
5 when you were doing the tests?
6
7
8
A. No, I can't.
Q. Did you -- I have People's -- a piece of paper
which I've marked as Exhibit 612, a blank piece of paper.
9 When you have -- when you have samples that are
10 somewhat limited in the quantity that you have so that you
11 can -- basically you can just tell by looking generally whether
12 there is going to be enough of a sample for you to do a full
13 series of tests or not; is that right?
14
15
16
17
18
19
20
21
22
23
24
25
A. In general, yes.
Q. When you have a sample that you suspect is blood,
and it is limited, basically before you do anything to it you
want to make sure that it is in fact blood and human blood or
else all the other tests are basically a waste of timeJ is that
right? •
A. That is true, yes.
Q. And, so it is -- in any stain you want to do first
the ortho-tolidine and precipitin test; is that correct?
A. Yes.
Q. That particular analysis, the ortho-tolidine
analysis essentially costs you nothing. I mean, there is so
26 little involved that it doesn't cost anything.
27
28
A.
Q.
In essence, yes.
Precipitin tests costs considerably less blood than
COMPUTERIZED TRANSCRIPT
" U , , CI o , , o :J
5
f
2
4617
1 a complete ABO or complete, you know, one group electrophoretic
2 run, is that right?
3
4
A.
Q.
It doesn't take as much blood, that is correct.
Other than A-4l, and I'm going to, if it is just to
5 make it easier while you look, write on the board for you, if it
6 is without objection, A-42.
7 There was not enough to do a complete set of tests,
8 is that right?
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
A.
Q.
That is true.
B-ll and B-12, not enough.
Again, that is true.
E-5 and E-6.
Again, that's true.
J-6.
That is true.
J-16.
Yes.
Let's see. L-3 and L-4.
That is true, yes.
C-4, C-5.
That is true, yes.
0-13, 0-14.
That is true.
And W-1, W-2, W-3, W-5 and W-7?
Yes, sir.
Now, let's see. As to these various ones, leaving
27 aside the initial tests which you have to do for everyone, the
28 ortho-tolidine and the species tests, how many tests could you
COMPUTERIZED TRANSCRIPT
II U , , ,~,
o , , .~,
J ·C .0
/~
1 , ---2
3
" 5
6
7
8
9
10
11
12
13
14 r~,
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4618
get out of A-42?
A. How many tests, including counting the enzymes
separately or together?
Q. Well, a Group I test, you do one enzyme, two
enzymes, three enzymes; you get -- it costs the same amount, the
same amount if you use up the same amount of sample.
A. Yes.
Q. Let's just talk about the tests where you do it in
terms of an item of sample consumption.
By the way, the ABO forward and reverse comes out
to just about as much as an electrophoretic run; is that right?
Little bit less?
A. Slightly less, but it is
Q. Essentially the same?
A. Yes.
Q. So, let's count the forward and reverse as Group I,
Group II, Group III, and any electrophoretic run is another
test.
A. Okay. As far as looking at it that way, as far as
the quantities of tests used, I would say three on A-42.
Q. B-l1?
A. Two. Or, excuse me. If you ignore the
ortho-tolidine and human, it would be one.
Q. B-12?
A. Two.
Q. E-5?
A. One.
Q. E-6?
COMPUTERIZED TRANSCRIPT
,-, U , , ,-, o , , 1-' .:1 -, ,
4619 ,~
1 A. One. r .... · 2 Q. J-6?
3 A. Two.
4 Q. J-16?
5 A. One.
6 Q. L-3?
1 A. None.
8 Q. L-4?
9 A. Two. .~!". ... ::.'
10 Q. C-4?
11 A. One.
12 Q. C-5?
13 A. One.
14 Q. D-13? f"" ,
15 A. One. ,-, 16 Q. D-14? U 11 A. Two. , 18 Q. W-l?
, 19 A. Two. ,-, 20 Q. W-2? iJ 21 A. Also two.
, 22 Q. W-3?
, 23 A. One.
,-, 24 Q. W-5?
.:1 25 A. One. .0 26 Q. And W-1?
.0
21 A. Four. "-/
28 Q. Now, we've already discussed, I believe that you
.""-
COMPUTERIZED TRANSCRIPT
4620
1 can, you know, rank not only individual tests like PGN but a
2 whole group of tests in terms of their informative power or
3 discriminatory power; is that right?
4 A. That is true.
5 o. And, you know, you also can -- you also can rank
6 them in terms of the likelihood that you are going to get a
7 result; is that right?
8
9
A.
o. That is true.
Okay. Arranged in terms of likelihood of result,
10 ABO is the most likely?
11 A. I would say transferrin is probably the most
12 likely.
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
o. Transferrin, then ABO?
A. Given that you have got the age of stain, that's
too old to get the transferrin.
o. Okay. So less than a year, transferrin.
A. Probably.
O. Then ABO.
A. Yes.
o. Haptoglobin.
A. Yes.
o. And then essentially I guess what, the Group I
would be the most likely next, the most likely to give results?
A. No. I think the Group II you are most likely to
get some results, yes.
o. Okay. But of the Group II result, the one you
would be mostly to get would be the ADA and AX.
A. Yes.
COMPUTERIZED TRANSCRIPT
1-' U , , .-., o , , o -, ·0 :I
t .....
"'--..
4621
1 Q. The ADA and AR, they're the least informative of
2 all.
3 A. They're also the least informative as compared
4 against say PGK and EsD. They are definitely the least
5 informative.
6 Q. And so taking the more informative of the tests,
7 the PGK is more likely to give you a result, for example, than
8 EAP?
9 A. Than EAP or Group?
10 Q. Yes.
11 A. It is heartier enzyme. So, yes.
12 Q. Then between the other two, essentially EAP and the
13 Group IV are more or less equal?
14
15
16
17
18
19
20
21
22
23
24
25
26
A. As far as age?
O. Yes.
A. Well, as far as kind of balanced between what
information you are going to get out of it, or can get out of it
really.
If you have a black variant that is -- and you
think that the blood could have been deposited by that person
with the black variant, then the Group IV is more important.
Q. I am not talking about the informative, just in
terms of likelihood of getting a result. There's two separate
things, right? Is that basically true?
A. Basically, yeah. I think if you take the Group II
and the Group IV together, just getting the results, they'd be
27 equal.
28 o. Now, so, as you sort of plan your strategy for, for
COMPUTERIZED TRANSCRIPT
I
" U I ,
'-:1 o :I t.
" U . I-' U
1
2
3
4
5
6
7
8
9
10
11
12
13 3
14 (~
15
16
17
18
19
20
21
22
23
24
25
26
27 ,--.
28
4622
the testing, you basically may have to devise a different
strategy if there is reason to suspect that your sample may have
been subject to age, heat, whatever, than if you can be
reasonably sure that it is relatively fresh; is that right?
A. That is true, yes.
O. SO, of these particular samples, based upon what
you were able to glean from their history, would it be fair to
say that L-3 and L-4 were samples, having been found
respectively outside and in, on a condensed beer can, that you
have to pay attention to the factors of degradation?
A. I would say so, yes.
O. I will put a check mark in that column.
W-l, W-2, W-5 through W-7, likewise because they
were found in a closed-up car in an area where you know there
was a considerable amount of moisture in the air. At that point
in time you also have to keep that in mind with them; is that
right?
A. Yes, you would.
O. But with the other ones that's not going to be a
problem basically.
A. Shouldn't be, no.
O. I will put check marks.
So, we have done basically two categories, the ones
with checks marks we have to take into account the effect of
age, heat and what have you, and the ones without checks marks
where you don't~ Is that fair to say?
A. Essentially, yes.
O. Now, in dealing with your information, A-42, in
COMPUTERIZED TRANSCRIPT
.',-, U
I , (I LI J L ,-, U
I ,
1 f
2
3
4
5
6
7
8
9
10
11
12
13
/~ 14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
4623
dealing with your selection of tests, did you pick the ones that
had -- the three tests that had the greatest power to inform in
this particular case?
A. I think if you look at the case as a whole, no.
Q. What about B-ll. Did you take the test, the one
test that had the most informative power for that particular
sample?
MR. KOCHIS: Your Honor, I am going to object as not
being relevant at this point. He hasn't done a more complete
profile on certain people and he might not have had it at the
time he ran the test. Which test he chose and the order ~ould
not be relevant.
THE COURT: How does it in any way effect his
credibility? I can think of no other way you can get this in.
MR. NEGUS: Well, it certainly affects his common sense.
That is the sort of thing serologists normally do.
THE COURT: No. I will sustain the objection, sir.
MR. NEGUS: Could we -- that was how I was going to
finish off the rest of the day. I have other charts.
THE COURT: Go on to other things, if you wish.
Something else?
MR. NEGUS: Well, it is only seven more minutes. I
haven't got the charts done up for the next
THE COURT: We can break now, if you prefer.
Take the rest of the week off.
Did you have something?
MR. KOTTMEIER: Yes, your Honor. I just wanted to be on
the record as far as the exhibits which are going to be --
COMPUTERIZED TRANSCRIPT
,-, U , , .--, o :J L ,-, .U .:1 .L
/,---.
1
2
3
4
MR. NEGUS: We can do that after the jury leaves.
THE COURT: You wish to remain in session?
MR. KOTTMEIER: No, your Honor.
4624
THE COURT: Okay. I will give you the rest of the week
5 off. I am working and they're working and so you are not all
6 off. We don't choose Friday for our golf matches.
7 Remember the admonition, don't talk about the case
8 with any person or let anybody discuss it with you, or express
9 or form any opinion on the matter until it is finally submitted
10 to you.
11 We appreciate your promptness in being here at all
12 times, ladies and gentlemen. Have a nice weekend. See you next
13 Monday at 9:30.
14 (The Jury retires from the courtroom.)
15
16
17
18
19
20
21
22
23
24
25
26
27
THE COURT: You wish to be heard on that further, Mr.
Negus?
MR. NEGUS: Can I wait until I read it in the transcript
and come back, if I want to be heard further, and talk to you
about it on Monday morning before we start?
THE COURT: Sure. Mr. Kottmeier, something on the
exhibits?
MR. KOTTMEIER: Yes, your Honor. All I want to do was to
have noted on the record the exhibits that I was requesting to
be released temporarily.
THE COURT: Have you discussed it with counsel?
MR. KOTTMEIER: Yes. I apologize, these aren't in
28 exactly the right order,
COMPUTERIZED TRANSCRIPT
',-, U , , ,-, o :I l.
" l.'
3
,Y"---"
1 , " ... 2
3
" 5
6
7
8
9
10
11
12
13
14
~ 15 -..-/
16
17
18
19
20
21
22
23
24
25
26
27
28
4625
THE COURT: That's all right. Take your time.
MR. KOTTMEIER: I have requested Exhibit 160, which is
the paper bag with the Star Trek towel. Exhibit 173, and that
is a sixteen by twenty photograph. And then the following are 7
eight by ten photographs: 181, 182, 187, 194, 197, 199, 200.
And the remainder are three by five photographs: 207, 214, 233,
242, 246, 251, 255 and 461.
All of these are just general pictures of the
exterior of the scene. We have duplicates in our files, both
sides do in the case. There is no problem.
THE COURT: All right. So you wish to remove those from
the possession of the clerk and to keep them in your possession
to return them next Monday morning?
MR. KOTTMEIER: Yes, your Honor.
THE COURT: Any objection?
MR. NEGUS: No, that is fine with me.
THE COURT: All right. The clerk will mark them out, Mr.
Kottmeier, and check them back in next week.
Anything further?
MR. KOTTMEIER: No, your Honor.
MR. NEGUS: Thank you.
THE COURT: Al~ right. Have a nice nice weekend.
(Adjournment.)
COMPUTERIZED TRANSCRIPT
'-~, o :J L
" u '-I